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Chapter 1 
General introduction, aim and outline 
 
1.1 General introduction 
The principle of self-healing has been around since the beginning of time. Living 
organisms, such as the human body, survive for prolonged periods of time due to their built-in 
capability to recover from damage, such as bone fractures or muscle ruptures. Mostly, this 
damage management
1
 even happens without any human intervention, while in some cases a 
little help is required to increase the rate of recovery, eg. by applying supports or braces. 
In contrast, damage prevention is the main drive in the development of engineered 
materials.
1, 2
 In order to postpone the inevitable damage event that will occur during their 
lifetime, engineered materials are increasingly reinforced and often overdesigned for their 
specific task. This unfortunately leads to excessive material usage during manufacturing, 
while inspection and maintenance of the final product are still required on a regular basis. 
These issues can be avoided by designing a material that can manage damage events by 
restoring its original properties via a built-in repair mechanism. Furthermore, this results in a 
more reliable material with a longer lifetime
1, 3, 4
 and a material that is also capable of 
repairing invisible, internal damage
4, 5
. Some engineered materials already demonstrate such 
self-healing capabilities. Roman aquaducts and other ancient structures stood the test of time, 
not because of the superior mechanical properties of the mortar that was applied, but because 
the lime cement can partially dissolve in moisture from the air and precipitate again in formed 
microcracks.
1
 A second example is the corrosion resistance of aluminium or stainless steel 
objects, which is caused by the formation of an oxidized layer at the surface preventing 
further damage by moisture. 
In engineered materials, self-healing can be achieved either by the material itself 
through its chemical nature (intrinsic) or by adding supplementary healing agents to the 
material to be healed (extrinsic).
5
 Intrinsic self-healing concepts on the one hand are based on 
the use of reversible physical or chemical bonds and are mostly applied in thermoplastic 
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polymer materials because these systems possess sufficient molecular mobility.
5, 6
 A 
thermosetting class of materials – worth mentioning here – are the vitrimers, which are 
thermosetting polymers with thermoplastic and intrinsic self-healing properties.
7
 Extrinsic 
self-healing concepts on the other hand are generally applied in thermosetting polymer 
materials and make use of phase-separation
8
 or different kinds of containers – microcapsules9, 
microvascular channels
10
 or hollow glass fibers
11
 – for the addition of the healing agents. 
Moreover, this self-healing can either happen in a fully autonomous fashion or require an 
external stimulus such as heat or UV-light to start or speed up the recovery process. When 
such a stimulus is needed, the materials are referred to as non-autonomous and remendable. 
For example, heat is often required in intrinsic self-healing systems.
5, 12
 
In this work, an autonomous extrinsic dual microcapsule approach will be used 
(Figure 1.1). In this concept, a two-compound liquid glue is incorporated in microsized 
containers and as such embedded in a solid matrix material.  
 
 
 
Figure 1.1. The concept of dual microcapsule self-healing. Top: a crack ruptures the microcapsules 
containing a liquid healing agent; center: the healing agents fill the crack because of capillary forces; 
bottom: the healing agents react with each other to form a solid polymer network and glue both crack 
surfaces back together. 
 
A three-step mechanism is responsible for the self-healing process: 1) fracture of the 
microcapsules, 2) filling of the crack with liquid healing agents and 3) solidification of the 
reactive mixture. 
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In the first step, the microcapsules containing the two liquid glue compounds are 
ruptured when a crack is propagating through the matrix material. It is crucial that the 
containers are broken, otherwise no self-healing action is possible. Therefore, the 
microcapsules need a shell that is strong enough to survive the matrix processing conditions, 
but brittle enough to break when matrix fracturing occurs. Providing sufficient adhesion 
between the microcapsule shell and the surrounding thermosetting material is also crucial to 
avoid debonding of the microcapsules. 
Secondly, the liquid healing agents flow into the damaged area because of capillary 
forces, filling the crack and emptying the microcapsules. Since the crack volume is smaller in 
the direction of the crack tip and consequently the capillary forces are larger, flow will most 
likely occur in that direction. If flow of the healing agents does not occur due to a very high 
viscosity or insufficient interaction with and wetting of the matrix material, the two reactive 
compounds will not mix and react with each other, thus also preventing any self-healing 
event. 
Finally, the liquid healing agents react with each other, forming a solid polymer 
network that adheres both crack surfaces back together and prevents the crack from 
propagating further. In this step, it is important to form a sufficiently strong healed network to 
prevent fracturing from happening on the same spot. Furthermore, it has to be noted that small 
voids are left behind in the material, as the microcapsules have released their content. 
Although this has a potential negative effect on the mechanical properties of the material, the 
most significant damage (the crack) has been healed. The relative recovery of (mechanical) 
properties is denoted as the healing efficiency. 
 
1.2 Aim 
In spite of the very broad range of methods and chemistries used in polymers and 
composites
13, 14
, only a limited part has found its way to industrial applications. In the case of 
autonomous extrinsic self-healing materials, an extensive range of chemical strategies with 
varying performances has been investigated. While recognizing that multiple self-healing 
systems reach very high healing efficiencies (>90%) at room temperature
15-20
, are able to 
demonstrate an increased fatigue lifetime
21-24
 and are used in industrially interesting fiber-
reinforced polymer composites
25-28
, we also notice potential issues that might explain the 
industrial restraint. These mainly include the usage of expensive compounds, a low stability 
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of the healing system at higher temperatures or ambient conditions, the toxicity of the used 
chemicals or too slow healing for crack propagation to be arrested. 
The aim of this research project is to develop autonomous extrinsic self-healing 
systems with a greater stability and faster kinetics than the existing concepts. Furthermore, 
additional industrial demands such as toxicity, upscalability and cost are also considered. This 
is done by focussing on chemistries that are readily accessible, that react rapidly at room 
temperature and that can withstand environmental conditions such as the presence of moisture 
or air, which might otherwise hamper the self-healing process via side-reactions. This also 
includes a stability requirement at elevated temperatures up to 180 °C – which is the curing 
temperature for some high-end epoxy composite applications – in order to avoid degradation 
or evaporation of the healing agents. This respectively would lead to a loss of reactivity or to 
preliminary fracturing of the microcapsules due to an internal pressure build-up. If all these 
requirements are met, the system is expected to be more industrially feasible than the existing 
concepts. 
The research is performed in close collaboration with other research groups at the 
UGent and VUB, as well as with industrial partners within the Strategic Initiative Materials 
(SIM) in Flanders. This platform enables us to fully analyze and characterize our self-healing 
systems from start to finish. 
 
1.3 Outline 
This Ph.D. manuscript consists of 4 major parts: state of the art (Chapter 2), the 
evaluation of chemistries for self-healing with manual injection (Chapter 3 and 4), the 
encapsulation of healing agents (Chapter 5) and the generation of autonomous extrinsic self-
healing materials (Chapter 6). Several chemistries are first screened for their healing potential 
and compatibility with the requirements, after which the best performing healing agents are 
encapsulated in microcapsules and tested in thermosetting materials. 
Chapter 2 aims at guiding both new and established researchers in the field of self-
healing by providing a clear overview of the most important chemistries used in autonomous 
extrinsic systems until today, together with their healing potential for different matrix 
materials and types of mechanical damage. A range of recent developments is discussed with 
indication of their strengths and weaknesses. An attempt is also made to demonstrate the 
Chapter 1 – General introduction, aim and outline 
 
5 
 
research opportunities that are still available for each described system and to find the areas 
that require further elaboration. 
In Chapter 3, a thiol-isocyanate chemistry is screened for the development of extrinsic 
self-healing epoxy materials. Firstly, it is possible to select multiple thiol and isocyanate 
healing agents that are thermally stable under industrially used epoxy curing conditions, have 
a low toxicity and still demonstrate sufficient adhesive bonding of two epoxy plates. 
Secondly, it is shown that the amine groups present in the epoxy matrix both serve as a 
catalyst for the addition reaction between a thiol and an isocyanate and as a way to covalently 
link the healed network structure to the surrounding thermoset. The tapered double cantilever 
beam (TDCB) geometry is used for evaluating the recovery of the fracture toughness at room 
temperature after different healing times. The effect of temperature and use of other matrices 
(vinyl ester and unsaturated polyester) is also investigated, demonstrating a catalytic effect by 
the cobalt initiator. 
In Chapter 4, maleimide chemistry involving amines and thiols is evaluated for the 
design of extrinsic self-healing epoxy materials. Model reactions show that amines react 
rapidly with maleimide compounds at room temperature via the Michael addition reaction. 
Moreover, thiols and maleimides react readily in the presence of tertiary amines that are 
available in the epoxy material. The solubility of both commercial aromatic and synthesized 
aliphatic maleimides is investigated, as well as their self-healing potential. Healing 
efficiencies and the solvent effect are evaluated using the TDCB test method with manual 
injection of the healing agents.  
Chapter 5 reports the microencapsulation procedures developed in our group. The 
encapsulation of a tetrafunctional thiol and different maleimides is performed using a 
polycondensation reaction of melamine-formaldehyde, while the isocyanate is embedded in 
polyurea microcapsules that are formed via an interfacial reaction of aromatic isocyanates and 
amines. The core content, size and shell morphology of the microcapsules was evaluated, 
showing large differences for the two methods. The polyurea shell is also modified with 
different hydrophobic agents to lower the water permeability. 
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In Chapter 6, autonomous extrinsic self-healing epoxy materials are generated using 
the dual microcapsule strategy with thiol-isocyanate and thiol-maleimide chemistries, new to 
the field of self-healing. The TDCB geometry is again used for evaluating the recovery of the 
fracture toughness at room temperature after 5 days. The spatial distribution and the fracture 
behavior of the microcapsules is also investigated, as well as the flow of the healing agents 
into the crack. Furthermore, parameters such as the microcapsule loading and core content are 
evaluated for the thiol-isocyanate combination, while the influence of the microcapsule ratio 
and solvent effect is checked for the thiol-maleimide chemistry. Finally, a first attempt to 
generate a glass fiber-reinforced polymer composite has been made. 
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Abstract 
This chapter aims at guiding both new and established researchers in the field of self-
healing by providing a clear overview of the fourteen most important chemistries used in 
autonomous extrinsic systems until today, together with their healing potential for different 
matrix materials and types of mechanical damage. The described self-healing systems require 
no manual intervention or external stimulus for the self-healing event to take place 
(autonomous) and utilize added healing agents to repair the damage (extrinsic). A range of 
recent developments is discussed with indication of their strengths and weaknesses. An 
attempt is also made to demonstrate the research opportunities that are still available for each 
described system and to find the areas that require further elaboration. As such, this chapter 
can help to point the reader in the directions these self-healing materials could follow in the 
future. 
 
This chapter is also published as a review: X. K. D. Hillewaere, F. E. Du Prez. Fifteen Chemistries for 
Autonomous External Self-Healing Polymers and Composites. Progress in Polymer Science, 2015.  
DOI: 10.1016/j.progpolymsci.2015.04.004.  
An overview of chemical strategies is also published in: S. Billiet, X. K. D. Hillewaere, R. F. A. Teixeira,  
F. E. Du Prez. Chemistry of Crosslinking Processes for Self-Healing Polymers. Macromolecular Rapid 
Communications, 2013, 34 (4), 290. 
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Chapter 2 
State of the art in autonomous extrinsic self-healing 
polymers and composites 
 
2.1 Introduction 
Nowadays, the field of self-healing is growing quite fast, encompassing a whole range 
of self-healing polymer systems. Inspired by nature, researchers develop engineered materials 
with an even further extended lifetime by auto-repairing the inevitable damage event that 
occurs during its use. This research topic now deals with various aspects of bulk 
thermoplastic and thermoset polymers, fiber-reinforced polymer composites, coatings and 
many more material types
1-22
 in which the benefits of a self-healing feature would outweigh 
the costs. 
Two important subdivisions are made in the framework of this chapter. Self-healing 
polymer systems can either be fully autonomous in their recovery of material properties or, on 
the other hand, require a stimulus such as heat or UV-light to initiate the recovery process. 
We opted for a discussion on the fully autonomous self-healing systems only and refer to the 
other systems as non-autonomous, remendable materials. Within this large field of 
autonomous materials, we then further consider two categories, namely extrinsic and intrinsic 
self-healing materials, where the material is given its self-healing capabilities respectively by 
adding supplementary healing agents in any kind of container (capsules, vascular network, 
etc.) or by its own chemical nature. The terms extrinsic and intrinsic, first proposed by Yuan 
et al.
3
 and later on taken over by many other groups worldwide
13-17
, should in this case not be 
confused with extrinsic and intrinsic physical properties of a material that are respectively 
dependent or independent on the amount of material present. 
Thus, we will only focus on autonomous, extrinsic self-healing polymer systems in 
this chapter, while redirecting the reader to other reviews for intrinsic self-healing concepts.
19, 
20
 Furthermore, we only focus on self-healing of mechanical properties and not on the 
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recovery of other material functions such as corrosion protection or conductivity. This 
“functional” self-healing has recently been discussed elsewhere.11, 16, 18 
The main goal of this chapter is to provide the reader with a distinct overview of the 
self-healing chemistries applied in autonomous extrinsic materials and provide unexplored 
research routes. As can be seen in Table 2.1, fourteen different self-healing chemistries have 
been defined and will be further explained in this chapter with their opportunities and 
limitations, for different types of damage (eg. quasi-static or fatigue damage) and for different 
materials. Four aspects of each self-healing chemistry are highlighted in the overview table: 
1) which matrix materials have been self-healed, 2) if there is a catalyst required, 3) what kind 
of damage has been repaired and 4) what is the reported efficiency of each system.  
Using Table 2.1 as a guide, the reader is redirected to the correct references and should 
immediately have an idea about how well a system performs for a specific matrix material in 
the case of quasi-static fracture damage (four columns on the left). The color legend is 
explained in the table caption. To our knowledge, each row contains all references in open 
literature until October 2014 for a specific self-healing chemistry. The four columns on the 
right indicate if there is a catalyst required and separate the relevant impact and fatigue 
damage tests from other fracturing modes. References concerning quasi-static fracture self-
healing in fiber-reinforced composites are also shown separately in the last column. 
For example, if the reader is interested in fatigue self-healing of epoxy materials, three 
potential chemistries emerge from the table as the most suitable option, indicated in green in 
the fatigue column (DCPD, amine-epoxy and thiol-epoxy). From the obtained references, 
reference 57 is then excluded because it deals with an acrylate matrix as found in the left 
section. 
In this chapter, every chemistry is divided in six subsections, unless no information on 
a specific topic was available. The “healing chemistry” section indicates the healing agents 
used, as well as the advantages and restrictions of the specific chemical concept. The “bulk 
epoxy” section describes the best self-healing results obtained for quasi-static fracture of bulk 
epoxy material. A similar description is given for other matrices in the “bulk matrices other 
than epoxy” section. The “impact” and “fatigue damage” sections respectively discuss the 
recovery from impact and fatigue damage in any matrix material, whether fiber-reinforcement 
is present or not. And finally, the “fiber-reinforced composites” section outlines the recovery 
of quasi-static fracture damage in glass- or carbon-fiber reinforced composites. 
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Table 2.1. Overview of extrinsic self-healing systems. Maximal healing efficiencies higher than 80%, from 
50-80% and from 0-50% are indicated in respectively green, orange and red. Blanks indicate that no self-
healing efficiency was given. In impact testing, sealing only was not taken into account to calculate the 
healing efficiency for the sake of comparison. In fatigue testing, only the fatigue life extension was taken 
into account and indicated in green if total crack arrest occurred. Any self-healing system that has not 
been impact/fatigue tested, was only analyzed in tensile, bending or mode I, II or III fracturing tests. 
Indentation or puncture damage is added to the impact column. Wear damage is added to the fatigue 
column. 
 
 Matrix Epoxy Epoxy 
vinyl 
ester 
Acrylates Other * Catalyst 
required 
Impact 
tested 
Fatigue 
tested 
Fiber-
reinforced 
composites Healing agent 
DCPD/ENB 23-54 55 56, 57 58 X 48, 49 43-47, 57 48-54 
Siloxanes 59 60  61-63 X 62 63  
Epoxy 64-75    X 69, 72  69-75 
Amine-epoxy 76-98   99-101  89-101 87 88-101 
Thiol-epoxy 102-108    X 105 106-108 105 
Thiol-ene   109, 110  X    
Azide-alkyne    111 X    
Acylhydrazine/ 
methacrylates 
112    X 112   
GMA 113        
Maleimides 114-116       116 
Isocyanates 117, 118   119   117, 118  
Cyanoacrylates 89, 90   120  89, 90  89, 90 
Vinyl ester 121 121   X 121  121 
Unsat. polyester 122    X 122  122 
*Other matrices consist of PS-PBD-PS, PDMS, poly(methacrylimide), poly(isobutylene), poly(isocyanurate) or 
unsaturated polyester respectively from top to bottom. 
 
2.2 Dicyclopentadiene/5-ethylidene-2-norbornene-based healing system 
The self-healing chemistry based on the ring-opening metathesis polymerization 
(ROMP) of dicyclopentadiene (DCPD) and 5-ethylidene-2-norbornene (ENB) (Scheme 2.1) 
is, judged by the number of publications, the most extensively investigated one. In what 
follows, both the great potential of this healing chemistry but also the drawbacks, mainly 
concerning the catalyst required, will be highlighted. Furthermore, the self-healing of 
different matrix materials and forms of damage is discussed. 
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2.2.1 DCPD/ENB healing chemistry 
The original concept using microcapsules in a thermosetting matrix to deliver liquid 
healing agents to a location of damage, was proposed by White et al. in 2001.
23
 Liquid endo-
DCPD and 1
st
 generation Grubbs’ catalyst (Scheme 2.1a) particles were introduced into an 
epoxy matrix to generate a self-healing material. Therefore, the liquid endo-DCPD monomer 
had to be incorporated in microcapsules prepared via a urea-formaldehyde (UF) 
polycondensation.
123
 When the epoxy material ruptures, these microcapsules break and 
release the liquid DCPD into the crack, where it comes into contact with the dispersed 
Grubbs’ catalyst and undergoes ring-opening metathesis polymerization (ROMP, Scheme 
2.1a). This multifunctional monomer thus forms a crosslinked network that adheres the epoxy 
crack surfaces back together.  
 
 
 
Scheme 2.1. (a) Ruthenium-based Grubbs' catalyst initiates ring-opening metathesis polymerization 
(ROMP) of endo-dicyclopentadiene (endo-DCPD)
23
; (b) Alternative healing agents and 2
nd
 generation 
Grubbs’ catalyst. 
 
The mechanism of this ROMP process has been described in publications comparing 
different monomers (endo- and exo-DCPD)
124
 and multiple Grubbs’ catalysts (1st, 2nd and 
Hoveyda-Grubbs’ 2nd generation).31 
In the monomer study, the exo-DCPD monomer (Scheme 2.1b) displayed an initial 
ROMP rate about 20 times faster than the endo-isomer due to steric reasons.
124
 Faster kinetics 
could lead to a lower catalyst loading requirement and could also be useful in fatigue testing 
where fast crack growth inhibition is needed. Nevertheless, most fatigue concepts discussed in 
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Subsection 2.2.5 applied endo-DCPD, presumably because exo-DCPD is not commercially 
available
125
 and the self-healing performance in quasi-static fracture tests was worse than 
when using endo-DCPD
29
. At low temperatures (0-4 °C) however, these fast reaction kinetics 
were beneficial for the self-healing process.
29
 
5-Ethylidene-2-norbornene (ENB, Scheme 2.1b) was also screened as a potential 
alternative for DCPD. ENB has an even higher ROMP reactivity than both DCPD isomers
125
, 
which could be used to finetune the reaction kinetics of the self-healing system. Mixtures of 
endo-DCPD and ENB were also suggested as suitable healing agents
126, 127
, but were not used 
in self-healing applications so far. More recently, ENB as such was embedded in 
nanocapsules comprising a polyurea-formaldehyde (UF) outer shell and an ethylene maleic 
anhydride (EMA) copolymer inner shell for use in self-healing epoxy matrices.
38-40
 
When comparing the 1
st
 and 2
nd
 generation Grubbs’ and the 2nd generation Hoveyda-
Grubbs’ catalysts31, the authors selected the 2nd generation Grubbs’ catalyst (Scheme 2.1b) as 
the most suitable for high-temperature (> 120 °C) self-healing applications as a result of its 
thermal stability and intermediate kinetics. The 2
nd
 generation Grubbs’ catalyst showed faster 
ROMP rates in solution compared to the 1
st
 generation catalyst, but this was not the case in 
bulk monomers. Consequently, no improved self-healing performance was noticed at room 
temperature. The 2
nd
 generation Hoveyda-Grubbs’ catalyst is thermally more stable, even up 
to 180 °C
128
, but unfortunately demonstrated too fast bulk reaction rates, which would inhibit 
a proper distribution of the healing agent in the crack due to preliminary polymerization. On 
the other hand, the 1
st
 generation Hoveyda-Grubbs’ catalyst, which was not included in this 
comparison, has been successfully applied in epoxy matrices in combination with ENB 
nanocapsules
38-40
, yielding very good self-healing results (see Subsection 2.2.2). 
The use of a Grubbs’ catalyst also has some other issues. It is for instance difficult to 
nicely disperse the catalyst particles in the epoxy material, resulting in the formation of large 
agglomerates. As a consequence, a sufficiently high loading is required to ensure that at least 
one particle is present in the crack path. One approach to solve this problem is to change the 
crystal morphology of the catalyst.
27
 Recrystallisation resulted in smaller crystals that are 
more rapidly dissolved in the epoxy and as such yield a better dispersion. Unfortunately, these 
smaller particles are also more susceptible to deactivation by the amine hardener used in 
epoxy resins. In fact, part of the catalyst reacts with the amine, resulting in loss of its catalytic 
ability. Nevertheless, better self-healing was obtained with the recrystallized Grubbs’ catalyst. 
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As an alternative, Rule et al. researched paraffin wax protection to more easily 
disperse the catalyst in the epoxy matrix and to shield the Grubbs’ catalyst from deactivation 
by the amine hardener at the same time.
26
 When the Grubbs’ catalyst was embedded in 
paraffin wax microspheres and used in a kinetic study, 69% of the reaction rate was retained 
after contact with an amine hardener, compared to full loss of reactivity in the unprotected 
case. Furthermore, this wax protection only reduced the reaction rate by 9% in comparison to 
fresh Grubbs’ catalyst. It also helped in dispersing the catalyst, leading to a much lower 
catalyst amount required for self-healing, as indicated in Subsection 2.2.2. A patent has also 
been filed for this protection method.
34
 In a more recent paper, the Grubbs’ catalyst was 
incorporated in silica-coated polystyrene particles for protection, with preliminary results 
demonstrating only modest self-healing.
41
 
In order to avoid the issues encountered with the Grubbs’ catalyst, the cheaper and 
more stable WCl6 catalyst, in combination with phenylacetylene as a co-activator, was also 
tried for the ROMP of exo-DCPD.
30
 Unfortunately, only a limited self-healing capability was 
observed in this case, which is therefore not further discussed. 
In conclusion of this section, it can be stated that the wax-protected 1
st
 generation 
Grubbs’ catalyst in combination with endo-DCPD as the healing agent displayed the best self-
healing behavior for most applications so far. 
 
2.2.2 DCPD/ENB healing of quasi-static fracture damage in bulk epoxy 
Using an epoxy tapered double cantilever beam (TDCB) geometry
129
, with 2.5 wt% of 
Grubbs’ catalyst and 10 wt% of endo-DCPD UF-microcapsules, an average fracture 
toughness (KIC) recovery of 60% compared to the original epoxy was measured after a 
healing time of 2 days.
23
 Furthermore, this healing efficiency was already obtained after 10 
hours.
24
 Improved fracture toughness recoveries over 90% were obtained after optimization of 
the concentration and size of both the catalyst particles and DCPD microcapsules.
24, 25
 With 
2.5 wt% of catalyst and 5 wt% of 180 µm sized DCPD capsules, the highest recovery could 
be obtained. Addition of the microcapsules also increased the KIC of the original epoxy by 
127% due to increased hackle markings and subsurface microcracking
25
. 
By embedding the Grubbs’ catalyst in wax microspheres, the catalyst loading required 
to obtain similar high recoveries can be drastically reduced.
26
 Indeed, only 5 wt% of wax 
microspheres containing 15 wt% of Grubbs’ catalyst (0.75 wt% Grubbs’ catalyst loading in 
total) was sufficient to obtain 93% healing efficiency when the same 10 wt% endo-DCPD 
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microcapsule loading was used. Even at a total Grubbs’ catalyst loading of only 0.25 wt%, a 
recovery over 70% was achieved. 
When ENB was used as healing agent in combination with the 1
st
 generation 
Hoveyda-Grubbs’ catalyst, even higher healing efficiencies could be obtained.38-40 Using a 
TDCB geometry, the fracture toughness recovery of a self-healing epoxy material was 
determined. With 5 wt% of the 1
st
 generation Hoveyda-Grubbs’ catalyst and either 10 or 20 
wt% of 760 nm sized UF/EMA-nanocapsules containing ENB, respectively 97% and 123% of 
the KIC could be recovered. Furthermore, the epoxy matrices used in this concept were cured 
at high temperatures (170 or 180 °C) after a lower temperature pre-cure cycle. This self-
healing system has also been patented.
42
 
Other ways than microencapsulation to deliver the liquid DCPD to the crack were also 
heavily explored. An overview of the delivery systems for all chemistries is given in Table 
2.2. Since delivery methods are not the focus of this chapter, the use of DCPD-containing 
microvascular systems is only discussed for one report in which promising results have been 
obtained. Using a direct-write assembly of fugitive inks, Toohey et al. introduced a 3D 
vascular network of microchannels (200 µm in diameter) in a ductile epoxy substrate 
underneath a brittle epoxy coating that contained up to 10 wt% of unprotected Grubbs’ 
catalyst.
35, 36
 Using four-point bending tests, multiple consecutive damage events (up to 7 
cycles) could be healed up to approximately 60% recovery of the load to failure, when a 12 h 
healing time at room temperature was allowed in between cycles.  
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Table 2.2. Overview of delivery systems per self-healing chemistry. Double crosses indicate that the 
delivery system was (also) used in fiber-reinforced composites. For the microcapsules, the used shell 
materials are also indicated (in between brackets). 
 
 Delivery system Micro- 
capsules
a
 
Hollow glass 
fibers 
Microvascular 
channels 
Other
b
 
Healing agent 
Diclopentadiene 
(DCPD)/ENB 
XX (UF)  X XX 
Siloxanes X (UF/PU)   X 
Epoxy XX (UF)   X 
Amine-epoxy X (UF) XX XX X 
Thiol-epoxy XX (MF)    
Thiol-ene X (UF)    
Azide-alkyne X (UF)    
Acylhydrazine/ 
methacrylates 
  X  
GMA X (MF)    
Maleimides X (UF)    
Isocyanates X (PUR)  X  
Cyanoacrylates  X XX  
Vinyl ester  XX   
Unsaturated polyester  XX   
a  
UF = urea-formaldehyde, PU = polyurethane, MF = melamine-formaldehyde, PUR = 
polyurea. 
b 
Other delivery systems consist of electrospun core-shell nanofibers, phase-separated 
droplets, plant fibers and etched glass bubbles, respectively from top to bottom. 
 
2.2.3 DCPD/ENB healing of quasi-static fracture damage in bulk matrices other than 
epoxy 
Apart from variations in the epoxy resins and the applied hardeners, other 
commercially available polymer matrices have been applied as well. For example, thermosets 
and thermoplastic materials, produced via radical polymerization, were tested and 
demonstrated varying self-healing performances.  
Wilson et al. used an epoxy vinyl ester resin, which is an epoxy resin modified with an 
unsaturated monocarboxylic acid and cured with radical initiators. In this case, a bisphenol A 
based epoxy resin was reacted with methacrylic acid and cured at room temperature with a 
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benzoyl peroxide and dimethylaniline initiation system.
55
 The 1
st
 generation Grubbs’ catalyst 
was again embedded in wax to prevent reaction with the matrix curing chemistry, since the 
free radicals have a detrimental effect on the catalyst. The wax microspheres of about 100, 50 
and 30 µm in diameter, containing 10 wt% of catalyst, preserved respectively 97, 90 and 88% 
of the catalyst activity in combination with the epoxy vinyl ester matrix. As a healing agent, 
the authors opted for the kinetically faster exo-DCPD encapsulated in UF-microcapsules. The 
best self-healing results were obtained with 15 wt% of 250 µm sized exo-DCPD 
microcapsules – relatively large for increased healing agent delivery – and 15 wt% of 53 µm 
sized wax microspheres. Using a TDCB tensile test, the self-healing material showed a 
recovery of 30% of the peak fracture load after 2 days of healing at room temperature. 
Biggs et al. combined the DCPD-Grubbs’ catalyst self-healing system with 
poly(methyl methacrylate) (PMMA) bone cement for anchoring joint replacements.
56
 This 
bone cement is made by mixing cement powder (PMMA-styrene copolymer, prepolymerized 
PMMA, initiator) with a liquid methyl methacrylate monomer mixture (also contains 
inhibitor). 2 wt% of 226 µm sized endo-DCPD UF-microcapsules and 0.25 wt% of 1
st
 
generation Grubbs’ catalyst particles were blended with the cement powder. Using CT 
specimens to measure fracture toughness, they obtained 80% healing efficiency after 2 days 
of healing at room temperature. Although these results were very promising, the authors did 
state that the biocompatibility of the DCPD and Grubbs’ catalyst must be further analyzed, 
prior to the use in bone cement. Fatigue fracture tests were also performed on CT samples 
with different compositions.
57
 These results are further discussed in Subsection 2.2.5. 
As a third example of non-epoxy matrices, polystyrene-b-polybutadiene-b-polystyrene 
(PS-PBD-PS) was tested by Chipara et al.
58
 This triblock copolymer was mixed with 5 wt% 
of UF-microcapsules containing DCPD and 1 wt% of Grubbs’ catalyst by dissolving the  
PS-PBD-PS in toluene, a solvent that is not swelling the microcapsules nor deactivating the 
Grubbs’ catalyst. The solution is then used for spin coating a thin polymer film (0.75 mm) at 
spinning rates below 500 rpm. Rectangular samples were cut from the film and stretched until 
break. While a set of control samples containing only capsules and no catalyst broke at a 
strain of 1500% and a tensile strength of 4 MPa, the capsule containing samples broke at 
1650% strain and 6.5 MPa stress (an average increase of 10 and 60% for the strain and stress 
respectively). During the test, the microcapsules were elongated along the stretching direction 
and eventually broken. Based on these results, the authors state that crack propagation is not 
the only way to trigger self-healing with microcapsules. The increase in strain is explained by 
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a lubricating effect of either the liquid DCPD monomer or the formed low molecular weight 
polyDCPD. The significant increase in ultimate stress could suggest a self-healing effect, but 
further studies are required to fully correlate this self-healing to the observations. Although 
both 1
st
 and 2
nd
 generation Grubbs’ catalysts have been used and several sizes of  
UF-microcapsules (90, 120 and 225 µm) have been synthesized, no description about the best 
catalyst or capsules has been reported. 
As evidenced by the above results, the quasi-static fracture recovery by the 
DCPD/Grubbs’ self-healing chemistry varies tremendously from one material to another. Wax 
protection of the catalyst is required in certain matrix materials, since the curing chemistry 
could deactivate the catalyst. 
 
2.2.4 DCPD/ENB healing of impact damage 
Impact damage is one of the most common forms of damage that all materials can 
encounter. In fiber-reinforced composites, high-velocity impacts cause the material to fracture 
and delaminate. These defects can then grow due to further (fatigue) loading, eventually 
leading to complete failure. 
Patel et al. studied the self-healing of impact damage in S2-glass fiber-reinforced 
epoxy composites.
48
 4 mm thick panels with 4 plies of plain woven S2-glass fabric (33 vol%) 
were generated using a hand lay-up process, applying an epoxy resin that contains 7.4 wt% of 
endo-DCPD UF-microcapsules and 2.3 wt% of wax microspheres with 10 wt% Grubbs’ 
catalyst. Both small and large microcapsules (35 and 125 µm) were used, respectively to 
ensure even distribution in the composite, including less accessible areas, and to supply a 
sufficient amount of healing agent to the crack.  Low-velocity impact tests were then 
performed with impact energies ranging from 18 to 45 joules. The impact damage crack 
length was quantified using a UV-fluorescent dye to visualize delamination and matrix 
cracking. Compression after impact (CAI) was performed to determine the residual 
compressive strength (RCS), which in turn was used to define the degree of recovery due to 
self-healing. Based on the crack length, addition of the UF-microcapsules to the composite is 
not significantly changing the impact damage resistance. However, the wax microspheres are 
shown to have a detrimental effect on the fracture resistance, probably due to a reduction in 
interlaminar shear properties, plasticization of the matrix or because they could act as voids. 
Nevertheless, in the 45 J energy impact tests, the self-healing samples showed a 50% 
reduction in total crack length compared to the original sample, after 2 days of healing at 
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room temperature without any applied pressure. This indicates good filling of the damage area 
with healed material. Furthermore, CAI measurements showed a 97 and 68% recovery of the 
RCS compared to undamaged panels, for the samples impacted at 18 J and 45 J respectively. 
The panels impacted with the highest energy have lower RCS recoveries because the damage 
volume is not completely filled. When a 1077 kPa lateral pressure was applied to these 
composite panels, the RCS recovery increased to 78% due to the reduction in the damage 
volume. It is worth noting here that the in-plane compressive strength of the undamaged 
composite is not significantly influenced by the presence of both UF-microcapsules and wax 
microspheres. 
The cheaper, but mechanically weaker E-glass fiber-reinforced epoxy composites 
were investigated by Moll et al.
49
 In their research, the authors focused on sealing off the 
damage in these composites, which are used for tanks to store liquid oxygen or hydrogen. 
Panels with 4 plies of plain woven E-glass fabric (36 vol%) were made via a hand lay-up 
process, using an epoxy resin with varying amounts of DPCD UF-microcapsules while 
keeping the concentration of wax microspheres containing the Grubbs’ catalyst constant  
(2.6 wt%). Samples were damaged by repeated indentation at a load of 410 N (10 times on 
each side of the sample). Afterwards, the panels were allowed to heal overnight at 30 °C. 
Pressurized nitrogen gas was then applied to one side of the sample and the output pressure 
was monitored on the other side. Sealing results up to 82% were obtained with 6.5 wt% of  
51 µm sized microcapsules. When a lower indentation load of 380 N was applied, the sealing 
efficiency even increased to 100%, thus demonstrating full sealing. Lower amounts of 
microcapsules or smaller capsule diameters (18 µm) rendered lower sealing percentages, 
indicating that the healing agent volume delivered to the crack is crucial.  
From these completely different self-healing objectives, two intermediate conclusions 
can be drawn. Firstly, refilling impact damage with healed material seems to work very 
efficiently in both reported cases and secondly, good recovery of mechanical properties is 
feasible at low-end impact energies. 
 
2.2.5 DCPD/ENB healing of fatigue damage 
Of similar importance to impact damage, fatigue damage is caused when thermosets 
and composite materials are subjected to repeated cycles of low loading, often far below their 
critical fracture load. Epoxy thermosets – EPON 828 resin and diethylenetriamine (DETA) 
hardener – have been tested by both Brown and Jones for their resistance against fatigue 
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damage. Brown et al. indicated that retardation of fatigue crack growth is caused by crack-tip 
shielding mechanisms, such as viscous flow of the healing agent (resisting the motion of the 
crack faces due to hydrodynamic pressure) and crack closure by the polymerized healing 
agent.
43, 44
 At higher loading, toughening of the epoxy due to the presence of microcapsules 
also played a role.
45
 As indicated earlier, the presence of liquid-filled microcapsules improved 
the fracture toughness of the epoxy thermoset by 127%.  
A TDCB geometry containing 20 wt% of 180 µm sized DCPD UF-microcapsules and 
2.5 wt% 1
st
 generation Grubbs’ catalyst, was used for fatigue testing with a varying mode I 
stress intensity factor range ∆KI = Kmax – Kmin. Crack lengths were measured optically and by 
sample compliance. Fatigue healing efficiency was then calculated by using the fatigue life 
extension based on the number of cycles. Both low-cycle and high-cycle fatigue tests – the 
number of cycles is respectively lower or higher than 10,000 – have been performed on the 
TDCB samples. Under low-cycle fatigue conditions, the mode I stress intensity factor range 
∆KI approaches the fracture toughness KIC, causing rapid crack growth. In this case, crack 
propagation in the self-healing samples proceeded as fast as in the control samples, because 
there was no time for the ROMP process to proceed. However, when a resting period of 10 
hours at room temperature and under load at the maximal stress intensity factor (Kmax) was 
introduced after partial crack growth, a polyDCPD wedge was formed in the crack (Figure 
2.1), effectively closing the crack and extending the fatigue life by about 70 to 120% 
(approximately times 2). This fatigue life extension did not occur when the sample was 
unloaded during the rest period. 
 
 
 
Figure 2.1. The formation of a polyDCPD wedge in the crack.
44
 Reproduced from Brown, White and 
Sottos with permission from Elsevier BV. 
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When ∆KI is reduced (0.338 MPa.m
1/2
), high-cycle fatigue conditions with a decreased 
crack growth rate were obtained. As a result, the sample fatigue life is longer than the 
polyDCPD gel time (25 min), allowing self-healing to take place during cyclic loading. This 
generated a fatigue life extension that ranged from about 90 to 210% (approximately times 3). 
When also in this case a resting period of 10 hours at room temperature and at Kmax was 
introduced, total crack arrest was achieved (no crack extension during 3 x 10
6
 cycles). If ∆KI 
is further decreased (0.270 MPa.m
1/2
), total arrest was also noticed during cyclic loading 
without a rest period, while the precrack length in the control sample still increased at a 
constant rate. 
Jones et al. used a recrystallized Grubbs’ catalyst that dissolved faster in DCPD and as 
such gelled the DCPD 4 times faster.
46
 Furthermore, the recrystallized catalyst was embedded 
in paraffin wax microspheres to protect it against amine deactivation. When using 5 wt% of 
these wax microspheres containing 5 wt% of the recrystallized catalyst in combination with 
20 wt% of 180 µm sized DCPD UF-microcapsules, crack growth could be retarded in higher 
∆KI regions (0.676 MPa.m
1/2
 or 0.62 KIC) than with the unprotected as-received Grubbs’ 
catalyst. The fatigue life could be extended more than 30 times compared to neat epoxy. 
When ∆KI is lowered to intermediate levels (0.500 MPa.m
1/2
 or 0.45 KIC), total crack arrest is 
achieved as a result of the faster reaction kinetics. 
Biggs et al. also performed fatigue tests on their self-healing PMMA bone cement for 
anchoring joint replacements.
57
 In bone cement, fatigue microcracking can lead to aseptic 
loosening, which is detachment of the implant from the bone caused by microscopic debris. 
Different self-healing cement compositions were evaluated and the best results were obtained 
with 2 wt% of 226 µm sized endo-DCPD UF-microcapsules and 0.25 wt% 1
st
 generation 
Grubbs’ catalyst mixed with the PMMA cement powder. Fatigue tests were performed using a 
compact tension (CT) geometry. The fatigue crack propagation rate is significantly lowered 
from 3 to 0.4 µm per cycle, leading to a more than twofold extended fatigue life, which is in 
the same order of magnitude as the results of Brown et al. with epoxy thermosets as described 
above. 
Jin et al. used the DCPD/Grubbs’ catalyst system for self-healing fatigue damage in an 
epoxy adhesive for bonding steel substrates.
47
 15 wt% of 130 µm sized UF-microcapsules 
containing DCPD and 2.5 wt% of 1
st
 generation Grubbs’ catalyst particles were embedded in 
a thin film (360 µm) of epoxy between two steel plates in a width-tapered double cantilever 
beam geometry. Firstly, quasi-static fracture performance was evaluated, demonstrating a 
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56% recovery of the original fracture toughness. Next, fatigue tests were performed with the 
same geometry. While the neat epoxy adhesive failed after less than 62 x 10
3
 cycles (∆KI = 
0.378 MPa.m
1/2
), the self-healing sample exhibited full crack arrest after a brief period of 
crack growth (Figure 2.2). 
 
 
 
Figure 2.2. Crack growth as a function of the number of cycles in fatigue testing with DCPD self-healing.
47
 
Black square: neat epoxy sample, blue triangle: control sample with dibutyl phthalate as an unreactive 
healing agent, red circle: self-healing sample with DCPD as a healing agent. Reproduced from Jin, Miller, 
Sottos and White with permission from Elsevier BV. 
 
In conclusion, the DCPD/Grubbs’ catalyst system is capable of slowing down fatigue 
crack growth in both the low and high loading regions and to a similar extent in both epoxy 
and PMMA bone cement. As already stated by Brown and Jones, significant crack arrest and 
life extension occurred when the in situ healing rate is faster than the crack propagation rate. 
By modifying the healing kinetics, full crack arrest is possible in low to intermediate loaded 
samples, implying that these materials could have an “indefinite” fatigue life. 
 
2.2.6 DCPD/ENB healing of quasi-static fracture damage in fiber-reinforced 
composites 
Both glass and carbon fiber-reinforced epoxy composites were tested for quasi-static 
fracture recovery. In such fiber-reinforced composites, not only matrix cracking has to be 
healed, but delamination between the fibers and the matrix as well. All microcapsule 
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composites are made via a hand lay-up technique or by manually aligning the fibers in the 
epoxy. 
Kessler et al. focused on this delamination damage in both woven E-glass
50
 and 
carbon fiber
51
 epoxy composites. As stated by the authors, woven composites are most suited 
for self-healing composites due to the presence of the interstitial regions (especially in plain 
weave), where a large number of microcapsules can reside without deteriorating the 
composite material properties too much. In the case of E-glass fiber-reinforced composites,  
5 mm thick panels were generated with 10-12 plies of either plain weave or 8H satin weave 
fabric, representing a fiber volume fraction of 27 and 29% respectively. Unfortunately, no 
autonomous self-healing samples were made. Either the DCPD/Grubbs’ catalyst mixture was 
manually injected into the crack, or 1.75 wt% the catalyst was incorporated in the epoxy and 
only the DCPD was injected. After 2 days of healing at room temperature, these double 
cantilever beam samples recovered respectively 67 and 19% of the fracture toughness. 
With carbon fiber reinforcement, autonomous self-healing epoxy composites were 
effectively manufactured. 6 mm thick panels were made with 16 plain weave carbon fiber 
plies, using an epoxy resin with 20 wt% of 166 µm DPCD UF-microcapsules and 5 wt% of 1
st
 
generation Grubbs’ catalyst in between the middle four plies. Width-tapered double-cantilever 
beam samples with a thin teflon film to initiate cracking were cut from these panels for 
fracture testing. A decreased virgin fracture toughness, compared to neat epoxy composites, 
was measured due to catalyst clustering, leading to unstable crack growth, and also because 
the resin layer thickness in between the carbon fiber plies was increased due to the presence 
of microcapsules. By lowering the amount of microcapsules to 10 wt%, the fracture toughness 
could again be increased by 21%. 
In the 20 wt% capsules case, up to 45% recovery of KIC was measured after 2 days of 
self-healing at room temperature. This lower recovery value can be explained by the lower 
amount of microcapsules that were broken in the regions where delamination primarily 
occurred. Healing at an elevated temperature of 80 °C lead to an increase in both the rate of 
polymerization and the ultimate degree of cure, yielding an increased fracture toughness 
recovery of up to 80%. As such, the heat generation in polymer composites during fatigue 
might help in increasing the reaction rate and thus in yielding higher healing efficiencies. 
In contrast to the woven composites, Sanada et al. made use of unidirectional carbon 
fiber-reinforced epoxy composites and investigated tensile strength rather than fracture 
toughness.
52
 Both neat and fiber-reinforced epoxy dogbone samples were tested. In the neat 
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epoxy samples, 2.5 wt% of Grubbs’ catalyst and a varying amount of 211 µm sized DCPD 
UF-microcapsules ranging from 10 to 40 wt% was embedded. The highest but still low 
ultimate tensile strength recovery (14%) was obtained with 40 wt% of microcapsules after 1 
day of healing at room temperature and 1 day at 80 °C. The healing efficiency increased with 
increasing microcapsule concentration, although the healed tensile strength remained 
constant. This increase in recovery is thus fully related to the tremendous decrease in virgin 
tensile strength (from approximately 35 MPa to 15 MPa). Based on the higher failure strain, 
an epoxy resin with 30 wt% of the microcapsules and 2.5 wt% catalyst was applied as a 
coating to the carbon fibers, which were then placed in a mould and fully cured with 
additional epoxy resin to form a 3 mm thick plate. Only dogbone samples with fibers 
perpendicular to the tensile direction demonstrated the delamination damage that was aimed 
for. After the same healing cycle, these samples recovered 19% of the ultimate tensile 
strength. 
Blaiszik et al. looked into the interfacial bond strength by depositing the DCPD 
microcapsules and Grubbs’ catalyst particles onto E-glass fibers.53 The authors opted for very 
small DCPD containing UF-microcapsules (1.5 µm in diameter) to avoid significant 
detrimental effects on the mechanical properties of the composite. A recrystallized Grubbs’ 
catalyst with enhanced cure kinetics, as indicated by Jones in fatigue tests (see Subsection 
2.5), was applied. A 1.2 wt% catalyst loading and different capsule loading densities (ρ = 
0.06-0.23) were applied to a single fiber before incorporation in a microdroplet of epoxy. 
These single-fiber microbond epoxy samples were then used to measure interfacial shear 
strength via fiber pull-out until complete debonding. The interfacial shear strength increased 
by 29% in the self-healing microcapsule samples compared to the neat glass-fiber control 
samples. After 1 day of self-healing at room temperature, 44% recovery of interfacial shear 
strength was obtained with the highest density of microcapsules.  
Finally, flexural stiffness recovery was researched for carbon fiber-reinforced 
composites using unique electrospun core-shell nanofibers to deliver the healing agent.
54
 By 
coelectrospinning DCPD and polyacrylonitrile, core-shell nanofibers with a diameter of 
several hundred nanometers to a couple of micrometers were formed. Via a wet lay-up and 
vacuum-assisted resin transfer molding process, these were incorporated at 4 laminate 
interfaces of an epoxy composite with unidirectional preimpregnated and cross-woven carbon 
fiber plies, containing 0.5 wt% of Grubbs catalyst in the epoxy matrix. 2.35 mm thick panels 
with 80 µm thick interlayers containing nanofibers (Figure 2.3) were then cut for three-point 
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bend tests. Samples were bent until interlaminar cracking occurred and then allowed to self-
heal for 2 hours at room temperature, yielding a flexural stiffness recovery up to 100%. 
Furthermore, this delivery system has a very low weight penalty (< 1 vol%) in the fiber-
reinforced composite. 
 
 
Figure 2.3. Scanning electron micrograph of the core-shell nanofiber interlayer in a unidirectional carbon 
fiber-reinforced epoxy composite.
54
 The scale bar is 10 µm. Reproduced from Wu, Rahman, Zhou, Pelot, 
Sinha-Ray, Chen, Payne and Yarin with permission from John Wiley & Sons, Inc. 
 
As described above, the recovery of quasi-static fracture damage in fiber-reinforced 
epoxy composites with the DCPD/Grubbs’ healing chemistry is significantly lower than in the 
bulk epoxy thermosets, mainly due to difficulties in healing the fiber-matrix interface. 
However, there is still room for optimization and further improvement as shown by the 
electrospun nanofiber concept. Additionally, glass fiber-reinforced epoxy composites showed 
greater potential in self-healing impact damage as discussed in Subsection 2.2.4. To our 
knowledge, no fatigue testing has been performed on fiber-reinforced polymers with the 
DCPD/Grubbs’ catalyst healing system. As already suggested by Kessler51, fatigue self-
healing of composites might be very promising.  
 
2.3 Siloxane-based healing system 
This self-healing system is relying on different siloxane-based healing agents that 
form polymers via either a tin-catalyzed polycondensation reaction or via a platinum-
catalyzed hydrosilylation. In spite of the excellent results in poly(dimethylsiloxane) (PDMS) 
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elastomers, this chemistry has not found its way towards other materials. Advantages and 
potential issues are discussed below. 
 
2.3.1 Siloxane healing chemistry 
The self-healing concept based on the tin-catalyzed polycondensation reaction of 
silanol-terminated poly(dimethylsiloxane) (HOPDMS) and poly(diethoxysiloxane) (PDES) 
(Scheme 2.2) was introduced by Cho et al. in 2006.
60
 In their work, the HOPDMS and PDES 
healing agents are not encapsulated, but embedded as phase-separated droplets in an epoxy 
vinyl ester thermosetting matrix by simple mixing before cure. The liquid di-n-butyltin 
dilaurate (DBTL) catalyst is co-encapsulated with chlorobenzene in separate polyurethane 
(PU) microcapsules, made via interfacial polymerization. When the vinyl ester material 
ruptures, both liquids come into contact with one another and start the siloxane crosslinking 
reaction at room temperature. 
 
 
 
Scheme 2.2. Condensation reaction of silanol-terminated poly(dimethylsiloxane) (PDMS) and its 
crosslinker poly(diethoxysiloxane) (PDES) in the presence of an organotin catalyst.
59
 
 
As stated by the authors, the main advantages of this chemistry are 1) its stability in 
humid or wet conditions and at elevated temperatures (up to 150 °C
130
), which allows for a 
broader range of applications and use in higher curing thermosets respectively, 2) a low cost 
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for the used components and 3) a limited amount of side reactions for the organotin catalyst, 
even under ambient air conditions.  
However, a major disadvantage is the incompatibility of the siloxane product with 
typical matrix materials such as epoxy and epoxy vinyl ester thermosets. Cho et al. had to add 
a silane adhesion promoter to the epoxy vinyl ester matrix to optimize wetting and bonding of 
the crack surface, since in its absence poor adhesion and practically no healing was 
observed.
60
 The results obtained with this chemistry are described in Subsection 2.3.2 & 
2.3.3. 
A second healing chemistry was applied by Keller et al. for self-healing PDMS 
matrices (see also Subsection 2.3.3). The authors used a hydrosilylation reaction between a 
vinyl-functionalized PDMS and a hydrosiloxane-PDMS copolymer with the aid of a platinum 
catalyst (Scheme 2.3a). Hydrosilylation reactions with organoplatinum compounds such as 
Karstedt’s catalyst (Scheme 2.3b) are assumed to proceed via the Chalk-Harrod 
mechanism
131
, forming a hydrido-silyl metal complex via oxidative addition, coordinating 
with the vinyl bond. Migratory insertion of the double bond into the Pt-hydrogen bond is then 
followed by reductive elimination of the alkyl-silyl product. This hydrosilylation reaction also 
benefits from a high temperature stability and low cost of monomers. Moreover, it is also 
relatively fast, already reaching its gel point after 5 hours at room temperature.
63
 The platinum 
catalyst in the zero oxidation state is considered non-toxic, as indicated by its use in breast 
implants. 
 
 
 
Scheme 2.3. (a) Hydrosilylation of vinyl-functionalized PDMS and a hydrosiloxane copolymer in the 
presence of a platinum catalyst 
61
; (b) potential platinum catalyst. 
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2.3.2 Siloxane healing of quasi-static fracture damage in bulk epoxy 
Mangun et al. focused on PDMS self-healing of the standard epoxy material.
59
 The 
authors encapsulated a range of HOPDMS/PDES mixtures with different molecular weights 
and ratios in 37 to 72 µm sized UF-microcapsules, since direct contact of the siloxane-based 
healing agents with the epoxy-amine matrix caused some matrix-catalyzed polycondensation 
reactions. DBTL, mixed 50:50 with hexyl acetate for viscosity reasons, was incorporated in 
33 µm sized PU-microcapsules. 1-15 wt% of the HOPDMS containing microcapsules and 
0.1-1.5 wt% of the DBTL microcapsules was added to the epoxy. The best healing efficiency 
was obtained with microcapsules containing the PDMS with the highest molecular weight 
(49,000 g/mol), PDES and a small amount of xylene to lower the viscosity. With a TDCB 
geometry, up to 52% recovery of fracture toughness was measured after 1 day of self-healing 
at room temperature. Silane adhesion promoters increased the compatibility of the siloxane 
product with the epoxy matrix, improving the healing efficiency by a large margin (from 34 to 
52%). When high-temperature curing of the epoxy was applied at 177 °C, the healing 
capability dropped to 28% recovery. 
 
2.3.3 Siloxane healing of quasi-static fracture damage in bulk matrices other than 
epoxy 
Apart from epoxy, both vinyl ester epoxy and PDMS matrices have been investigated. 
Cho et al. looked into self-healing of an epoxy vinyl ester thermoset with 12 wt% phase-
separated HOPDMS/PDES, 3.6 wt% DBTL PU-microcapsules and 4 wt% of adhesion 
promoter added to the matrix.
60
 The phase-separated droplet size was measured at 1-20 µm, 
while the PU microcapsules had a diameter of 50 – 450 µm. Using a TDCB geometry, only 
24% recovery of the original fracture toughness could be obtained after healing for 1 day at 
50 °C. Due to the addition of the self-healing system, the virgin fracture toughness of the 
material is increased by 88%. 
Low healing efficiencies could be expected, since the siloxane product has a 
significantly lower stiffness and fracture toughness than the vinyl ester matrix and would thus 
be more suited for filling and sealing cracks. Although functional self-healing of coatings for 
corrosion protection is not the focus of this chapter, it should be noted that this siloxane 
chemistry is indeed very effective at sealing off the metal substrate from harmful moisture.
130
  
Chapter 2 – State of the art in autonomous extrinsic self-healing polymers and composites 
 
29 
 
Keller et al. obtained the best self-healing results for an elastomeric PDMS matrix 
using the platinum-catalyzed hydrosilylation crosslinking reaction mentioned in Subsection 
2.3.1.
61
 Self-healing was introduced by combining 2 types of UF-microcapsules, one 
containing the vinyl-functionalized PDMS and the platinum catalyst and the other the 
hydrosiloxane copolymer. Using tear tests, the authors noticed a microcapsule toughening 
effect, increasing the virgin tear strength by 25% when 20 wt% of capsules was added. Over 
100% tear strength recovery was reached with 15-20 wt% vinyl-PDMS/Pt catalyst 
microcapsules and 5 wt% of hydrosiloxane microcapsules after 2 days of healing at room 
temperature. Surpassing a value of 100% is explained by tearing of the PDMS material next 
to the original crack path (Figure 2.4).  
 
 
 
Figure 2.4. Scanning electron microscope image of a tear surface with the healed crack path deviating 
from the original crack path (indicated with arrows).
61
 Reproduced from Keller, White and Sottos with 
permission from John Wiley & Sons, Inc. 
 
When comparing the 3 used matrix materials, it can be summarized that the PDMS 
chemistry shows significantly better self-healing results with matrices that are more 
compatible with the healed network, such as PDMS itself. The addition of adhesion promoters 
to the other matrices is essential to obtain improved self-healing. A potential second solution 
could be the use of any remaining vinyl bonds in the epoxy vinyl ester in combination with 
the platinum catalyst to covalently attach the hydrosiloxane containing healed material to the 
matrix.  
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2.3.4 Siloxane healing of impact damage 
Where self-healing of impact damage is concerned, only sealing of puncture damage 
was investigated by Beiermann et al. for a 3 layer flexible laminate.
62
 Therefore, a PDMS 
material containing microcapsules is sandwiched between 2 polyurethane-coated nylon layers, 
generating a laminate with a total thickness of 1.5 mm. Again, the HOPDMS/PDES/DBTL 
catalyst system is embedded, using 25 wt% of 220 µm sized UF-microcapsules with the 
HOPDMS/PDES mixture and 6 wt% of 180 µm sized PU-microcapsules containing the 
DBTL catalyst with chlorobenzene to lower the viscosity.  
To assess the sealing capability, the laminates were either punctured with a needle or 
cut with a razor blade and left to heal for 1 day at room temperature. Sealing was then defined 
by pressuring one side of the sample with an inert gas and measuring the output on the other 
side. 100% of the samples with a 0.49 mm diameter puncture could be sealed, while larger 
holes were sealed in less than 10% of the samples. Increasing the HOPDMS/PDES 
microcapsule size to 500 µm helped to seal larger punctures (up to 1.61 mm), closing off 
almost 20% of the samples. However, when a 0.49 mm puncture was applied, only 50% of the 
samples were sealed. Cut damage was sealed in 33% of the samples. Lowering the thickness 
to increase the flexibility of the laminate also lowered the sealing performance. When 
pressure was applied during the healing time, no sealing was obtained because the healing 
agent was forced from the puncture before the healing reaction was complete. Using 
HOPDMS/PDES microcapsules only also yielded a sealing recovery, most likely due to 
polymerization under the influence of residual DBTL catalyst in the matrix. 
Samples that did not seal off the puncture probably did not have ruptured 
microcapsules or had an insufficient damage coverage by healing agent. In the case of the 
smaller microcapsule size for the same capsule weight loading, the probability to rupture 
capsules is higher, while with the larger microcapsules, the amount of healing agent delivered 
to the crack is increased. A mixture of both microcapsules might thus improve the sealing 
efficiency. 
 
2.3.5 Siloxane healing of fatigue damage 
Keller et al. investigated self-healing of torsion fatigue in two different PDMS 
elastomers.
63
 The same double-microcapsule system is used as in the quasi-static fracture 
research: 1 type of UF-microcapsules containing the vinyl-functionalized PDMS, the Pt 
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catalyst and 20 wt% hexane to lower the viscosity, and a second type containing the 
hydrosiloxane copolymer. Circular discs with a circumferential precrack were generated for 
torsion fatigue testing. It was noticed that microcapsules have a deteriorating effect on the 
original fatigue behavior, with a torsional stiffness reduction most likely related to a 
lubrication effect of the healing agent. However, after a period of 5 hours, corresponding to 
the gel time of the healing agents, a sharp increase in torsional stiffness was observed, almost 
fully recovering the virgin torsional stiffness in the matrix with the lower stiffness. Only 
adding initiator capsules also rendered a less pronounced torsional stiffness recovery, due to 
reaction with residual vinyl functionalities in the matrix as well as initiator-initiator 
interactions. With 5 wt% of vinyl-PDMS containing capsules and 5wt% of hydrosiloxane 
containing capsules, an increase of 54% in terminal stiffness was obtained in comparison to 
the neat PDMS. Furthermore, the terminal crack length was reduced by 24% with the self-
healing system as a result of crack-tip shielding and the lubrication effect, significantly 
extending the fatigue life. The lubrication effect also caused a crack length reduction by 9 and 
16% when respectively only the hydrosiloxane or the vinyl-PDMS capsules were added. 
Keller et al. also tested the self-healing of wear in a PDMS-based elastomeric coating 
with a two-part PDMS-based self-healing chemistry, but concluded that this chemistry is 
inappropriate for this kind of damage for various reasons such as the reaction rate and 
viscosity.
117
 
 
2.4 Epoxy-based healing system 
Two different epoxy-based approaches have been investigated, but both make use of 
epoxy resin as the only reactive healing agent. Either catalysts or solvents were added and in 
some cases heating is required to make the self-healing system work more efficiently. As 
shown below, both systems demonstrate very promising results. The non-autonomous self-
healing systems based on meltable epoxy particles
132, 133
 or thermoplastic additives
134-138
 are 
not discussed in this chapter. Functional self-healing was also obtained with this chemistry 
using a single-part UV-curing epoxy in a flexible sensor skin.
139
 
 
2.4.1 Epoxy healing chemistry 
The application of epoxy resin as a single healing agent was introduced by Yin et al. 
in 2007.
70
 The authors used the ring-opening polymerization of epoxy, initiated by a  
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CuBr2(2-MeIm)4 complex containing the 2-methylimidazole (2-MeIm) hardener (Scheme 
2.4). This latent hardener complex is dissolved in the epoxy matrix and dissociates into CuBr2 
and 2-methylimidazole at 130-170 °C. Therefore, this system is not considered autonomous. 
Upon fracture of the epoxy resin containing UF-microcapsules, the epoxy comes into contact 
with the CuBr2(2-MeIm)4 complex, but only cures when the sample is heated to sufficiently 
high temperatures to release the imidazole. When the sample is placed at 120 °C, little 
reaction occurs, while the epoxy resin cures almost completely within 1 hour or 20 min at 
respectively 130 or 170 °C. This heating step could restrict the use of this self-healing system 
in industrial applications. A potential solution for this issue is the encapsulation of the 
separate imidazole compound in poly(caprolactone) microcapsules
140
, which would result in a 
fully autonomous system reacting at room temperature. 
 
 
Scheme 2.4. Curing of epoxy resin with 2-methylimidazole.
20, 70  
 
An alternative, autonomous epoxy-based strategy was devised by Xiao et al.
72
, using 
epoxy-loaded microcapsules made via a novel UV-initiated radical polymerization of epoxy 
diacrylates and a polymerizable emulsifier
141
 in combination with a quite active catalyst 
BF3.OEt2. Because immediate mixing of this catalyst into the epoxy matrix resulted in 
processing issues due to a fast polymerization-induced viscosity increase, encapsulation was 
required. However, since this catalyst is highly hygroscopic, microencapsulation via the 
classic approach would result in loss of activity.  Therefore, BF3.OEt2 was absorbed in porous 
plant fibers (short sisal fibers), which were subsequently coated with polystyrene to protect 
their content. After insertion of these fibers in the epoxy matrix, the BF3.OEt2 catalyst 
gradually diffused into the surrounding matrix, providing a good spatial distribution. A major 
advantage over the CuBr2(2-MeIm)4 latent hardener system is found in the rapid cationic 
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chain polymerization of the epoxy resin at room temperature. This self-healing chemistry 
combination is one of the fastest healing systems with recoveries over 70% obtained within 
30 min at 20 °C (see Subsection 2.4.3). Another added value of this system is the small 
catalytic amount that is required to cure the epoxy throughout the crack, since the reaction 
proceeds as long as the catalyst is present. To further increase the versatility of the epoxy-
BF3.OEt2 self-healing system, a method to encapsulate the catalyst via infiltration of hollow 
microcapsules has also been developed.
142
 
A third method was developed by Coope et al. by combining the epoxy resin with 
Sc(OTf)3 as the Lewis-acid catalyst for the epoxide ring-opening polymerization.
65
 As 
highlighted by the authors, this catalyst combines a low cost and toxicity with a high stability 
and availability. In this case, the UF-microcapsules contained epoxy resin together with ethyl 
phenylacetate (EPA), a low-toxic solvent with a boiling point of 229 °C to lower the 
viscosity, in different ratios. The Sc(OTf)3 could be dispersed as such in the epoxy matrix. As 
indicated in Subsection 2.4.2, this self-healing chemistry also benefits from a temperature 
increase, although it also works to a certain extent at room temperature. 
Finally, a fourth method based on self-healing with the aid of a solvent, containing 
additional epoxy resin, was reported by Caruso et al.
66, 67
 This methodology makes use of 
solvent swelling of the epoxy matrix to bring residual amine and epoxide functional groups on 
both sides of the crack into close contact with one another, allowing them to react at room 
temperature. When a range of solvents was screened, polar aprotic solvents such as 
nitrobenzene, N-methyl pyrrolidone, dimethylacetamide, dimethylformamide (DMF) and 
dimethyl sulfoxide demonstrated the best healing potential. Unfortunately, these solvents are 
difficult to encapsulate due to their high polarity and as a consequence, the next most suitable 
solvent, chlorobenzene, was selected for encapsulation in urea-formaldehyde microcapsules. 
Both microcapsules containing only chlorobenzene and chlorobenzene with 5 wt% additional 
epoxy resin in order to increase the crosslinking possibilities with residual amines, were 
evaluated. Due to the toxicity of this aromatic solvent, alternatives such as phenyl acetate and 
EPA have also been tested.  
The four major approaches in epoxy-based self-healing systems all rely on 
encapsulated epoxy and an additional hardening trigger. While heating is required in the 
CuBr2(2-MeIm)4 system, it is straightforward to incorporate this latent hardener in the epoxy 
matrix. Sc(OTf)3 particles can also be dispersed as such and work at room temperature, but 
only to a limited extent. In contrast, the use of a BF3.OEt2 catalyst generates a very fast curing 
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progress at room temperature, but for the same reactivity reason has to be encapsulated to 
avoid processing issues with the epoxy. It could be useful to opt for other matrices in this 
case. Finally, the epoxy-solvent system excels in its simplicity by using only one type of 
microcapsules and room temperature self-healing. However, it depends on the presence of 
residual amines to allow the curing of the epoxy resin to occur and has some durability issues 
concerning solvent diffusion. 
 
2.4.2 Epoxy healing of quasi-static fracture damage in bulk epoxy 
Yin et al. obtained the highest fracture toughness recovery with 10 wt% of 30-70 µm 
sized UF-microcapsules containing the epoxy resin and 2 wt% of dispersed CuBr2(2-MeIm)4 
latent hardener. Using a single-edge notched bend (SENB) geometry, 111 % recovery of the 
virgin fracture toughness was recorded after a healing time of 1 hour at 130 °C (non-
autonomous system). The fact that this value exceeds 100% is explained by the higher 
fracture toughness of the healed network, which is 1.23 times that of the epoxy matrix. When 
performing tensile tests, the addition of the microcapsule system surprisingly did not decrease 
the tensile strength nor affect the Young’s modulus significantly. This is a very relevant 
advantage over other systems. However, the fracture toughness remains similar as well, even 
with 20 wt% of microcapsules, due to a mix of effects induced by the hardener and the 
microcapsules. Only slight toughening was observed in some cases. 
Similar results were achieved by Rong et al. with both the epoxy resin and the 
imidazole hardener encapsulated.
64
 Therefore, 20 wt% of 42 µm sized UF-microcapsules 
containing the epoxy resin and 4 wt% of encapsulated imidazole hardener (10 µm in size) 
were embedded in the epoxy matrix. The SENB samples were then healed for 30 min at 120 
°C and for the same period at 140 °C. 
Coope et al. embedded 20 wt% of 100-250 µm sized UF-microcapsules containing a 
core of 25, 50 or 75 wt% of epoxy (in EPA) in the epoxy matrix, together with 2.5 wt% of 
Sc(OTf)3 catalyst. TDCB samples were used for fracture toughness determination and were 
allowed to heal for 2 days at room temperature, 45 or 80 °C. The best results were obtained 
with microcapsules containing a 75 wt% epoxy in EPA core, yielding 49% and 86% KIC 
recovery at 45 and 80 °C respectively. However, at room temperature, the highest healing 
efficiency obtained was only 20% with the 25 wt% epoxy in EPA core, indicating that the 
viscosity of the healing agent could be a determining factor. Only when the healing time for 
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the 50 and 75 wt% epoxy in EPA core samples was increased to 7 days, similar recoveries of 
respectively 19 and 13% were reported. The authors also report a good microcapsule shelf-life 
of at least 6 months. 
In the solvent self-healing concept, the best results were obtained with 200 µm sized 
UF-microcapsules containing 5 wt% of epoxy resin in either chlorobenzene, phenyl acetate or 
EPA.
143
 Using an epoxy TDCB geometry with 15 wt% of solvent-epoxy microcapsules
67
, 
100% full recovery of the fracture toughness was measured after 1 day at room temperature, 
while a sample containing 5 wt% of solvent-epoxy microcapsules already reached 80%. 
Furthermore, multiple healing events (up to 3-5 times with a 7 days waiting time in between) 
were possible due to deviation of the newly formed cracks from the original crack path. The 
authors indicated a healing efficiency decrease down to approximately 80% after 30 days. The 
durability of this self-healing system was further investigated by Neuser et al.
68
, indicating 
severe healing agent loss over time (up to 11 weeks) due to ambient moisture uptake and 
premature diffusion of the solvent through the shell of the microcapsules. Caruso et al. 
already synthesized double-walled polyurethane/UF microcapsules before in order to improve 
the thermal stability of the EPA containing microcapsules.
144
  
From the results above, it can be concluded that both the epoxy-latent hardener and the 
solvent-epoxy self-healing system are potent self-healing chemistries, capable of full KIC 
recovery, a feature that only a handful concepts could achieve. However, the epoxy-latent 
hardener system requires a remending step (heating), limiting its industrial feasibility. 
Unfortunately, no comparison could be made with the BF3.OEt2 catalyzed system which was 
only tested for impact damage.  
 
2.4.3 Epoxy healing of impact damage 
Impact damage self-healing was investigated for plain woven C-glass fabric epoxy 
composites.
69
 Therefore, a 2.1 mm thick fiber-reinforced epoxy plate was made via a hand 
lay-up and compression molding process, comprising four plies (30 vol%) and an epoxy 
matrix with 10 wt% of 40 µm sized epoxy resin UF-microcapsules and 2wt% of  
CuBr2(2-MeIm)4 latent hardener. These plates were low velocity impacted with a 
hemispherical tip at an impact energy of 1.5 – 3.5 J, followed by CAI tests both before and 
after a self-healing step of 30 min at 140 °C (non-autonomous system). Prior to impact, an 
enhanced compression strength of the composite was observed upon incorporation of the self-
healing system, most likely due to the reduced material stiffness.  
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When CAI tests were performed after an impact at 1.5 J and the required healing time, 
the virgin compression strength was approached, indicating that practically all cracks were 
filled and healed. Acoustic through-mode scanning showed the complete disappearance of 
any impact damage in this case. A compression strength recovery of 94% was noted. 
However, when the impact energy was increased to 2.5 J, only 58% CAI recovery was 
obtained. This can be explained by the changing fracture behavior: at low energy impact, only 
matrix cracking occurred, while at higher energies also delamination and fiber rupture took 
place, leading to fiber-rich regions that are more difficult to fill and heal. Increasing the 
microcapsule content to 20 wt% in the low impact case did not alter the recovery, while at  
2.5 J, the CAI recovery increased to 70%. Compression of the samples (60 kPa) further 
improved this high impact self-healing up to 71 and 90% recovery in the 10 and 20 wt% 
microcapsule samples respectively. Furthermore, different failure modes in CAI tests before 
and after self-healing were noticed and the failure zone in the self-healing samples was not 
located in the original impact region, demonstrating significant recovery. This might be 
caused by the stronger healed matrix, as indicated in Subsection 2.4.2. Increasing the 
microcapsule size from 40 to 65 or 140 µm did not affect healing efficiency significantly. 
Although larger microcapsules were expected to heal more damage due to a higher healing 
agent volume delivery, the smaller ones could more easily penetrate fiber-rich regions and 
heal damage occurring there. This observation was also seen in other self-healing systems 
(see eg. Subsection 2.2.4). 
Although these results, especially at lower impact energies, are promising for self-
healing of impact damage, the heating step remains a limiting factor. This issue is not 
encountered in the epoxy-BF3.OEt2 self-healing system. Samples containing varying amounts 
of sisal fibers and microcapsules were impacted to failure and allowed to self-heal for 2 hours 
at room temperature, followed by a second impact test.
72
 The authors observed that at least  
5 wt% of epoxy microcapsules and 0.75 wt% of plant fibers containing approximately  
32 wt% of catalyst was needed to provide significant self-healing of impact damage 
(approximately 85% recovery of impact strength). Manual injection of epoxy resin into a 
control sample, only containing 1.5 wt% of sisal fibers, even yielded 98% impact strength 
recovery. Addition of both the plant fibers and the microcapsules resulted in a limited 
deterioration of the static mechanical properties of the epoxy material. The reduction in 
flexural strength, flexural modulus and impact strength was respectively 6.5, 3 and 14%. The 
system retained its healing capability for at least 12 months, demonstrating good durability. 
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Based on these quite impressive results at low loading of healing containers, this 
epoxy-BF3.OEt2 self-healing chemistry could open up vast opportunities when utilized in both 
bulk polymers and fiber-reinforced composites prone to impact damage. The fast kinetics 
could also prove to be very useful in extending fatigue life. 
  
2.4.4 Epoxy healing of quasi-static fracture damage in fiber-reinforced composites 
Yin et al. further elaborated their non-autonomous self-healing system in plain woven 
E-glass fabric reinforced epoxy composites, generating a 4.5 mm thick panel via hand lay-up 
of 12 preimpregnated fiber plies (27 vol%).
70
 10 wt% of the epoxy resin UF-microcapsules 
and 2 wt% of CuBr2(2-MeIm)4 latent hardener were added to the four centre layers. When 
tested for the interlaminar fracture toughness recovery, using a double cantilever beam (DCB) 
geometry, a lower healing efficiency of 68% was obtained after 1 hour at 130 °C. The authors 
suggested a deviation from the optimal epoxy resin / hardener ratio in certain damage areas, 
resulting in inhomogeneous curing, as the cause of the decreased recovery compared to the 
fiber-free samples (see Subsection 2.4.2). Similar results (just over 70% recovery) were 
obtained with C-glass reinforced epoxy composites with the same fiber composition and  
30 wt% of epoxy microcapsules added to the central layers.
71
 Tensile tests revealed that the 
tensile strength in fiber-reinforced composites is strongly reduced with microcapsule contents 
higher than 20 wt% due to severed impregnation and interfacial coupling. Below that content, 
95% of the tensile strength is retained. 
The same group also investigated the durability of the epoxy-based self-healing 
system, indicating a decrease in healing efficiency from 70 to approximately 60% in the first 
two months of storage at room temperature, after which the system remained stable up to 18 
months.
73
 It is postulated that the epoxy resin diffusion sites are eventually blocked because 
the leaking resin was cured by remaining amine curing agent in the matrix. 
Although this chemistry again shows high KIC recoveries in fiber-reinforced 
composites, the requirement of external heating still inhibits fully autonomous self-healing. 
The use of the imidazole microcapsules, mentioned in Subsection 2.4.1, could provide a 
suitable, autonomous alternative. 
For use of the solvent self-healing system in fiber-reinforced composites, the 
capability to self-heal interfacial bond strength was investigated for both E-glass/epoxy
74
 and 
carbon/epoxy
75
 interfaces. 2.1 µm sized UF-microcapsules containing a 3 wt% epoxy resin in 
EPA core were applied to a single E-glass fiber before incorporation into an epoxy 
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microdroplet. This small microcapsule size was chosen to avoid a decrease in mechanical 
properties of the fiber-reinforced composite. The interfacial bond strength was then tested 
with the single-fiber microbond epoxy samples (Figure 2.5) via fiber pull-out until full 
debonding. Full recovery of the interfacial bond strength could be obtained after 1 day of 
healing at room temperature, which is more than twice the recovery of 44% recorded in the 
DCPD self-healing system (see Subsection 2.2.6). A slightly lower bond strength recovery 
(still up to 91%) was noticed for the carbon fiber samples. 
 
 
 
Figure 2.5.  Single-fiber microbond epoxy sample with epoxy-solvent microcapsules on the E-glass fiber.
74
 
Reproduced from Jones, Blaiszik, White and Sottos with permission from Elsevier BV. 
 
2.5 Amine-epoxy-based healing system 
The amine-epoxy combination is commonly applied for the generation of both epoxy 
thermosets and fiber-reinforced composite matrices. Therefore, using the same healing agents 
should provide good adhesion with and similar material properties as the epoxy matrix. 
Because of the extensive amount of research on this self-healing chemistry, the discussion of 
the concept will be divided in paragraphs that describe hollow glass fiber (HGF), vascular and 
microcapsule delivery (Table 2.2). 
 
2.5.1 Amine-epoxy healing chemistry 
Already in 1996, Dry introduced this dual-compound self-healing chemistry in HGFs 
embedded in an epoxy matrix.
89
 The HGFs containing either epoxy resin or amine hardener 
were aligned in pairs to ensure good spatial distribution and mixing of both compounds. Upon 
fracture, the healing agents come into contact with each other and react via nucleophilic ring-
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opening polymerization of the epoxide (Scheme 2.5) to form rigid networks at room 
temperature.  
 
 
 
Scheme 2.5. Reaction of bisphenol A diglycidyl ether with diethylenetriamine.
 
  
 
When properly mixed, these healing agents will react to high conversions within a 
timeframe of minutes to several days at 25 °C, depending on the structure of the compounds 
used. Increasing the temperature (in some matrices up to 180 °C or more) drastically lowers 
the time required for curing. Furthermore, the reaction continues as long as the curing 
temperature exceeds the Tg of the newly formed network, until the material vitrifies due to the 
increasing crosslinking density and consequently, a Tg that rises above the curing temperature. 
This vitrification will only occur if the final Tg is higher than the temperature applied. For 
self-healing applications, these amine and epoxy healing agents were delivered to the damage 
area using separate HGFs
89-96, 99, 100
, vascular channels
76-79, 87, 97, 98, 101
 or microcapsules
80-86
. At 
least two patents were filed for the HGF self-healing system.
145, 146
 More information on the 
different encapsulation techniques can be found in the following Subsection. 
 
2.5.2 Amine-epoxy healing of quasi-static fracture damage in bulk epoxy 
Vascular networks with the amine-epoxy chemistry were introduced by Toohey et al. 
in a ductile epoxy substrate underneath a brittle epoxy coating via direct-write assembly of 
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fugitive inks.
76
 Using four-point bending, over 60% recovery of the load to failure was 
measured for 16 consecutive self-healing cycles with healing times of 2 days at 30 °C for each 
cycle. Hansen et al. further elaborated this concept using a different vascular arrangement, 
retaining approximately 50% healing efficiency after 30 cycles and yielding up to 100% 
recovery in some cycles.
77
 By applying heat via a third vascular network containing a heat 
transfer liquid, the reaction rate could be enhanced and similar results were obtained after a 
decreased healing time of 4 and 1.5 hours at 50 and 70 °C respectively.
78
 Using a double 
cleavage drilled compression (DCDC) geometry, Hamilton et al. recorded a similar 86% KIC 
recovery in the first cycle, but observed a steady decrease down to 40% in the following 13 
cycles.
79
 This demonstrates that the design of vascular systems has a significant influence on 
the healing efficiency. 
Incorporation of this amine-epoxy self-healing chemistry into microcapsules proved to 
be significantly more challenging than other chemistries due to the reactivity of the amine 
hardener. Although this chapter does not focus on the synthesis of microcapsules, it has to be 
mentioned that three different microcapsule types were tested to incorporate the amines via 
infiltration: nanoporous silica microcapsules
80
, UF-microcapsules
81, 82
 and etched glass 
bubbles
83-86
. The best results were obtained by Jin et al., incorporating 7 wt% of hollow UF-
microcapsules infiltrated with amine hardener in an epoxy material together with 10.5 wt% of 
epoxy resin UF-microcapsules (2:3 weight ratio of capsules).
81
 The epoxy resin contained  
14 wt% of n-butyl glycidyl ether to lower the viscosity. Using a TDCB geometry, a 91% 
recovery of the fracture toughness was measured after 2 days of self-healing at room 
temperature. Unfortunately, reverse diffusion of the amine out of the UF-microcapsules was 
noticed at 120 °C and the healing efficiency also decreased to 68% after six months. These 
stability issues were solved by modifying the healing agent composition and the microcapsule 
shell structure, yielding a stability up to 150 °C and no loss of recovery after six months 
82
. 
The epoxy material with 5 wt% of 111 µm sized UF-microcapsules containing 
polyoxypropylenetriamine (440 g/mol) and 5 wt% of 123 µm sized polyurethane/UF-
microcapsules containing a bisphenol A-based epoxy resin with 26 wt% of o-cresyl glycidyl 
ether as a low viscosity reactive diluent (1:1 weight ratio of capsules), rendered a similar 
fracture toughness recovery of 89%. 
Up to 93% recovery of KIC could also be obtained with an epoxy TDCB geometry 
containing 11 wt% of 67 µm sized etched glass bubbles infused with DETA as the amine 
hardener and 4 wt% of 256 µm sized UF-microcapsules containing an epoxy resin diluted 
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with EPA, but only when heating at 50 °C is applied for 1 day.
83, 85
 In this case, reverse 
diffusion was already observed at 80 °C.
84, 85
 A decline in Young’s modulus and tensile 
strength of respectively 20 and 50% was observed when 15 wt% of healing agent carriers was 
incorporated into the epoxy matrix. 
The self-healing capability of all HGF systems was investigated using impact testing. 
Consequently, the reader is redirected to Subsection 2.5.4, dedicated to that specific damage 
mode, for a discussion on their performance. 
From the results above and the impact tests on the HGF delivery systems, it can be 
concluded that no matter which delivery method was used (Table 2.2), all concepts are 
capable of repairing the screened mechanical property for more than 90%. In view of the 
different compositions, this is the self-healing chemistry yielding the most consistently high 
healing efficiencies. 
 
2.5.3 Amine-epoxy healing of quasi-static fracture damage in bulk matrices other than 
epoxy 
The amine-epoxy self-healing chemistry was also applied in poly(methacrylimide) 
rigid closed-cell foams used as a core for composite sandwich structures. Williams et al. 
fabricated a sandwich structure consisting of a 10.5 or 16 mm thick poly(methacrylimide) 
core and two E-glass fiber-reinforced epoxy skins (0.5 mm thick).
99, 100
 In the core, in-plane 
PVC or silicone tubing with a diameter of 1.5 mm was added and so-called riser holes with 
the same diameter were drilled perpendicular to the laminate plane. This double semi-vascular 
network was then filled with either the epoxy resin or the amine hardener.  
Chen et al. introduced the vascular microchannels closer to the critical failure region 
at the skin-core interface by adding an additional epoxy layer on one side, in between the  
12.7 mm thick poly(methacrylimide) core and the E-glass fiber-reinforced epoxy skin.
101
 In 
this case, the vascular channels were made using steel wire scaffolding. 
Since the authors all focused on the recovery of impact damage in these sandwich 
structures, more details of their performance are given in Subsection 2.5.4.   
 
2.5.4 Amine-epoxy healing of impact damage 
Pang et al. generated 2 mm thick fiber-reinforced epoxy composite panels with  
10 preimpregnated plies of E-glass fibers and 8 plies of HGFs, symmetrically situated in the 
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subsurface region (underneath the first two full glass fiber plies), resulting in a fiber volume 
fraction of 61.5%.
91, 92
 In this case, the HGFs have an outer diameter of 60 µm and a 50% 
hollow fraction. These are then filled with either the amine hardener or the epoxy resin via 
vacuum assisted liquid infiltration, using 30 wt% of acetone to decrease the viscosity of the 
resin. This filling technique was investigated earlier by Bleay et al. for different healing 
agents
90
, demonstrating that a low viscosity is critical to fill these HGFs. Following filling and 
sealing of the HGFs, the fiber-reinforced panels were indented at a load and displacement rate 
set to mimick an impact energy of 0.5 J. Four-point bending was used both before and after 
the indentation step to determine the flexural strength of the composite. A drop in strength 
down to 75% of the original composite was recorded after indentation. After 1 day of self-
healing at room temperature, the flexural strength was restored to 97% of the original value. 
Unfortunately, the authors also noted a severe deterioration of the system’s self-healing 
capability after 9 weeks without a clear cause.
91
  
Additional research was done to further elaborate this HGF system, with 4 HGF layers 
spread out over the complete sample depth.
93, 94
 As shown in Figure 2.6, the fibers released 
the low-viscosity epoxy and amine core throughout the complete damage area after 
indentation fracturing, demonstrating up to 100% recovery of the flexural strength. Carbon 
fiber-reinforced composites were also tested with similar results
95, 96
, but specific attention is 
required to avoid delamination at the plane of the HGFs. This resulted in a significant 
deterioration of the material properties. 
 
 
 
Figure 2.6. Impact damaged cross-section of a 16-ply E-glass fiber-reinforced composite with 4 layers of 
HGFs containing the amine-epoxy healing agents and a UV fluorescent dye, added to the healing agents 
for visualization.
94
 Reproduced from Trask, Williams and Bond with permission from The Royal Society. 
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Impact damage recovery of carbon-fiber reinforced epoxy composites with 
microvascular systems was also researched by Norris et al.
97, 98
 Therefore, vascular channels 
were made by embedding steel wire (0.25 or 0.5 mm in diameter) in a 3.8 mm thick, 28-ply 
composite panel (60 vol%) and removing them after curing. A slightly improved fracture 
toughness was observed due to crack blunting, which is comparable to the crack pinning and 
crack redirecting effects in respectively microcapsule and HGF systems. The authors 
thoroughly investigated the effect of the location, orientation and size of the vascular 
microchannels in the fiber plies.
147, 148
 Following an impact at 10 J that resulted in a 25% loss 
of compression strength, CAI tests revealed over 96% recovery of the original compression 
strength for all vascule locations and sizes after 1 day of healing at room temperature. 
However, the mode of failure in the samples with the vascular channels placed in the centre of 
plies resembled the fracturing in undamaged samples in approximately half of the cases, while 
in the asymmetrically placed channel samples the fracturing behaviour was completely 
different. As stated by the authors, centrally positioned vascular channels were more capable 
of infusing the most severe interlaminar damage regions. Furthermore, the presence of one 
single vascule in the impact zone was sufficient for large-scale damage infusion (Figure 2.7). 
The authors also devised a pressure stimulus triggered and a continuously circulated system, 
yielding recoveries of 94 and 100% respectively. 
 
 
 
Figure 2.7. Vascular channel in a carbon fiber-reinforced epoxy composite demonstrating UV dye doped 
healing agent delivery to an impact damage area.
98
 © IOP Publishing. Adapted from Norris, White, 
McCombe, Chatterjee, Bond and Trask with permission from IOP Publishing. All rights reserved. 
 
The poly(methacrylimide) sandwich structures of Williams et al. (see Subsection 
2.5.3) were impacted at 3 J and analyzed via four-point bending and CAI tests, both before 
and after the impact damage event. In four-point bending tests, the undamaged samples failed 
with the formation of core shear cracks, while the impacted samples demonstrated severe skin 
buckling. After 1.5 days of self-healing at room temperature, core shear cracking was again 
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the dominating failure mode and occurred far from the impact region. Furthermore, the skin 
compressive stress at failure, measured in CAI tests, was significantly reduced after impact, 
but 82% was recovered after self-healing for 2 days at room temperature. However, because 
one of the healing agents did not infiltrate the damage area, most likely due to a blocked riser, 
half of the samples did not heal at all. Pressurizing the sample tubing improved the recovery 
up to 114%. Chen et al. performed a similar analysis on undamaged samples, unhealed 
samples impacted at 7.2 J and impacted samples healed for one week at room temperature.
101
 
Figure 2.8 shows the two different failure modes (skin debonding and core shear cracking) 
occurring in CAI tests, as well as a completely self-healed crack. The healing agents were 
dyed blue for visual clarity. 
 
 
 
Figure 2.8. Different failure modes during compression-after-impact (CAI) testing: (a) a control sample 
with no prior impact, demonstrating skin debonding, (b) a control sample with prior impact damage, also 
resulting in core shear cracking and (c) a self-healing sample with prior impact damage, showing a fully 
healed crack 
101
. © IOP Publishing. Reproduced from Chen, Peters and Li with permission from IOP 
Publishing. All rights reserved. 
 
As concluded similarly in Subsection 2.5.2, independent of the delivery method or 
composition, all concepts are capable of recovering more than 90% of either the flexural or 
compressive strength. Therefore, this self-healing chemistry has a great potential for industrial 
use. 
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2.5.5 Amine-epoxy healing of fatigue damage 
The ability of the amine-epoxy chemistry to self-heal fatigue damage was only tested 
for vascular systems.
87
 In a DCDC epoxy sample, vascular microchannels were created at 5 
mm from the central hole by inserting nylon fibers (230 µm in diameter) in the epoxy matrix 
and removing them after curing. This DCDC geometry is then loaded under cyclic 
compression, generating crack growth at both the top and the bottom of the central hole.  
As discussed in Subsection 2.2.5 for DCPD, Jones et al. could further retard and fully 
arrest fatigue crack growth, only by using faster kinetics in comparison to the work of Brown 
et al. Consequently, the authors in this case also used a rapidly curing amine-epoxy healing 
chemistry. Via DSC measurements, a reaction conversion of 77% was measured after 10 min 
at room temperature.  
In the amine-epoxy samples, the maximum stress intensity factor Kmax ranged from 
0.62 to 0.84 times the quasi-static KIC, a level that is significantly higher than the ones applied 
for the DCPD system. The amine-epoxy self-healing was most effective at impeding slower 
propagating cracks with complete crack arrest at Kmax equal to 0.62 KIC. Also here, this self-
healing effect is attributed to hydrodynamic pressure crack-tip shielding due to viscous flow 
of the healing agents and polymerization with wedge formation in the crack. When the 
applied Kmax was equal to 0.73, 0.78 and 0.84 times KIC, the fatigue life extensions obtained 
were respectively 490% (fatigue life times 6), 380% (times 5) and 80% (almost times 2). At 
the highest Kmax, the healing performance of the dual-compound vascular system and the 
control containing only one healing agent were practically the same, indicating that the 
polymerization reaction was too slow to have any effect on the high crack propagation rate at 
these loads. Consequently, only the hydrodynamic pressure crack-tip shielding was 
responsible for the observed fatigue life extension. 
The pumping rate of healing agents also influenced the fatigue recovery. When the 
healing agents were pumped at rates < 2 µL/h in the case of a 0.62 KIC applied stress 
intensity, obstruction of the vascular channels was noted due to polymerization at the inlet. 
Above that rate, increased fatigue crack retardation occurred. This critical pumping rate 
increased with the applied Kmax, going from 4 µL/h for 0.73 KIC to 10 µL/h for 0.84 KIC. 
To conclude, this self-healing chemistry demonstrates a fatigue damage recovery 
behavior comparable to the DCPD system, but works at a higher stress intensity factor range 
due to the larger volume of healing agent delivered to the crack via vascular channels and 
pumping. 
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2.5.6 Amine-epoxy healing of quasi-static fracture damage in fiber-reinforced 
composites 
Both HGFs and vascular channels containing the two-compound chemistry have been 
applied in fiber-reinforced composites (Table 2.2) and demonstrated outstanding healing 
efficiencies. Most of the compositions and results are already discussed in Subsections 2.5.3 
& 2.5.4. 
Certainly worth mentioning is the study of Patrick et al. on the design of the 
microvascular channels in fiber-reinforced epoxy composites.
88
 As already noticed in 
Subsection 2.5.2, the vascular design has a large influence on the self-healing capabilities. 
The authors stitched a sacrificial poly(lactic acid) fiber in either a parallel or a herringbone 
vascular pattern throughout the 8 plies of 8H satin weave E-glass fabric in the preform, before 
applying vacuum assisted resin transfer molding to insert the epoxy matrix. Two separate 
vascular channels were then infused with the amine of the epoxy resin (1:2 volumetric ratio). 
From the 4 mm thick composite panels, DCB test samples were cut to assess the recovery of 
interlaminar fracture resistance, demonstrating over 100% healing efficiency after 2 days of 
self-healing at 30 °C in the herringbone architecture. These herringbone samples also allowed 
for three consecutive cycles at 100% recovery due to better mixing of the healing agents in 
the crack area. Both the parallel and herringbone design showed an increased fracture 
resistance of respectively 3 and 10%, attributed to crack-tip blunting. 
The influence of these kind of stitched vascular systems on the tensile properties of 
and damage evolution in fiber-reinforced composites was further investigated for different 
patterns, indicating modest reductions in the tensile strength and Young’s modulus.149 The 
damage progression was only affected in a limited way. 
 
2.6 Thiol-epoxy-based healing system 
This dual capsule approach, combining multifunctional thiols and epoxy resins as 
healing agents (Scheme 2.6), demonstrates very good healing results and also industrial 
applicability due to its thermal stability. One drawback is the requirement of a catalyst for the 
reaction to proceed rapidly. Only self-healing of epoxy materials has been investigated with 
this chemistry. The studies of quasi-static fracture, impact and fatigue damage are discussed 
below.  
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Scheme 2.6. Reaction of TetraThiol and bisphenol A diglycidyl ether with the formation of a thio-ether 
polymer network. 
 
2.6.1 Thiol-epoxy healing chemistry 
Yuan et al. introduced this self-healing chemistry in 2008
102
, by combining a low-
viscosity diglycidyl 1,2,3,6-tetrahydrophthalate (DTP) epoxy resin (Scheme 2.7) with 
pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol, Scheme 2.6) and benzyl-N,N-
dimethylamine (BDMA, Scheme 2.7) as a tertiary amine catalyst. As a result of deprotonation 
of the thiol-functional group by the amine catalyst, its nucleophilicity is strongly increased, 
allowing the nucleophilic ring-opening reaction with the epoxide to proceed rapidly at room 
temperature. Since the thiol and epoxide also react slowly without catalyst, these were 
incorporated in separate melamine-formaldehyde (MF) microcapsules following the same 
procedure
150
. Because the basic amine catalyst could not be co-encapsulated, the 
microcapsules containing TetraThiol are infiltrated with the catalyst by immersion.
102
 
 
 
Scheme 2.7. Epoxy resins and tertiary amine catalysts used in the thiol-epoxy self-healing concept. 
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As stated above, this exothermic thiol-epoxy reaction is relatively fast. An isothermal 
DSC study indicated that most of the reaction heat is developed within 1 hour at 20 or 30 °C, 
leading to almost full cure of the network.
102
 When the thiol-epoxy reaction was studied on 
the crack surface of a self-healing epoxy sample using confocal Raman spectroscopy, a 50% 
epoxide group conversion was observed within 30 min.  
A full parameter investigation was performed using other epoxy resins and catalysts, a 
similar trifunctional thiol and different capsule ratios and sizes.
103
 A bisphenol A diglycidyl 
ether-based epoxy resin (EPON 828, Scheme 2.7) was tested, together with  
2,4,6-tris(dimethylaminomethyl)phenol (DMP-30, Scheme 2.7) and triphenylphosphine (TPP) 
as catalysts. The catalysts demonstrated a decreasing reaction rate in the following order: 
DMP-30 > BDMA > TPP. It has to be noted that TPP was not miscible with TetraThiol and 
was incorporated as such in the epoxy matrix instead.  
Temperature stability tests were performed on the microcapsules. TGA and DSC 
measurements revealed that the DTP/TetraThiol/BDMA healing system is stable up to  
150 °C
102
, while the EPON 828/TetraThiol/DMP-30 microcapsule system could be used up to 
200 °C
108
. Thermal aging was also evaluated both before (see also Subsection 2.6.2)
108
 and 
during the self-healing process
104
. 
 
2.6.2 Thiol-epoxy healing of quasi-static fracture damage in bulk epoxy 
Both thiol-epoxy systems mentioned above obtained similar self-healing results. When 
2.5 wt% of 93 µm sized MF-microcapsules containing DTP and 2.5 wt% of 
TetraThiol/BDMA MF-microcapsules were added into an epoxy TDCB geometry, a fracture 
toughness recovery of 105% was measured after 1 day of healing at room temperature.
102
 
Furthermore, 82 and 88% recovery could already be obtained after 3 hours at respectively  
20 °C and 30 °C, while 100% was only exceeded after 12 hours. Although the reaction slowed 
down significantly when cooled below room temperature, still 86 % recovery was achieved 
after 36 h at -10 °C. This is possible due to the low freezing points of -51 and -68 °C for DTP 
and TetraThiol respectively. Both MF-microcapsules used were also very stable over time: 
after 1 year, less than 1 wt% of the core was lost. Addition of 10 wt% of microcapsules 
reduced the elastic modulus by 5% and the tensile strength by 28%, while the fracture 
toughness was increased by approximately 15% due to crack pinning upon fracture. 
A recovery value of 105% was also obtained with 10 wt% of EPON 828 containing 
microcapsules and 10 wt% of TetraThiol/DMP-30 microcapsules, even when the TDCB 
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samples were exposed to 200 °C for 12 hours prior to the measurements.
108
 Below this 
temperature, no loss of performance caused by either thermal degradation or leakage of the 
microcapsules is noticed. Also in this case, the 20 wt% of added capsules increased the 
fracture toughness of the original epoxy material (by 20%). Additionally, medium (140 °C) 
and high (180 °C) temperature curing epoxy matrices were tested and demonstrated similar 
recovery results compared to the low temperature (40 °C) curing material. 
 
2.6.3 Thiol-epoxy healing of impact damage 
Yuan et al. also researched low-velocity impact damage self-healing in woven glass 
fabric-reinforced epoxy composites.
105
 Using a hand lay-up process, 2.1 mm thick panels with 
4 plies of plain woven C-glass fiber fabric (41 vol%) were made, applying an epoxy resin 
with 12 wt% of the combined multithiol and epoxy containing MF-microcapsules. 
Microcapsules of approximately 10, 50 and 100 µm in diameter were used separately to 
investigate the effect of both size and delivered healing agent volume. The larger 
microcapsules were mainly found in interstitial regions where the fiber bundles cross, while 
the smallest capsules could also penetrate the interior of fiber bundles. 
Changing the impact energy resulted in different fracture patterns. Low impact energy 
tests (1.5 J) only caused matrix cracking, while increasingly higher impact energies  
(2.5 – 5.5 J) induced delamination and finally fiber fracture. Also puncture damage with a 
high energy impact of 15 J was investigated. Addition of the microcapsules decreased the 
impact modulus, but slowed down internal crack propagation and showed a small toughening 
effect in the maximum damage load. Acoustic through-mode scans were then used to 
visualize the damage before and after self-healing. Following a 1.5 J energy impact, a damage 
area reduction of 18, 85 and 97% was noticed after respectively 30 min, 6 and 12 hours at 
room temperature. The damage area after a higher energy impact of 3.5 J was only 52% after 
1 day of self-healing. This decrease can be explained by the larger damage volume, type of 
damage and the limited damage accessibility in fiber-rich regions. CAI measurements 
indicated true mechanical recovery, showing an RCS recovery up to 86%. 
Although very promising results were achieved, no further studies on fiber-reinforced 
epoxy composites were performed with this chemistry. 
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2.6.4 Thiol-epoxy healing of fatigue damage 
The self-healing of fatigue damage was also studied by Yuan et al.
106, 107
, by adding  
10 wt% of 100 µm sized MF-microcapsules containing epoxy resin and 10 wt% of 100 µm 
sized TetraThiol/DMP-30 MF-microcapsules. The epoxy mixture in this case consisted of a  
1:1 ratio between bisphenol A diglycidyl ether (EPON 828) and resorcinol diglycidyl ether  
(J-80, Figure 15). Addition of these microcapsules caused an increase in fracture toughness as 
mentioned in Subsection 2.6.2, resulting in slower crack propagation during fatigue testing. A 
TDCB geometry was used for fatigue tests at room temperature with different stress intensity 
factor ranges (∆KI).  
First, high cycle tests with a low ∆KI (0.504 MPa.m
1/2
) were performed on both 
control and self-healing compositions. In comparison, the KIC of the neat and self-healing 
epoxy was measured at respectively 0.587 and 0.695 MPa.m
1/2
. Manual injection of the  
epoxy resin/TetraThiol mixture without a tertiary amine catalyst rendered a fatigue life 
extension of about 200% (fatigue life times 3, see Figure 2.9), fully related to hydrodynamic 
pressure crack-tip shielding by the viscous liquid mixture during cyclic loading. Embedding 
the same mixture without the catalyst in microcapsules yielded an extension of about 1200% 
(fatigue life times 13) due to the additional toughening effect of the microcapsules on the 
resistance to fracture.  
 
 
 
Figure 2.9. Crack length as a function of the number of cycles in fatigue testing of (a) a neat epoxy sample, 
(b) a manually healed sample, (c) a control sample with thiol-epoxy microcapsules but lacking the tertiary 
amine catalyst and (d) a thiol-epoxy self-healing sample including the amine catalyst.
107
 Reproduced from 
Yuan, Rong, Zhang, Yang and Zhao with permission. 
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In the case of fully autonomous self-healing samples, polymeric wedge formation and 
adhesive bonding also played a role, leading to full crack arrest and an “infinite” fatigue life at 
this low ∆KI (Figure 2.9d). Mainly cohesive failure is noticed in this case. When the ∆KI 
value is increased to 0.554 MPa.m
1/2
,
 
crack growth was only slowed down and not arrested, 
yielding a fatigue life extension of about 600%. Both cohesive and adhesive failure was 
observed when ∆KI was higher. A further increase in ∆KI (approaching KIC) rapidly decreased 
the healing efficiency to zero. However, when a rest period of 10 min was introduced at a 
high ∆KI (0.605 MPa.m
1/2
), a fatigue life extension of about 1300% was obtained. 
Similar results were obtained when the samples were exposed to 200 °C for 12 hours 
prior to the measurements (using only the EPON 828 resin for thermal stability reasons).
108
 
No fatigue testing was done on fiber-reinforced composites. 
In comparison to earlier mentioned fatigue self-healing, it can be concluded that this 
self-healing chemistry seems to work faster with a similar efficiency, resulting in longer 
fatigue life of the epoxy materials. 
 
2.7 Thiol-ene-based healing system 
The radical thiol-ene reaction was tested in an acrylate-based material for its self-
healing capabilities. While this system could be useful, it did not demonstrate very good 
quantitative healing efficiencies in a fully autonomous extrinsic design, leaving space for 
further research and improvement. 
 
2.7.1 Radical thiol-ene healing chemistry 
The radical thiol-ene addition reaction was introduced in the field of self-healing by 
Van den Dungen et al. in order to recover damage in poly(methyl acrylate), styrene-acrylate 
and pure acrylic coatings.
109, 110
 The authors combined separately encapsulated TetraThiol 
with either a diacrylate (1,6-hexanediol diacrylate) or a dinorbornene (1,6-hexanediol 
di(norborn-2-ene-5-carboxylate)) to form a thio-ether containing network (Scheme 2.8). The 
network formation was accelerated at room temperature by the radical photoinitiator  
2,2-dimethoxy-2-phenylacetophenone (DMPA) dispersed in the coating and applying UV 
irradiation for 1 hour.  
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Scheme 2.8. Reaction of TetraThiol and 1,6-hexanediol diacrylate or 1,6-hexanediol di(norborn-2-ene-5-
carboxylate with the formation of a thio-ether polymer network. The reaction is triggered using  
2,2-dimethoxy-2-phenylacetophenone (DMPA) as a radical photoinitiator. 
 
The diacrylate and TetraThiol healing agents were incorporated in UF-micro- or 
nanocapsules (respectively 1-10 µm or 100-350 nm in size), while the dinorbornene 
compounds were enclosed in polystyrene nanocapsules. With 10 wt% of TetraThiol and  
15 wt% of dinorbornene nanocapsules embedded in a poly(methyl acrylate) coating for 
example, only partial recovery of a cut in the coating was observed. The same was noticed for 
the diacrylate containing samples. This was attributed to either aggregation of the 
microcapsules or the limited amount of healing agent delivered to the crack by the 
nanocapsules. No quantitative healing degree was determined. 
The authors visualized the release of TetraThiol in the cut with a rhodamine-based 
fluorescent probe dispersed in the poly(methyl acrylate) matrix.
151
 This probe generated an 
intense Rhodamine fluorescence signal due to reaction with the released multifunctional thiol, 
demonstrating that TetraThiol was present over the entire length of the cut. 
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2.8 Azide-alkyne-based healing system 
The Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reaction was only used for 
the self-healing of poly(isobutylene) (PIB) materials. 
 
2.8.1 Azide-alkyne healing chemistry 
Gragert et al. investigated the CuAAC reaction for self-healing of a high molecular 
weight (250,000 g/mol) PIB matrix using the dual microcapsule approach.
111
 This Cu(I)-
catalyzed Huisgen 1,3-dipolar cycloaddition reaction, defined as a “click” reaction by 
Sharpless et al.
152
, combines an alkyne and azide to form a very stable 1,2,3-triazole ring. The 
reaction only proceeds at room temperature when the Cu(I)-catalyst is present. For 
autonomous self-healing, the authors thus required a Cu(I)-catalyst suitable for fast 
crosslinking.  
As shown in Scheme 2.9, two liquid multivalent alkynes were combined with a liquid 
azido-telechelic three-arm-star PIB (Mn = 3,900 g/mol), made via cationic polymerization and 
end group modification, to form triazole-crosslinked networks. The Cu(I)Br(PPh3)3 catalyst 
showed the fastest gelation time at elevated temperatures (380, 60 and 10 min at respectively 
40, 60, 80 °C) but also works at room temperature. This low temperature reactivity is also 
explained by the autocatalytic effect of the 1,2,3-triazole rings on subsequent azide-alkyne 
“click” reactions, as seen by an increase in reaction rate while the reaction proceeds.153, 154 
Nevertheless, the authors still apply 5 days of healing time to ensure proper healing.  
 
 
 
Scheme 2.9. Reaction of the low molecular weight alkynes and the liquid polymeric trivalent azide with 
the formation of a 1,2,3-triazole crosslinked network.
111
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2.8.2 Azide-alkyne healing of quasi-static fracture damage in bulk matrices other than 
epoxy 
For obtaining self-healing samples, 10 wt% of 21 µm sized UF-microcapsules 
containing trivalent polymeric azide and 5 wt% of alkyne UF-microcapsules were 
incorporated in the poly(isobutylene) (PIB) matrix material. The healing agents were 
encapsulated in separate microcapsules for immiscibility and thermal stability reasons. The 
three-arm-azide (10 wt%) was dissolved in decalin to generate non-aggregated microcapsules. 
2 wt% of Cu(I)Br(PPh3)3 catalyst was added to the PIB matrix, together with 4wt% of  
tris[(1-benzyl-1H-1,2,3-triazole-4-yl)methyl]amine as a base. This base further enhanced the 
catalytic process, but also protected the catalyst from degradation. 
During a dynamic mechanical analysis (DMA) tensile test, 150% strain was applied 
and the tensile storage modulus was determined at low amplitudes. A significant decrease of 
30% was measured, most likely due to release of the healing agents from the broken 
microcapsules. Then, the samples were allowed to heal for 5 days at room temperature or at 
60 °C, yielding a nearly full recovery of the tensile storage modulus of respectively 91% and 
107%.  
Clearly, the first results are promising. However, no matrices comparable to the other 
chemistries have been used and only DMA testing has been applied. Apart from the healing 
agents, also a solvent, a base and a catalyst are required. Further research would have to point 
out if this well-known chemistry is suitable for self-healing of other matrices and polymer 
composites. 
 
2.9 Acylhydrazine/methacrylate-based healing system 
Recently, an acylhydrazine/methacrylate double chemistry strategy was applied to 
self-heal impact damage volumes about two orders of magnitude larger than any other self-
healing system. Although the healing agent system is relatively complex, this concept was the 
first to demonstrate significant mechanical recovery of an epoxy material that sustained large 
volumetric loss. Furthermore, a novel multistep approach was used in this strategy. 
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2.9.1 Acylhydrazine/methacrylate healing chemistry 
White et al. looked into self-healing of large damage volumes in 3 mm thick epoxy 
sheets.
112
 By using a vascular delivery system with a two-stage self-healing chemistry, 
comprising a gelation step and then a solidification step, large gaps could be filled and healed. 
The acid-catalyzed gelation shown in Scheme 2.10a takes place within several minutes 
forming a self-supporting viscoelastic scaffold, while the bulk polymerization to a structural 
solid (Scheme 2.10b) takes place within 1-2 hours, generating a stiff polymer material similar 
to an interpenetrating network. 
 
 
Scheme 2.10. (a) Gel formation: reaction of acylhydrazine-terminated PEG (Gelator A) with tris[(4-
formylphenoxy)methyl]ethane (Gelator B) under the influence of an acid gel catalyst; (b) Solidification 
reaction via either radical polymerization of 2-hydroxyethyl methacrylate (HEMA) or thiol-ene Michael 
addition of trimethylolpropane tris(3-mercaptopropionate) (TTMP) with 1,3-glyceryl dimethacrylate 
(GDMA). Methyl ethyl ketone peroxide (MEKP), cobalt naphtenate (CoNp) and Cupferron are the 
initiator, promoter and inhibitor for their respective reactions.
112
 
 
The gelation stage consists of an acid-catalyzed condensation reaction between 
Gelator A, a bis-acylhydrazine-terminated poly(ethylene glycol) (PEG), and Gelator B, the 
trifunctional aldehyde tris[(4-formylphenoxy)methyl]ethane (Scheme 2.10a). This 
crosslinking reaction generates a semi-solid gel with dynamic acylhydrazone bonds. These 
dynamic bonds enable continuous growth of the gel when fresh healing agents are added and 
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as such allow deposition of newly formed material without being dependent on surface 
tension forces only. To make this possible, gelation and deposition have to occur within 
approximately the same time scale. 
Two different approaches were tested for the solidification stage. On the one hand, a 
radical polymerization of 2-hydroxyethyl methacrylate (HEMA) was investigated (Scheme 
2.10b), using a radical redox reaction between the methyl ethyl ketone peroxide (MEKP) and 
the cobalt naphtenate (CoNp) promoter to initiate the process. On the other hand, a thiol-ene 
Michael addition between trimethylolpropane tris(3-mercaptopropionate) (TTMP) and 1,3-
glyceryl dimethacrylate (GDMA) was utilized. As stated by the authors, the monomers were 
selected to fit stringent requirements, comprising a high boiling point, non-wetting properties, 
a low viscosity, suitable cure kinetics and the ability to dissolve the gelation monomers.  
This two-stage curing system was finetuned for its self-healing purpose at room 
temperature by modifying the amount of gel catalyst or promoter. In the thiol-ene system, 
cupferron was added as an inhibitor to slow down the thiol-ene polymerization rate and as 
such avoid premature stiffening. Two separate storage modulus plateaus were measured with 
DMA for the gel and solidification stage, in which the latter is several orders of magnitude 
higher than the former one.  
 
2.9.2 Acylhydrazine/methacrylate healing of quasi-static fracture damage in bulk 
epoxy 
The acylhydrazine/methacrylate self-healing system was incorporated in an epoxy 
matrix using two separate vascular channels, each containing a different, stable and low 
viscous monomer solution, as indicated in Table 2.3. 
Using samples with a controlled filling volume, holes up to 9 mm in diameter could be 
filled with the acylhydrazine/methacrylate vascular system, while non-gelling control 
solutions only could fill gaps up to 6.3 mm in diameter. Applying nitrogen pressure to one 
side and measuring the output on the other side indicated that complete sealing of a hole with 
a diameter of 7.5 mm was obtained after 1 day of self-healing at room temperature. Next, the 
self-healing epoxy plates were impacted with a 4 mm wide striker, generating a hole with 
radiating cracks up to 35 mm in diameter. Closing of the gap was managed within 20 min 
and, already after 3 hours, approximately 60% sealing efficiency was achieved when applying 
the same nitrogen pressure. When the healed samples were then re-impacted, a 62% recovery 
of total absorbed energy was measured. 
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Table 2.3. Content of the vascular channels in the two different acylhydrazine/methacrylate healing 
systems.
112
 
 
 HEMA thermoplast Thiol-ene thermoset 
Vascular channel 1 Gelator A (56%) 
Gel catalyst 
HEMA 
CoNp promoter 
 
Gelator A (56%) 
Gel catalyst 
GDMA (30%) 
TTMP 
Cupferron inhibitor 
CoNp promoter 
Vascular channel 2 Gelator A (44%) 
Gelator B 
HEMA 
MEKP initiator 
Gelator A (44%) 
Gelator B 
GDMA (70%) 
MEKP initiator 
 
As a conclusion, it can be noted that even more complex self-healing systems are able 
to self-heal materials to a significant extent. Furthermore, by controlling reaction kinetics, 
macro-scale damage of several millimeters in diameter can be healed. This self-healing 
system indicates that a general healing chemistry can be finetuned to fit a specific application 
and this concept is expected to trigger more research in the direction of self-healing of macro-
scale damage. 
 
2.10 Glycidylmethacrylate-based healing system 
The self-healing concept based on reacting encapsulated glycidylmethacrylate with 
residual amines in the matrix was only used in epoxy materials. Although a solvent effect is 
also present, this healing chemistry might only result in significant results in amine-
containing matrices as discussed below. 
 
2.10.1 Glycidylmethacrylate healing chemistry 
Meng et al. introduced the bifunctional glycidylmethacrylate (GMA, Scheme 2.11) as 
a healing agent for epoxy matrices.
113
 As stated by the authors, GMA is non-toxic, has a low 
viscosity and a high boiling point (189 °C), making it very suitable for self-healing 
applications. Since GMA is miscible with the epoxy resin, its compatibility also leads to a 
solvent effect as described in Subsection 2.4.1 for solvent-epoxy self-healing, inducing 
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swelling of the epoxy matrix and at the same time forming hydrogen bonds with the present 
hydroxyl and tertiary amine groups. The epoxide and methacrylate group of GMA can then 
react via respectively a ring-opening or Michael addition reaction with residual primary and 
secondary amines in the matrix as shown for primary amines in Scheme 2.11, thus only 
requiring a single healing agent. This mechanism could inhibit its self-healing capability in 
other matrices that do not contain residual primary or secondary amines. In that case, addition 
of amine containing microcapsules might be necessary. 
 
 
 
Scheme 2.11. Reaction of glycidyl methacrylate with primary amines. 
 
2.10.2 Glycidylmethacrylate healing of quasi-static fracture damage in bulk epoxy 
To obtain autonomous self-healing samples, 10 wt% of 190 µm sized GMA  
MF-microcapsules were added to both an epoxy matrix with a stoichiometric weight ratio of 
100:12 epoxy/DETA and an excess amine ratio of 100:20 to provide primary and secondary 
amines at the crack surface. It has to be noted that the used epoxy in stoichiometric ratio with 
its hardener, at the curing conditions applied, is only 85% cured and thus also has residual 
primary and secondary amine groups in the matrix.
155
 Using the TDCB geometry and 
allowing the samples to heal for 3 days at room temperature yielded a 75% fracture toughness 
recovery in the stoichiometric epoxy material, while over 90% was obtained for the matrix 
with an excess of DETA hardener. Although the authors fully attribute the former result to the 
solvent effect and hydrogen bonding, the covalent bonding effect due to residual amine 
groups cannot be excluded. The latter result confirms the positive influence of an increased 
amount of primary or secondary amine groups. 
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Although this self-healing system is dependent on the presence of amine groups, it 
demonstrates good results for epoxy materials. The simplicity of only having to add one type 
of microcapsules is definitely a clear advantage over many other systems, which might be 
beneficial for the use in fiber-reinforced composites. 
 
2.11 Maleimide-based healing system 
The maleimide self-healing chemistry is based on the Diels-Alder reaction of 
maleimides with furan rings. So far, only epoxy thermosets have been given self-healing 
properties with this extrinsic system. As discussed below, promising results are achieved, but 
some disadvantages might lead to industrial restraint. The non-autonomous system using a 
meltable reversible Diels-Alder gel is not discussed in this chapter.
156
 This chemistry has also 
been applied in an epoxy coating for corrosion protection.
157
 
 
2.11.1 Maleimide healing chemistry 
Peterson et al. first investigated the Diels-Alder reaction between maleimides and 
furans as an extrinsic healing agent system in 2010.
116
 Therefore, the authors added 40 wt% of 
furfurylglycidyl ether (FGE, Scheme 2.12) to the epoxy resin (EPON 828) and cured it with 
4,4’-methylene biscyclohexanamine (MBCA) to generate a furan-functionalized epoxy 
thermoset. The authors then dissolved N,N’-(methylene-di-4,1-phenylene)bismaleimide 
(MBM) in dimethylformamide (DMF) at a maximum concentration of 0.58 M (approximately 
22 wt%) and used manual injection of this solution into the crack to self-heal the epoxy 
matrix. In later publications by the same group, different solvents and multifunctional 
maleimides were also tested.
114, 115
 Apart from DMF, toluene and phenyl acetate were applied, 
demonstrating a different matrix swelling behavior, which is discussed below.  
N,N’-(2,2,4-trimethylhexane-1,6-diyl)bismaleimide (TMBM, Scheme 2.12) and 
poly(phenylmethane maleimide) (PMM) with n = 0.5 (on average 2.5 maleimide moieties per 
molecule) were investigated as alternative maleimide healing agents. 
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Scheme 2.12. Self-healing of a furan-functionalized epoxy thermoset with a bismaleimide solution in 
phenyl acetate. 
 
In this self-healing system, the primary self-healing mechanism is covalent bond 
formation between the furan-functionalized epoxy matrix and the maleimide healing agents, 
but a secondary solvent effect also contributes to the self-healing via swelling of the matrix 
and consequently mechanical interlocking (also discussed in Subsection 2.4.1 for solvent-
epoxy self-healing). Swelling is actually required to bring both crack surfaces into close 
contact with each other in order to bridge the gap with the maleimide healing agent (Scheme 
2.12). Consequently, when insufficient swelling takes place, no covalent bonding between 
both crack surfaces and limited self-healing will be obtained. In swelling tests, a maximum 
mass uptake by the epoxy material of 170, 40 and 150% was noticed for DMF, toluene and 
phenyl acetate respectively, indicating DMF and phenyl acetate as the solvent of choice. 
As indicated in Table 2.4, the solubility of the multifunctional maleimides in these 
solvents is very different. For all three maleimides, the polar DMF clearly dissolves the 
highest concentration, while toluene is the least performing solvent. However, using the 
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regular emulsion polycondensation reaction to encapsulate this maleimide solution for 
autonomous delivery to the crack, only the water immiscible solvents are suitable. For this 
reason, and because TMBM yielded the best self-healing results in preliminary tests, UF-
microcapsules containing a TMBM/phenyl acetate solution were generated.  
 
Table 2.4. Solubility of maleimide healing agents in different solvents.
115
 
 
 Maximum concentration (M) 
Maleimide DMF toluene phenyl acetate 
MBM 0.58 - 0.13 
TMBM 1.16 0.30 0.40 
PMM 1.46 - 0.42 
 
2.11.2 Maleimide healing of quasi-static fracture damage in bulk epoxy 
Preliminary compact tension (CT) tests using manual injection to deliver the healing 
agent solution into the fractured furan-epoxy matrix, indicated 80% recovery of the initial 
strength with a TMBM/phenyl acetate solution (0.40 M or 12 wt%) after 1 day of healing at 
room temperature.
115
 In comparison, phenyl acetate only yielded 44% recovery (similar to 
DMF). Manually injecting a 0.58 M MBM/DMF solution, showed an equally significant 70% 
recovery of load at failure after 12 hours of healing at room temperature, compared to 28% 
recovery with DMF only.
116
 Similar results were obtained after 1 day, while increasing the 
healing time to 20 days yielded a 90% recovery.
114
 In the latter case, solvent diffuses away 
from the crack, resulting in a more dry and stronger system with covalent bonding. 
Pratama et al. obtained the best autonomous self-healing results with a 10 wt% 
amount of 181 µm sized UF-microcapsules, containing a 0.13 M (approximately 4 wt%) 
solution of TMBM in phenyl acetate, embedded in the furan-functionalized epoxy matrix.
115
 
Encapsulation of higher TMBM concentrations could not be done due to early precipitation of 
the TMBM from the emulsion, rendering low microcapsule yields. Using a CT geometry, 
71% recovery of the initial strength was achieved after 1 day of healing at room temperature, 
in comparison to 43% with microcapsules containing only phenylacetate. This clearly 
indicated that, next to the solvent effect, also a significant amount of recovery was obtained 
via the Diels-Alder covalent bonding.  
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Additionally, the authors suggested the use of hollow glass fibers, and are 
investigating the application in other thermosetting matrices such as epoxy vinyl esters and 
polyurethanes. 
 
2.11.3 Maleimide healing of quasi-static fracture damage in fiber-reinforced 
composites 
Unfortunately, only manual injection of the healing agent was used to repair fiber-
reinforced composite materials with the maleimide healing chemistry.
116
 Three test 
procedures were applied: flexural three-point bend, short beam shear and DCB tests.  
6.35 mm thick fiber-reinforced composite panels with 14 plies of woven E-glass fabric 
(24 vol%) were made via resin transfer molding. Three-point bending tests were then 
performed on rectangular samples until failure. This was followed by drilling holes in the 
failure site to manually inject the healing agent. After a healing time of 1 day at room 
temperature, a negative healing efficiency was observed, because this value was calculated in 
relation to the residual strength of the material and not the strength of the virgin composite. 
After 7 days, a positive 48% recovery was obtained. Short beam shear tests were performed 
on the same panels, using glass capillary tubes through which the healing agent was manually 
delivered. Again, 1 day of room temperature healing yielded negative results, while after 7 
days up to 37% recovery of peak load to failure was achieved.  
Finally, mode I interlaminar fracture was tested with a DCB geometry. After the first 
fracture, the healing agent solution was injected into the opened crack. Room temperature 
healing for 7 days rendered up to 68% recovery of the interfacial strength. Approximately 
70% of the interlaminar failure was adhesive failure of the matrix-fiber interface, where no 
healing is possible due to the absence of furan functional groups on the glass. 
 
2.12 Isocyanate-based healing system 
The isocyanate reaction with polyols or water has been applied for self-healing of 
polyisocyanurate and epoxy materials respectively. With the generation of a foam for self-
healing of macro-scale damage and the retardation of wear damage, two new concepts have 
been introduced with this chemistry. Although not discussed in this chapter, this chemistry 
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has also been applied in the recovery of the corrosion protection properties of epoxy 
coatings.
83
 
 
2.12.1 Isocyanate healing chemistry 
Microvascular channels, separately containing the two healing agents that generate 
foams in damaged areas, were introduced in polyisocyanurate rigid foams by Patrick et al.
119
 
This commercial two-compound polyurethane foam formulation on the one hand comprises 
methylene diphenylene diisocyanate and on the other hand a blend of polyols, 
hydrofluorocarbon blowing agents and a chlorinated phosphate ester flame retardant. Upon 
coming into contact with one another in a crack, these healing agents will undergo a 
volumetric expansion because the reaction heat of the nucleophilic addition of the alcohol to 
the isocyanate causes the blowing agents to evaporate. In this way, far larger macro-scale 
damage can be filled and repaired compared to the thermoset network forming concepts. As 
determined by rheometry, this isocyanate-polyol chemistry only needs 24 minutes at room 
temperature to reach its gel point. 
Both Keller
117
 and Khun
118
 made use of the reactivity of isocyanates towards water to 
self-heal wear damage in epoxy materials. As mentioned earlier in Subsection 8.1, isocyanates 
form amines when reacting with water and react further with other isocyanates to form strong 
urea-bonds (Scheme 2.13). The rate of the reaction is determined by the nucleophilic addition 
of water with the isocyanate. Both authors encapsulated hexamethylene diisocyanate in PUR-
microcapsules for this self-healing purpose, using an earlier described interfacial 
polymerization method.
158, 159
 
 
 
Scheme 2.13. Reaction between isocyanates via the consecutive formation of N-substituted carbamic acids 
and amines in the presence of water. 
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2.12.2 Isocyanate healing of quasi-static fracture damage in bulk matrices other than 
epoxy 
In order to assess the quasi-static fracture self-healing capabilities of the isocyanate-
based chemistry, Patrick et al. introduced microvascular channels in a SENB geometry of a 
closed-cell polyisocyanurate foam.
119
 The closed-cell structure allowed the incorporation of 
two 970 µm sized vascular channels, each containing one of the foaming compounds. In this 
way, over 100% recovery of the fracture toughness was obtained in the best arrangement after 
1 day at room temperature. When retesting the sample, this high recovery resulted in cracks 
deviating from the original crack path. The polyurethane foam formation in the crack is 
visualized in Figure 2.10. A small decrease in stiffness and KIC of respectively 11 and 9% 
was noted due to the presence of horizontally aligned vascular channels or 2 and 3% for 
vertically aligned channels. Up to four damage recovery cycles could be repaired, after which 
the isocyanate channels got blocked by healed foam. 
 
 
 
Figure 2.10. New polyurethane foam formation in the crack of a vascular self-healing polyisocyanurate 
rigid foam.
119
 Reproduced from Patrick, Sottos and White with permission from Elsevier BV. 
 
2.12.3 Isocyanate healing of fatigue damage 
Keller et al. embedded 10 wt% of HDI containing microcapsules to test the self-
healing of wear damage in a 3.2 mm thick epoxy coating applied on an aluminum plate.
117
 
Sand erosion tests were performed by spraying sand particles under a 90° angle onto the 
epoxy coating. Samples were consecutively eroded over a 2 week period and healed for 1 day 
at room temperature. The authors noticed that non-reactive cores have a significant negative 
impact on the erosion performance of epoxy coatings with a 337% greater mass loss 
compared to the neat epoxy due to immediate loss of core material. As such, it is very likely 
that solvent healing does not work with erosive damage. With HDI as a reactive compound on 
the other hand, a lower 43% additional material loss was recorded in comparison to neat 
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epoxy. This still means that a regular epoxy coating performs better than a self-healing epoxy 
coating in the case of erosive damage, indicating that this kind of microcapsule self-healing 
does not work for all forms of damage. 
However, the same concept renders an added value for the self-healing of wear 
damage due to friction in an epoxy material.
118
 In order to assess the self-healing potential, 
Khun et al. slided a steel ball over the self-healing epoxy surface at a speed of 3 cm/s under a 
load of 1 N for 17 x 10
4
 laps. Up to 15 wt% of 104 µm sized HDI PUR-microcapsules were 
embedded in the epoxy matrix. The authors noticed that the addition of this amount of 
microcapsules decreased the mean friction coefficient from 0.72 for the neat epoxy to 0.66 for 
the self-healing material, indicating a lubricating effect of the HDI healing agent. 
Furthermore, the formation of new polyurea layers in the wear path was observed. Both 
effects lead to a decrease in the wear width and depth with increasing capsule content. 
However, both the hardness and Young’s modulus of the epoxy material were significantly 
lowered by approximately 28% of the original value. 
 
2.13 Cyanoacrylate-based healing system 
Cyanoacrylates are mostly known for their use in super glues, demonstrating 
extraordinary adhesive properties. Although this one-part healing agent concept was already 
mentioned in some of the very first self-healing publications, it had not been elaborated 
further until recently. To our knowledge, it is the only chemistry that has been used in fiber-
reinforced polyester composites so far. 
 
2.13.1 Cyanoacrylate healing chemistry 
The use of a single-part cyanoacrylate healing agent was also introduced by Dry in 
1996.
89
 Therefore, HGFs were filled with a cyanoacrylate liquid and added to an epoxy 
matrix. Upon fracture of this material, the cyanoacrylate comes into contact with moisture 
from the air and as such starts a rapid anionic homopolymerization (Scheme 2.14). 
Cyanoacrylates in super glues already show adhesion after seconds to minutes at room 
temperature, but reach their full strength only after multiple hours depending on the humidity. 
Similar results can be expected in self-healing materials. The fact that only one healing agent 
is required, certainly is a major advantage for self-healing applications, eliminating mixing 
issues or the use of catalysts. 
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Scheme 2.14. Anionic polymerization of methyl 2-cyanoacrylate initiated by hydroxyl anions in ambient 
moisture. 
 
2.13.2 Cyanoacrylate healing of impact damage 
Next to the amine-epoxy self-healing chemistry, Dry demonstrated that single-part 
cyanoacrylate healing agents incorporated in HGFs have the ability to deflect cracks from the 
original crack path in the epoxy matrix after self-healing for long times (up to 8 months).
89
 
However, no further quantification was performed.  
Bleay et al. tried incorporating cyanoacrylates in a HGF-containing 24-ply S2-glass 
fiber composite with a thickness of 6.5 mm.
90
 Unfortunately, the HGFs with an external and 
internal diameter of 15 and 5 µm could not be filled with the vacuum assisted liquid 
infiltration technique, probably due to HGF ends being blocked by cured cyanoacrylate. 
Therefore, the cyanoacrylate healing agents were not further tested. As suggested by the 
authors, larger diameter HGFs could solve this problem. The HGFs with an outer diameter of 
60 µm used by Pang et al. (see Subsection 2.5.4) could be useful, although the authors in this 
case added 30 wt% of acetone to the epoxy resin in order to fill the tubing. 
 
2.13.3 Cyanoacrylate healing of quasi-static fracture damage in fiber-reinforced 
composites 
Only Fifo et al. fully characterized the cyanoacrylate self-healing system in E-glass 
fiber-reinforced unsaturated polyester composites.
120
 In a 10-ply fiber-reinforced composite, 
microvascular channels were created with nylon chords that were embedded in between the 
middle plies and extracted after curing of the polyester matrix. A low viscosity cyanoacrylate 
adhesive containing a rubber toughened additive was then injected into the vascular channels. 
Using three-point bending tests, samples were tested until failure, mainly demonstrating 
flexural failure, but also different degrees of delamination. After 1 day of healing at room 
temperature, the maximum load and flexural stiffness were recovered for 46 and 85% 
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respectively. In one sample, up to 94% of original load and 97% of the flexural stiffness was 
regained. The lower healing efficiency in the other samples was attributed to fracturing of the 
reinforcing fibers. Two samples had significantly lower recoveries, probably due to blockage 
of the channels caused by premature polymerization or leakage of the healing agent from the 
crack. Closer proximity of the vascular channels to the most vulnerable layers could lead to 
increased healing efficiencies. 
 
2.14 Vinyl ester-based healing system 
Vinyl ester resins have been applied as healing agents in both epoxy and vinyl ester 
thermosetting materials. However, only a parametric study was performed. 
 
2.14.1 Vinyl ester healing chemistry 
Motuku et al. embedded a bisphenol A based vinyl ester resin (Scheme 2.14) as a 
healing agent in HGFs.
121
 In the presence of a peroxide initiator and, if necessary, an 
accelerator, this vinyl ester forms rigid networks via radical polymerization. Using a vacuum 
assisted resin transfer molding process, the authors generated 3.5 mm thick, plain weave  
S-2 glass fiber-reinforced composites (20 plies) with both epoxy and epoxy vinyl ester 
thermosets as the matrix material. One layer of healing agent containing HGFs was 
introduced in the middle of the panels. Low velocity impact energies (22-56 J) were sufficient 
to rupture the HGFs and release the healing agent into the damaged area. Several factors such 
as the spatial distribution of the fibers were investigated, indicating that three broken storage 
fibers delivered a healing agent volume large enough to cover most of the impact damage. 
However, no quantitative recovery of properties as a result of self-healing was mentioned in 
this publication. 
 
 
 
Scheme 2.14. Vinyl ester healing agent.
121
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2.15 Unsaturated polyester-based healing system 
Although a large share of the thermoset resin demand comprises unsaturated 
polyesters, little research has been performed on its self-healing capabilities. To our 
knowledge, only one publication investigated the healing potential of this radical crosslinking 
reaction in a fully autonomous system. Since this chapter focuses on autonomous self-healing, 
meltable particle systems using thermoplastic polyesters as healing agents are not 
discussed.
160, 161
 
 
2.15.1 Unsaturated polyester healing chemistry 
Zainuddin et al. recently studied the use of unsaturated polyester resins as healing 
agents in E-glass fiber-reinforced epoxy composites.
122
 Therefore, HGFs were infiltrated with 
two parts of the self-healing chemistry via capillary action. An isophtalic acid based polyester 
resin, combined with the accelerator cobalt octoate (65 wt% solution in mineral spirits, 
Scheme 2.15) was embedded as one part in the HGFs, while the methyl ethyl ketone peroxide 
initiator (MEKP, Scheme 2.15) was infused in separate HGFs. Upon release, both liquids 
come into contact with each other, initiating the radical crosslinking reaction of the 
unsaturated carbon-carbon bonds in the polyester backbone. 
 
 
 
Scheme 2.15. Methyl ethyl ketone peroxide (MEKP) initiator and cobalt octoate accelerator for the 
polymerization of unsaturated polyesters. 
 
2.15.2 Unsaturated polyester healing of impact damage 
The self-healing properties of the E-glass fiber-reinforced epoxy composites were only 
evaluated using low-velocity impact testing.
122
 Via vacuum assisted resin infusion molding, 
an epoxy composite panel was generated with 2 x 4 plies of plain woven E-glass fabric and a 
layer of HGFs in between. A 2:1 HGF ratio of respectively the fibers with polyester resin and 
5% accelerator and the fibers with MEKP was inserted. These panels were then impacted at 
56 J, which is sufficient to rupture the HGFs. Samples were then allowed to heal for 2-4 days 
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at room temperature, yielding at best a 54% recovery of the original peak load and an increase 
of 86% in energy to peak load compared to the control sample after the 2
nd
 impact. These 
results are attributed to a combined effect of HGF reinforcement and healing agent curing. 
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2.16 Concluding remarks and outlook 
Autonomous extrinsic systems have shown great self-healing potential for a range of 
polymer materials and fiber-reinforced composites. Although fourteen different chemistries 
were reported to our knowledge, larger than 90% and up to full mechanical recovery from 
quasi-static fracture damage was only obtained in six self-healing systems: the DPCD-, 
siloxane-, epoxy-, amine-epoxy-, thiol-epoxy- and azide-alkyne-based systems. With the 
siloxane and azide-alkyne chemistry, this self-healing efficiency was only reached in a PDMS 
and PIB matrix respectively. This already indicates that this efficiency is relative to the matrix 
used and can vary tremendously due to different matrix-healed network interactions. 
From Table 2.1 and the discussed results, it can be concluded that epoxy thermosets 
have been researched most extensively, both in bulk as in fiber-reinforced composites. Only a 
few publications dealt with other matrices. Surprisingly, only one self-healing chemistry 
(cyanoacrylate-based) has been applied to the class of unsaturated polyesters, the largest of 
the bulk thermoset materials. Clearly, there are plenty of opportunities for future research in 
those and other polymeric materials. 
The way the healing agents are delivered to the crack also has a significant effect on 
the recovery. In most cases, the difference in healing efficiency can be explained by flow 
issues, related to the viscosity of the healing agent. In several chemical strategies, small 
amounts of solvent are added to lower the viscosity and improve the recovery. Based on the 
results with different delivery systems (microcapsules, HGFs or microvascular channels) in 
both the DCPD and amine-epoxy concept (Table 2.2), it can be stated that the delivery system 
as such does not influence the healing efficiency much. This allows more flexibility for future 
industrial use, although the introduction of such delivery systems into commercial 
applications is not evident. This also indicates that the chemistry inside the delivery system is 
the limiting factor. 
However, the delivery systems do have a significant effect on the original material 
properties. In general, a negative effect on the tensile strength and Young’s modulus was 
observed, while the fracture toughness was increased. This should be taken into account when 
considering industrial feasibility and future applications, but it is also important to consider 
that the self-healing property could compensate for the loss in strength. 
The autonomous extrinsic self-healing systems also showed promising results for self-
healing of impact and fatigue damage. Most systems are fast enough to slow down crack 
propagation through hydrodynamic action and reactive crosslinking, leading to full recovery 
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of compression strength after impact or total crack arrest in fatigue testing. The self-healing 
systems were especially efficient at low to medium energy impacts and stress intensity ranges. 
Torsion fatigue, friction wear and puncture damage could also be mechanically healed or 
sealed to a significant extent. 
In spite of the good promises, little real-life commercial applications were found for 
autonomous extrinsic self-healing systems. This industrial restraint could potentially be 
explained by the gap between academic research and the industry. Although not easy, the 
conceptual idea of most self-healing systems could and should, in my opinion, be taken to an 
upscalable application in close collaboration with industrial partners. Systems such as the 
DCPD- and amine-epoxy-based self-healing chemistries have certainly been researched 
sufficiently to allow tunability for specific applications. The multistep self-healing 
acylhydrazine/ methacrylate system also displayed useful finetuning options that could trigger 
more application-specific research. We believe that this correlation with real-life applications 
will become more significant in the near future, since the fundamental aspects of extrinsic 
self-healing are getting more and more established. 
However, despite being around for more than a decade, even the DCPD- and amine-
epoxy-based self-healing chemical strategies have not rendered the large industrial 
breakthrough. Because the chemistry inside the delivery systems appears to have the biggest 
impact, additional research on a widely applicable chemistry, which even better fits the 
industrial demands, is required. Its efficiency should also be demonstrated in a large range of 
matrix materials, including epoxy vinyl ester and unsaturated polyester thermosets as well as 
fiber-reinforced composites. 
In the context of real-life applications, “functional” self-healing is also getting 
increased attention. Recovery of other than mechanical properties, such as barrier 
properties
130, 162
, hydrophobicity
163, 164
 or conductivity
165, 166
, has already been shown. 
Although not within the scope of this chapter, the extrinsic self-healing chemistries will for 
sure see applications in that direction. Furthermore, hybrid materials recovering multiple 
functions would be even more interesting. For example, why would it not be possible to 
create a coating with a self-cleaning surface layer, a self-sealing corrosion protection layer 
and a self-healing adhesive primer? I look forward to the further exploration of this intriguing 
field of autonomous extrinsic self-healing materials.  
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Abstract 
A thiol-isocyanate chemistry was screened for the development of extrinsic self-
healing epoxy materials. Firstly, it was possible to select multiple thiol and isocyanate healing 
agents that are thermally stable under industrially used epoxy curing conditions, have a low 
toxicity and still demonstrate sufficient adhesive bonding of two epoxy plates. 
Hexamethylene diisocyanate (HDI), its isocyanurate trimer and trimethyl hexamethylene 
diisocyanate (TMDI) proved to be very suitable isocyanates for self-healing, while TetraThiol 
and TriThiol rendered similarly good results. Secondly, it is shown that the amine groups 
present in the epoxy matrix both serve as a catalyst for the addition reaction between a thiol 
and an isocyanate and as a way to covalently link the healed network structure to the 
surrounding thermoset. The tapered double cantilever beam (TDCB) geometry is used for 
evaluating the recovery of the fracture toughness at room temperature after different healing 
times. Using manual injection of the healing agents into the crack, a healing efficiency up to 
130 % is obtained for the EPIKOTE 828 epoxy material. The effect of temperature and use of 
other matrices (vinyl ester and unsaturated polyester) was also investigated, demonstrating a 
catalytic effect of the cobalt initiator. 
 
Parts of this chapter are also published in: X. K. D. Hillewaere, R. F. A. Teixeira, L.-T. T. Nguyen,  
J. A. Ramos, H. Rahier, F. E. Du Prez. Thiol-isocyanate chemistry for autonomous self-healing of epoxy 
thermosets. Advanced Functional Materials, 2014, 24 (35), 5575. 
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Chapter 3  
Thiol-isocyanate chemistry for self-healing 
 
3.1 Introduction  
As discussed in Chapter 2, the research field of self-healing covers a wide range of 
chemical strategies. In this Ph.D. research, we aimed to tackle some of the disadvantages 
mentioned in the previous chapter by developing a fast self-healing system, which uses low 
toxic, thermally stable and inexpensive healing agents and at same time is efficient at ambient 
conditions, eg. in the presence of moisture or air. Furthermore, this chemistry should be 
independent of the matrix material to be healed. In our search, we mainly focused on fast 
“click” or “click-like” chemistries1, 2 to match these requirements. 
“Click” reactions such as the Cu(I)-catalyzed azide-alkyne cycloaddition (CuAAC)3 
and thiol-ene radical addition reaction
4
 were already elaborated in self-healing applications. 
Although promising results were obtained, several drawbacks could not be overlooked. On 
the one hand, the CuAAC chemistry makes use of a copper-containing catalyst, which is 
readily oxidized
5, 6
 and could result in toxicity issues when applied on industrial scale. On the 
other hand, the radical thiol-ene chemistry requires the addition of an initiator to generate 
radicals for the reaction. When a photoinitiator is applied, daylight stability might hamper the 
long-term use, while in the thermal initiator case, the system no longer heals autonomously, 
since an external heat trigger is required. Additionally, the presence of oxygen could also 
inhibit the radical healing process. Taking all of the system requirements mentioned in the 
previous paragraph into account, only the thiol-isocyanate, thiol-vinyl sulfone, thiol-bromo 
and thiol-ene Michael addition reactions were considered. In the first instance, a  
thiol-isocyanate healing strategy, new to the field of self-healing, was adopted for reasons of 
reactivity and availability of a variety of appropriate chemicals on large scale.  
Multifunctional isocyanates are widely used to manufacture polyurethane (PU) foams, 
coatings and elastomers for the use in the automotive sector, construction works, the sports 
industry and many more.
7, 8
 Some examples of the large amount of PU applications are 
insulation foams in buildings (the largest application), seating foams, protective coatings and 
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adhesives in cars, electronics and wood furnishings, industrial wheels, ski boots, golf club 
grips, shoe soles and spandex (elastane) in clothing. For the generation of these 
polyurethanes, isocyanates are combined with polyols or H2O and suitable Lewis acid 
catalysts such as dibutyltin dilaurate (DBTL) or bases (e.g. tertiary amines). The most 
commonly used isocyanates are methylene diphenyl diisocyanate (MDI), polymeric MDI, 
hydrogenated MDI, toluene-2,4-diisocyanate (TDI), hexamethylene diisocyanate (HDI), HDI 
isocyanurate or biuret oligomers, isophorone diisocyanate (IPDI) and naphthalene 
diisocyanate (some compounds can be found in Scheme 3.1a). Important to mention is the 
potential health hazard when using low molecular weight isocyanates, since exposure to 
isocyanate vapors can cause asthmatic symptoms and lead to sensitization of the skin and the 
respiratory system over time.
9
 
 
 
 
Scheme 3.1. (a) Screened multifunctional isocyanates: Methylene diphenyl diisocyanate (MDI), toluene-
2,4-diisocyanate (TDI), isophorone diisocyanate (IPDI), hexamethylene diisocyanate (HDI),  
2,2,4-trimethyl hexamethylene diisocyanate (TMDI, 1:1 mixture with 2,4,4-TMDI), HDI isocyanurate 
trimer (HDI3) and MDI uretonimine trimer (MDI3); (b) Screened multifunctional thiols: Pentaerythritol 
tetrakis(3-mercaptopropionate) (TetraThiol) and trimethylolpropane tris(3-mercaptopropionate) 
(TriThiol). 
 
Chapter 3 – Thiol-isocyanate chemistry for self-healing 
81 
 
On the other hand, multifunctional thiols are commonly applied in coating 
applications, adhesives and sealants.
10, 11
 Examples of thiol applications are epoxy and 
polythiourethane floor coatings, adhesives in electronic circuit boards and aircraft fuel tank 
sealants. Both the nucleophilic addition to epoxides or isocyanates and the UV- or thermally 
initiated radical thiol-ene reaction are used to form polymer networks with tunable 
properties.
10
 Two other important industrial applications for thiols and their derivatives are 
their use as chain transfer agents to modify the molecular weight of polymers and as reagents 
or accelerators in the (photo-)vulcanization process of rubbers.
12, 13
 Because thiols often have 
a strong penetrating odor, they are also incorporated in natural gas as non-toxic odorant for 
the detection of gas leaks.  
Because of the industrial applicability mentioned above, it is surprising that the 
combination of thiols and isocyanates was not evaluated earlier for self-healing applications. 
Thiols react with isocyanates via a nucleophilic addition reaction with the formation of 
thiourethane bonds. Although the thiol-isocyanate reaction proceeds slowly without a catalyst, 
tertiary amines or phosphines are generally added to speed up the reaction.
1, 14, 15
 Since the 
reaction in that case proceeds to full conversion in a timeframe of minutes, it is expected to be 
very suitable for self-healing. The reaction of isocyanates with amines has also been 
considered, although it is more difficult to encapsulate amines due to their reactivity and 
hydrophilicity. 
In this chapter, a selection of multifunctional isocyanates is screened for their toxicity, 
thermal stability and adhesive capability in combination with multifunctional thiols. The 
thiol-isocyanate reaction kinetics are also evaluated for the use in self-healing applications, 
which require fast inhibition of crack propagation to minimize the crack volume to be healed. 
The most suitable healing agent mixtures are then manually injected into the crack area of a 
broken epoxy, vinyl ester or unsaturated polyester matrix to evaluate the maximal healing 
potential of these adhesives. 
 
3.2 Selection of suitable healing agents 
3.2.1 Qualitative screening of isocyanates 
In order to assess the healing potential of the thiol-isocyanate chemistry, the adhesive 
bonding capability of several monomer mixtures was first tested qualitatively. For this, 
pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol, Scheme 3.1b) was selected as a 
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multifunctional thiol due to its high thermal stability (see Subsection 3.2.2)
16
, availability, 
functionality and its former use in self-healing applications.
4, 17-20 
The thiol functionality is 
also stable up to at least two years, as confirmed by 
1
H NMR and LC-MS measurements (see 
Appendix). This compound was combined with four commercially available bifunctional 
isocyanates. Methylene diphenyl diisocyanate (MDI), toluene-2,4-diisocyanate (TDI), 
isophorone diisocyanate (IPDI) and hexamethylene diisocyanate (HDI) (Scheme 3.1a) were 
mixed with TetraThiol in a 1:1 ratio of functional groups in order to generate a glue, capable 
of strongly adhering two epoxy plates to each other. Adhesive bonding was then evaluated by 
inserting these mixtures in between two smooth epoxy plate pieces and allowing them to react 
at room temperature without any applied pressure. The adhesion was checked manually at 
different time intervals, distinguishing liquid adhesion from adhesive bonding by the reacted 
network. 
Two types of epoxy compositions were used to obtain these plates: the EPIKOTE 828 
LVEL epoxy resin and diethylenetriamine (DETA) were mixed in equimolar amounts  
(100:11 weight ratio) and cured for 1 day at 25 °C and 1 day at 40 °C in a silicon mold, while 
the RIM 135 resin was combined with the RIMH 137 hardener in an equimolar 100:30 weight 
ratio and cured for 1 day at 40 °C and 16 h at 80 °C. EPIKOTE 828 LVEL is a standard 
general purpose epoxy resin (branded EPON in the U.S. and designated like that further on). 
The RIM formulation is more specifically designed for infusion and injection processes,  
eg. applied in the manufacturing of wind turbine rotor blades, ships and sports equipment. 
The reader is redirected to Subsection 3.3.4 for additional details on the chemical structure 
and degree of curing. 
 
As shown in Table 3.1 (Entry 1 and 2), the aromatic isocyanates MDI and TDI did not 
demonstrate good adhesion properties for the EPON 828 epoxy material. This was attributed 
to their high reactivity towards the thiol, which lead to early precipitation. As a consequence, 
further diffusion and reaction of monomers were hampered, resulting in a weak network. This 
problem did not occur with the aliphatic isocyanates IPDI and HDI (Entry 3 and 4), since 
these are less reactive compared to the aromatic ones
7, 21, 22
. In fact, the IPDI-TetraThiol 
network did not solidify completely at all, even after 10 days, resulting in limited adhesion as 
well. HDI on the other hand showed promising results with some adhesive bonding already 
occurring after 6 hours, while the plates can no longer be detached after 2 days as a result of 
the formation of a strong polythiourethane network. When forced with a spatula and hammer, 
the epoxy plates break apart with the sound of fracturing glass and in some cases, the epoxy 
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was broken rather than the adhesive joint. The resulting amorphous HDI-TetraThiol network 
has a glass transition temperature of 60 °C as measured with DSC (Figure 3.1), which is in 
the same order of magnitude as the used epoxy materials (see Subsection 3.3.4). Comparable 
results were obtained with the RIM 135 epoxy plates (Entry 8 and 9). 
 
Table 3.1. Qualitative adhesion tests with different healing agent mixtures and epoxy plates. Weak 
adhesion is indicated in light grey, strong adhesion (non-detachable) is indicated in dark grey. 
 
     Time (hours) 
# NCO SH Ratio * Epoxy 6 8 16 18 20 22 24 48 72 
1 MDI TetraThiol 1:1 EPON 828 - - - - - - - - - 
2 TDI TetraThiol 1:1 EPON 828 - - - - - - - - - 
3 IPDI TetraThiol 1:1 EPON 828 - - - - - - - - - 
4 HDI TetraThiol 1:1 EPON 828          
5 TMDI TetraThiol 1:1 EPON 828 - -        
6 HDI3 TetraThiol 1:1 EPON 828 -         
7 MDI3 TetraThiol 1:1 EPON 828 - - - - - - -   
8 IPDI TetraThiol 1:1 RIM 135 - - - - - - - - - 
9 HDI TetraThiol 1:1 RIM 135          
10 TMDI TetraThiol 1:1 RIM 135 - -        
11 HDI3 TetraThiol 1:1 RIM 135 -         
12 MDI3 TetraThiol 1:1 RIM 135 - - - - - - -   
13 IPDI TriThiol 1:1 RIM 135 - - - - - - - - - 
14 HDI TriThiol 1:1 RIM 135          
15 HDI3 TriThiol 1:1 RIM 135 -         
16 MDI3 TriThiol 1:1 RIM 135 - - - - - - -   
17 HDI TetraThiol 1:0.2 RIM 135 - - - - - - - - - 
18 HDI TetraThiol 1:0.4 RIM 135 - - - - - -    
19 HDI TetraThiol 1:0.6 RIM 135 -         
20 HDI TetraThiol 1:0.8 RIM 135 - -        
21 HDI TetraThiol 1:1.1 RIM 135 - -        
* NCO/SH functional group ratio. 
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Figure 3.1. DSC thermogram of the HDI-TetraThiol final healed network, showing the glass transition at 
60 °C (inset visualizes the amorphous thiol-isocyanate network). 
 
In a next stage, trifunctional isocyanates were considered due to their lower toxicity 
and higher boiling point compared to the bifunctional compounds (see Subsection 3.2.2). 
Both the HDI isocyanurate trimer (HDI3) and MDI uretonimine trimer (MDI3) (Scheme 3.1a) 
were evaluated and demonstrated adhesive behavior, similar to their bifunctional counterparts 
(Table 1, Entry 6, 7, 11 and 12). In contrast to MDI however, limited adhesion was observed 
after 2 days for the MDI3. Early precipitation again prevented stronger adhesive bonding, 
even when longer curing times were applied.  
A commercial 1:1 mixture of 2,2,4-trimethyl hexamethylene diisocyanate and  
2,4,4-trimethyl hexamethylene diisocyanate (TMDI, Entry 5 and 10, Scheme 3.1a) was also 
tested for the same reasons. Due to the similarity in molecular structure compared to HDI, 
containing primary aliphatic isocyanate groups, adhesive bonding was expected to be 
comparable. However, the TMDI-TetraThiol reaction appeared to be slightly slower than the 
HDI-TetraThiol one, which could be related to a limited steric effect of the methyl groups in 
the vicinity of the isocyanate. This slower healing was later confirmed via manual injection 
(Section 3.4). 
In order to check the versatility of the thiol crosslinker, the trifunctional 
trimethylolpropane tris(3-mercaptopropionate) (TriThiol) was investigated (Entry 13 – 16). 
Based on the results, it can be stated that TetraThiol can easily be substituted by other 
multifunctional thiols with a comparable structure and reactivity. 
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Since this dual compound approach in self-healing might result in off-stoichiometric 
distributions of both healing agents in the fractured epoxy material, the ratio of the thiol 
compared to the isocyanate was varied (Entry 17 – 21). A strong decrease in adhesion was 
noted when the amount of thiol functional groups was lower than 0.6 times the amount of 
isocyanate functional groups. When the amount of thiol functions is equal or lower than  
0.5 times the isocyanate amount, the statistical chance that more than 2 thiol functions per 
molecule will react decreases significantly, yielding far less crosslinking points. According to 
the Flory-Stockmayer equation (Equation 3.1 & 3.2), the theoretical gel point can actually no 
longer be reached when the functional group ratio drops below 0.67. All calculated 
conversions are shown in Table 3.2. 
1 2
1 2
1
( 1)( 1)r f f
  
 
 
(3.1) 
1 2B   (3.2) 
 
Table 3.2. Flory-Stockmayer calculations of thiol-isocyanate monomer conversions to reach the gel point. 
f1 and f2, α1 and α2 are the functionalities and conversions of respectively the thiol and the isocyanate. 
 
# SH f1 NCO f2 B r * α1 α2 
1 TetraThiol 4 HDI 2 0.5 1 0.41 0.82 
2      0.8 0.46 0.91 
3      0.67 0.50 1.00 
4      0.6 0.53 1.05 
5      0.4 0.65 1.29 
6      0.2 0.91 1.83 
7 TetraThiol 4 HDI3 3 0.75 1 0.35 0.47 
* SH/NCO functional group ratio. 
 
The reactivity of isocyanates towards amines was also assessed, both for their use as a 
potential healing agent combination and as the covalent linking reaction between the healed 
network and residual amines in the epoxy matrix. In adhesive testing, all evaluated primary 
and secondary amines reacted instantly, leading to early precipitation and exothermic heat 
generation. In fact, some of the amines react so fast with isocyanates that a film is formed 
immediately when poured together in a vial, generating an increasingly thick product barrier 
between both reactants until diffusion becomes so slow that growth of the layer is arrested. 
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The reaction can then be re-initiated when the barrier is pierced, as noted by further 
precipitation and heat generation. Although this fast reaction is not suitable as the bulk 
network forming reaction for self-healing applications due to diffusion issues, it does ensure 
covalent linkage between the thiol-isocyanate healed network and the epoxy matrix. However, 
preliminary reactions of the isocyanate with amines at the crack surface, upon flowing from 
the microcapsule into the crack, and during the encapsulation process, cannot be excluded. 
 
3.2.2 Toxicity and stability of healing agents 
From the adhesive bonding tests, HDI emerges as the best self-healing candidate. 
However, HDI is considered toxic, which would be an issue in further industrial applications. 
Since HDI3 is approximately ten times less toxic
23, 24
 and rendered adhesive bonding results 
comparable to HDI, this isocyanate was additionally selected for use in quantitative self-
healing tests. This trimer is widely used in industrial context, especially in coating 
formulations where strict Volatile Organic Compound (VOC) limits are applied. This is fully 
explained by its low vapor pressure (0.001 Pa) at room temperature compared to HDI  
(0.7 hPa). TMDI was selected as a third healing agent candidate for similar reasons.
25
  
 
A second advantage of HDI3 and TMDI over HDI is their thermal stability, which is 
important for high-end epoxy applications that use curing temperatures up to 180 °C. While 
TGA measurements already indicated a 2% weight loss for HDI at 75 °C under nitrogen 
atmosphere, this weight loss was only reached at 198 °C for the trimer (Figure 3.2). TGA 
measurements under ambient atmosphere yielded similar results. Although TMDI has a 
slightly lower boiling point compared to HDI3 (149 °C), it is still useful as a healing agent in 
frequently used curing conditions of 120 °C, while HDI is not. The TetraThiol is even more 
thermally stable with a 2% weight loss only occurring at 279 °C under nitrogen atmosphere.  
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Figure 3.2. TGA thermograms under nitrogen (left) and air (right) of hexamethylene diisocyanate (HDI), 
HDI isocyanurate trimer (HDI3) and pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol). 
 
Another potential issue with isocyanates is their stability in the presence of moisture. 
Over time, nucleophilic addition of water to the isocyanate will occur with the formation of an 
unstable N-substituted carbamic acid. With release of CO2 and heat, the carbamic acid 
decomposes to form amines, which can also participate in the healing reaction and actually 
react faster with other isocyanates than thiols, as already indicated in Subsection 3.2.1. In that 
case, strong polyurea bonds are formed. Therefore, we believe that moisture has no negative 
influence on the network formation. 
 
3.3 Reaction kinetics 
3.3.1 Theoretical description 
In the past, the reaction kinetics of the thiol-isocyanate combination were studied 
using both aromatic
21, 26-28
 and aliphatic isocyanates
21, 29
 as well as different thiols. The 
reaction mechanism is considered to involve deprotonation of the thiol by the amine catalyst 
with the formation of a strongly nucleophilic thiolate anion (Scheme 3.2).
29
 This thiolate 
anion then adds to the isocyanate carbon with the formation of a stable thiourethane bond, 
regenerating the tertiary amine catalyst in the process. 
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Scheme 3.2. General scheme of the thiol-isocyanate reaction, catalyzed by a tertiary amine, with the 
formation of a thiourethane product.
29
 
 
When the overall reaction rate is written as a function of the disappearance of the 
isocyanate, which is the functional group followed in the kinetic study in Subsection 3.3.2, 
Equation 3.3 is obtained, showing a dependency on the concentration of the thiol, the 
isocyanate and tertiary amine
21
; k is the reaction rate constant. 
 
 
   3
'
' ''
d R NCO
k R NCO R SH R N
dt
 
    (3.3) 
 
Since the concentration of the tertiary amine catalyst remains constant, the reaction 
rate is given by Equation 3.4, indicating a second-order reaction. k’ is then the apparent 
reaction rate constant, which is dependent on the tertiary amine concentration. The rate 
constant value equals 0.217 L.mol
-1
.sec
-1
 for a reaction involving hexyl isocyanate (0.73 M), 
butyl 3-mercaptopropionate (0.73 M) and triethylamine (2.3 x 10
-3
 M) in benzene as a 
solvent.
29
 
 
 
  
'
' '
d R NCO
k R NCO R SH
dt
 
    (3.4) 
 
Although this equation considers the main mechanism, additional interactions between 
different compounds also play a significant role. As indicated by Dyer et al.
28
, interactions 
between the amine catalyst and isocyanate – making the isocyanate more susceptible to 
nucleophilic attack – could not be excluded. Furthermore, the same authors also demonstrated 
a catalytic effect of the newly formed thiourethane product, most likely via interactions with 
the isocyanate-amine complex. This was evidenced by a strongly increased reaction rate when 
both the amine and the thiourethane were present. In the case where only a thiourethane was 
added, a reaction rate approximately 3-4 times the rate of the uncatalyzed reaction was 
measured. Since the rate constant for the latter is approximately 5 x 10
-7
 L.mol
-1
.sec
-1
 
26
, 
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which is really low and considered almost zero
21
, the catalytic effect of the product is thus 
rather small. This effect only became significant as the reaction progressed and the 
concentration of thiourethane increased.
26
 This autocatalytic effect was also observed in DSC 
analysis of the HDI-TetraThiol curing kinetics, performed in collaboration with the Physical 
Chemistry and Polymer Science research group at the Vrije Universiteit Brussel (Prof. Hubert 
Rahier, FYSC, Department of Materials and Chemistry). 
From Equation 3.4, it is clear that catalytic effect is directly proportional to the amount 
of catalyst. Furthermore, the catalysis is dependent on the basic strength of the amine, but also 
on the amount of steric hindrance around the nitrogen atom. Both the tertiary amine 
concentration and potential steric hindrance could have an important influence on the reaction 
kinetics in self-healing applications. For more details, the reader is referred to the  
literature.
21, 28
  
Additionally, it is important to mention that the thiourethane connection is prone to 
hydrolysis or alcoholysis under basic conditions (Scheme 3.3).
30-32
 This reaction requires a 
strong base such as NaOH, NaOMe or NaOEt, capable of withdrawing a proton from water or 
the alcohol to generate a sufficiently strong anionic nucleophile. After hydrolysis, the formed 
N-substituted carbamic acid is readily converted to the amine with the release of CO2 and 
heat. Consequently, it is plausible that the thiol-isocyanate self-healing concept does not 
perform well in strong basic environments. 
 
 
 
Scheme 3.3. Hydrolysis of a thiourethane under basic conditions, with the formation of a thiol and an 
amine. 
 
3.3.2 Kinetic study with online Fourier transform infrared spectroscopy 
Since rapid inhibition of crack propagation leads to smaller crack volumes to be 
healed, a fast healing reaction is favorable. Therefore, a kinetic study of the thiol-isocyanate 
reaction was performed using online FTIR spectroscopy and microcalorimetry measurements. 
For the online infrared study, the peak areas of both the isocyanate and thiourethane carbonyl 
stretches (2278 and 1675 cm
-1
 respectively) were monitored in situ during the reaction. HDI 
was combined with isooctyl 3-mercaptopropionate, a model compound with a thiol functional 
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group similar to TetraThiol (Scheme 3.4), but with only one functionality to avoid 
crosslinking and subsequent precipitation of the product. A concentration of 0.5 M in 
chloroform was used.  
 
 
 
Scheme 3.4. Model reaction of HDI with isooctyl 3-mercaptopropionate, catalyzed by a tertiary amine. 
 
When both reagents were mixed together in a 1:1 ratio of functional groups and 
allowed to react for one hour, little to no reaction was observed. As shown in Figure 3.3, the 
isocyanate carbonyl stretch absorption remained constant and no formation of thiourethane 
groups was detected. The prominent absorption peak of the ester carbonyl stretch of the 
monofunctional thiol at 1727 cm
-1
 was used as a reference, since the peak intensity should 
remain constant during the reaction. If any solvent evaporated as a result of the release of 
reaction heat, the intensity of this peak would increase because of the change in concentration. 
 
 
 
Figure 3.3. Online FTIR 2D plot of the model reaction of hexamethylene diisocyanate with isooctyl  
3-mercaptopropionate, catalyzed by N,N-diisopropylethylamine (DIPEA) or the epoxy matrix powder. 
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 On the other hand, when 5 mol% of N,N-diisopropyl-ethylamine (DIPEA) was added 
as a catalyst after one hour, the thiol-isocyanate reaction immediately proceeded to full 
conversion in less than 7 min. This can be clearly seen in both the decrease and increase in 
peak intensity of the isocyanate and thiourethane carbonyl stretches respectively. This is 
similar to what has been described earlier in literature for the thiol-isocyanate combination 
with tertiary amines.
1, 15
 
Since the epoxy matrix contains a vast amount of tertiary amines, a similar experiment 
was performed with this material as a catalyst (Figure 3.3). Therefore, the epoxy plates 
described above were in the first instance ground to a powder with an average granule size of 
± 100 μm. A large amount of EPON 828 powder (1.50 g vs 4.37 g of thiol) was added to the 
reaction mixture to simulate the crack surface area to crack volume ratio in the targeted self-
healing application. Upon addition of the powder, the isocyanate carbonyl stretch steadily 
decreased until a conversion of 60% was reached after 3 hours. When twice the amount of 
epoxy powder (3.00 g) was used, the conversion increased to 70% after 3 hours. This 
experiment clearly indicates the catalytic effect of the epoxy matrix on the thiol-isocyanate 
reaction. As a consequence, tertiary amines should not necessarily be incorporated in the 
microcapsules. Steric hindrance of the free electron pair on the nitrogen atom might explain 
the slower reaction kinetics.
28, 29
 It is important to mention that the high reaction rate of the 
thiol-isocyanate reaction could also impede proper mixing of the healing agents in the crack 
area. 
 
3.3.3 Kinetic study with microcalorimetry 
The catalytic effect of the epoxy matrix was confirmed in an additional 
microcalorimetry study where TetraThiol was reacted with the HDI trimer in the absence of 
any solvent. When the TetraThiol-HDI3 reaction was monitored over time at 25 °C without a 
catalyst, a low reaction rate was observed (Figure 3.4). Therefore, these compounds cannot 
be encapsulated in one single capsule. On the other hand, adding EPON 828 epoxy powder to 
the same mixture increased the reaction rate significantly, again demonstrating the catalytic 
effect of the matrix. As can be seen in Figure 3.4, a similar conversion of 25% was reached 
after 3 days with ‘epoxy catalyst’ as after 5 days without catalyst.  
After 8 days without catalyst, a conversion of 35% was obtained, which is the 
conversion of thiol functional groups required for the HDI3-TetraThiol mixture to gel, as 
indicated earlier in Table 3.2 (Flory-Stockmayer calculations). This is confirmed by 
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observations of a HDI3-TetraThiol stock solution forming an elastic gel after approximately 7 
days. The average conversion of thiol and isocyanate functional groups (41%) is only reached 
after 11 days, which is consistent with the full solidification of the stock solution in 
approximately 10 days. 
 
 
 
Figure 3.4. Comparative microcalorimetry study of the thiol-isocyanate reaction of TetraThiol with HDI3 
at 25 and 60 °C without catalyst and catalyzed by the epoxy matrix powder (EPON 828). 
 
In a second test, the influence of temperature on the reaction was investigated. Heating 
the TetraThiol-HDI3 mixture to 60 °C without the presence of a catalyst resulted in a 
significant increase in reaction rate. After 3 days, a reaction conversion of 71% was obtained. 
An even larger increase was noticed when the epoxy powder catalyst was added (93% 
conversion after 3 days). It is important to mention that in this second case, the vitrification 
temperature of the epoxy powder of 56 °C (see Subsection 3.3.4) is exceeded. Part of the 
increase in the measured reaction heat could thus be caused by further curing of the epoxy 
powder. 
 
3.3.4 Curing kinetics of epoxy 
As mentioned in Subsection 3.2.1, two epoxy compositions were used for the 
generation of epoxy matrices. 
The EPON 828 epoxy resin, consisting of bisphenol A diglycidyl ether and derived 
short oligomers with two epoxide functionalities (Scheme 3.5), was combined with an 
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equimolar amount of DETA, an aliphatic amine with a functionality equal to five  
(Scheme 3.5). Using a standard temperature program for curing the epoxy material (1 day at 
room temperature, followed by 1 day at 40 °C) 
33
, a DSC study revealed a conversion of the 
epoxide groups of 85% (see Figure 3.5). As equimolar amounts of the amine hardener were 
used, 15% of the initial amine functionalities (most likely secondary and some primary 
amines) have not reacted and are still available to take part in the healing reaction. During the 
curing process, vitrification of the mixture will hamper higher conversions because of 
diffusional constraints. After the curing process used in this study, the Tg of the epoxy 
material is 56 °C, while after a heating cycle up to 200 °C to ensure complete curing, the Tg 
rises to about 130 °C. This can best be seen in the reversing heat capacity curve from the 
MDSC-thermogram (bottom curve), where only the heat capacity is retrieved, while the 
reaction exotherm is retrieved in the non-reversing curve (not shown). 
 
 
 
Scheme 3.5. (a) EPON 828 epoxy resin and diethylenetriamine (DETA) hardener; (b) RIM 135 epoxy 
resin, consisting of bisphenol A diglycidyl ether and 1,6-hexanediol diglycidyl ether, and RIMH 137 
hardener, consisting of an aliphatic polyetheramine and isophorone diamine. 
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Figure 3.5. MDSC thermograms (amplitude = 0.5 °C and period = 60 s) of the cured EPON 828 resin. The 
first heating shows the Tg (56 °C) after the standard cure procedure followed by the residual reaction, 
while the second heating (129 °C) shows the final Tg after full cure. Curves are shifted vertically for 
clarity. 
 
The RIM 135 epoxy resin – a combination of bisphenol A diglycidyl ether and  
1,6-hexanediol diglycidyl ether (Scheme 3.5) – was cured with an equimolar amount of the 
RIMH 137 hardener, which is mainly composed of an aliphatic polyetheramine and 
isophorone diamine, each with four functionalities (Scheme 3.5). When the temperature 
program for curing (1 day at 40 °C and 16 hours at 80 °C) was applied, a DSC study revealed 
a complete conversion of the epoxides. Indeed, the Tg of the epoxy material after the applied 
curing process and after a heating cycle up to 200 °C was found to be identical, i.e. 76 °C. As 
equimolar amounts of the amine hardener were used, practically all amine functionalities have 
reacted during the curing program. Thus, the RIM epoxy material that results from curing of 
an equimolar ratio of resin to hardener does not contain a significant amount of unreacted 
amines, and hence no residual amine functionalities at the crack surfaces that can help in 
chemically linking the epoxy surface to the healing agent. 
 
3.4 Healing of thermosets with manual injection 
In the next stage, the healing potential of the thiol-isocyanate chemistry was fully 
quantified, including an investigation of the influence of the healing time, the viscosity, the 
temperature and the matrix material to be healed. 
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3.4.1 Quantitative analysis of self-healing 
Since the thiol-isocyanate chemistry showed great potential for healing epoxy 
materials, the extent of its healing capability was examined using a Tapered Double 
Cantilever Beam (TDCB) test. In accordance with the protocol proposed by White et al.
34, 35
, 
a tapered epoxy sample with a side groove (47 mm in length) and a thickness of 2.5 mm in the 
groove was used (Figure 3.6). A precrack was generated by tapping the sample onto a fresh 
razor blade following the ASTM D4045 standard. As indicated by Schön et al. for PMMA 
fracture analysis
36
, this is the method introducing the least residual stress at the crack tip, thus 
resulting in more consistent fracture toughness values. It has to be noted that the variability in 
measured peak load and healing efficiency is mostly related to the generation of this precrack 
and more specifically to deviations of the (pre)crack from the center of the side groove. The 
standard deviation values are in accordance to previous reports concerning TDCB testing in 
self-healing materials.
34, 35, 37, 38
 
 
 
 
Figure 3.6. Tapered Double Cantilever Beam (TDCB) test geometry (all dimensions in mm).
39
 Reproduced 
from Brown with permission from the author. 
 
In a first stage, virgin epoxy material was loaded until fracture, followed by manual 
injection of the optimal mixture of TetraThiol with HDI or HDI3 into the crack area (30 μL, 
1:1 ratio of functional groups). After removal of excess of healing agent, these samples were 
clamped and allowed to heal for 1, 3 or 5 days at 25 °C. This was then followed by a second 
fracture test. About 10 samples were tested for every healing time, using both the EPON 828 
and RIM 135 epoxy material. The efficiency of healing fracture damage was determined by 
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the ratio of the healed over the virgin peak load to fracture, as this equals the ratio of the 
measured fracture toughness after healing and before initial fracture in the TDCB geometry
39 
and thus gives an indication of the recovery of the resistance to fracture. As can be seen in 
Figure 3.7, the recovery of peak load to fracture increases over time, reaching up to 85 ± 8% 
after 1 day, 111 ± 12% after 3 days and 130 ± 14% after 5 days for the EPON 828 matrix 
material with HDI3 and TetraThiol as the healing agents. The reason for the healing efficiency 
exceeding 100% is two-fold: on one hand, a healed polythiourethane network with a greater 
resistance to fracture is formed, and on the other hand, the sample is forced to break into this 
newly formed network because of the side groove in the TDCB geometry. This high recovery 
is considered to be an important advantage in the microcapsule self-healing concept, because 
the epoxy material is expected to break next to the healed crack when a second damage event 
occurs. In the final self-healing application, new microcapsules would then be ruptured, 
resulting in additional self-healing events. 
 
 
 
Figure 3.7. Healing efficiency and healed load after 1, 3 or 5 days at 25 °C, combining TetraThiol with 
HDI or HDI3 as healing agents in EPON 828 or RIM 135 epoxy material. TetraThiol is abbreviated as TT 
for clarification. 
 
It is also clear that the RIM material renders lower healing efficiencies (Figure 3.7), 
although 100% is still reached after 5 days. This is ascribed to the fact that the healed peak 
load to fracture is compared to a higher virgin peak load for the RIM 135 matrix (84 ± 8 N vs. 
61 ± 7 N for the EPON 828 material). The network formation is not influenced by the 
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difference in both epoxy materials, since the healed peak load values are not significantly 
different for both matrices (Figure 3.7). This is valid for both the HDI- and HDI3-TetraThiol 
combination. 
 
Shorter and longer healing times have also been tested. When the EPON 828 matrix 
material was allowed to heal for 8 hours with the HDI3-TetraThiol mixture, a healing 
efficiency of 61 ± 7% was obtained. Increasing the time from 5 to 10 days did not further 
improve the recovery (124 ± 12%), while an increase to 30 days even demonstrated a slight 
decrease (108 ± 6%). No clear reason for this small drop could be found, although further 
crosslinking could lead to increased embrittlement with a slight decrease in the material’s 
fracture resistance. 
Manual injected mixtures of TMDI and TetraThiol (30 μL, 1:1 ratio of functional 
groups) appeared to cure slower, confirming the results obtained with the qualitative adhesion 
tests. After 3 days of healing with this mixture, the EPON 828 material recovered 77 ± 9% of 
the virgin peak load to fracture, which is similar to the results obtained after 1 day with the 
HDI- or HDI3-TetraThiol combination. As stated earlier, this might be caused by a limited 
steric effect of the methyl groups in the vicinity of the isocyanate. After 5 days, no further 
improvement of the healing efficiency was observed (76 ± 14%). Therefore, this combination 
was not further elaborated. 
 
3.4.2 Solvent effect on self-healing 
Diffusion problems, which could potentially occur with the healing agents in the 
crack, have also been investigated. When TetraThiol was added on top of HDI3 without 
mixing, the reaction only took place at the interface of both viscous liquids, which was 
observed visually as a steadily growing solid layer in between the liquid phases. Although the 
diffusion occurs over several mm, which is exceeding the distance between microcapsules in 
the self-healing epoxy, it is still slow. Thus, in spite of the healing agents being completely 
miscible in one another, spontaneous mixing is hampered by their high viscosities (500 and 
1300 cP for TetraThiol and HDI3 respectively). 
A potential solution to this diffusion issue is the addition of a compatible, high boiling 
solvent to lower the viscosity of both compounds. Methyl benzoate (MB), having a low 
toxicity and a boiling point of 200 °C, was selected as a suitable solvent for both healing 
agents. When increasing amounts of this solvent are mixed with TetraThiol and HDI3, the 
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viscosity is drastically reduced (Figure 3.8a). In order to have an equal distribution of both 
healing agents into the crack, a similar viscosity would be favorable. As can be seen from the 
graph, this is the case when 10 and 20 wt% of MB is added to TetraThiol and HDI3 
respectively, rendering a viscosity of 185 and 160 cP. 
 
 
Figure 3.8. (a) Viscosity of TetraThiol and HDI3 with increasing percentage of methyl benzoate as a 
solvent. (b) Decrease in healing efficiency in EPON 828 samples with increasing amount of methyl 
benzoate after 3 days of healing via manual injection. 
 
However, this approach also has some disadvantages. Firstly, the addition of MB to 
the HDI3 microcapsules results in a faster loss of core content over time, most likely due to 
solvent swelling of the polyurea shell. Secondly, the maximum healing efficiency that can be 
obtained decreases with increasing amount of solvent (Figure 3.8b). This was measured using 
manual injection of the healing agent mixture with 10 to 40 wt% of MB added compared to 
the amount of TetraThiol. When more than 10 wt% of MB was used, the healing efficiency 
dropped significantly. The drop can be fully explained by the decrease in amount of healing 
agent present in the crack and a potential plasticizing effect of the solvent, leading to a weaker 
network. To minimize this negative impact, microcapsules were used containing the 
TetraThiol in combination with a small amount (5-10 wt%) of the viscosity-lowering solvent 
(see Chapter 5). 
 
3.4.3 Temperature effect on self-healing 
The effect of temperature was also investigated, since the microcalorimetry analysis 
showed that the reaction rate significantly increases with temperature. At least 4 EPON 828 
samples were healed with the HDI3-TetraThiol combination for 3 days at 40 and 60 °C. The 
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slight increase to 40 °C significantly improved the recovery from 111 ± 12 to 126 ± 3%, while 
the increase to 60 °C resulted in a decrease in healing efficiency to 98 ± 14%. Both results 
could be explained by an increase in thiol-isocyanate reaction rate. First, the effect of heating 
on the healing reaction must be distinguished from the devitrification effect of the epoxy 
material. Therefore, a blank epoxy sample was clamped without healing agents added and 
subsequently left at 40 and 60 °C for 3 days each. Temperatures of 40 and 60 °C are below 
and just above the vitrification temperature of 56 °C (see Subsection 3.3.4). At both 40 and  
60 °C, no recovery in fracture toughness was recorded after 3 days. Thus, the observed 
temperature effect on the healing efficiency in the manually healed epoxy samples is fully 
related to an increase in the thiol-isocyanate reaction rate. This means that the recovery 
increase at 40 °C can be explained by a higher conversion after 3 days. On the other hand, the 
decrease at 60 °C could be explained by a further increase in reaction rate, hampering 
monomer diffusion due to fast gelation. Since in this case the vitrification temperature is 
exceeded, the reduction in residual free epoxide and amine groups at the crack surface might 
also have an influence.  
The capability of the reaction to proceed at lower temperatures was also tested. When 
5 EPON 828 samples were healed with the HDI3-TetraThiol combination for 3 days at -2 °C, 
a significant healing efficiency of 50 ± 6% was recorded. Although this value is much lower 
than the recovery at 25 °C, it shows that the system is also capable of healing at low 
temperatures, e.g. during cold periods.  
 
3.4.4 Self-healing of matrices other than epoxy 
In a final stage, the self-healing potential of the thiol-isocyanate chemistry was also 
screened for use in two other matrices: a) an epoxy vinyl ester (Atlac 430 resin) and b) an 
unsaturated polyester (Synolite 1717-N-1 resin). Both resins are intended for use in glass-
fibre reinforced composites with a high chemical resistance (eg. in vessels, hydraulics, 
pipelines or sewage systems). The Atlac 430 resin is a bisphenol A diglycidyl ether-based 
vinyl ester dissolved in styrene and is cured with methyl ethyl ketone peroxide (MEKP) as the 
radical initiator and cobalt octoate as an accelerator (Scheme 3.6). The Synolite resin is an 
isophtalic acid-based polyester with unsaturated carbon-carbon bonds in the backbone, 
dissolved in styrene, and is cured with the same initiator system.  
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Scheme 3.6. Epoxy vinyl ester resin (Atlac 430), methyl ethyl ketone peroxide (MEKP) initiator and cobalt 
octoate accelerator. 
 
Both resin-hardener mixtures were first placed in a silicon mold at room temperature 
for 1 day, followed by a post-cure process of 1 day at 80 °C (Atlac 430) or 2 hours at 80 °C 
and 3 hours at 110 °C (Synolite) to obtain 2 mm thick transparent plates. Also in this case, 
adhesive bonding was first evaluated by inserting the HDI- and HDI3-TetraThiol mixtures in 
between two smooth plate pieces and allowing them to react at room temperature without any 
applied pressure. Again, the adhesion was checked manually at different time intervals (Table 
3.3). Compared to the epoxy materials, similar adhesion results were obtained with both 
matrices, indicating that the reaction proceeds at a comparable rate despite the absence of 
tertiary amines to catalyze the reaction. In fact, interactions with the initiator system are 
responsible for this enhanced reaction rate. Indeed, cobalt octoate is known as a useful 
catalyst for nucleophilic addition reactions with isocyanates
40
, since it is able to act as a Lewis 
acid and as such renders the isocyanate more susceptible to nucleophilic attack. This was 
confirmed by mixing this compound with HDI and TetraThiol, resulting in gelation overnight 
compared to 7 days without cobalt octoate. 
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Table 3.3. Qualitative adhesion tests with different healing agent mixtures and epoxy plates. Weak 
adhesion is indicated in light grey, strong adhesion (non-detachable) is indicated in dark grey. 
 
     Time (hours) 
# NCO SH Ratio * Matrix 6 8 16 18 20 22 24 48 72 
1 HDI TetraThiol 1:1 Atlac 430          
2 HDI3 TetraThiol 1:1 Atlac 430 - -        
3 HDI TetraThiol 1:1 Synolite          
4 HDI3 TetraThiol 1:1 Synolite - -        
* NCO/SH functional group ratio. 
 
Preliminary TDCB tests to quantify the healing efficiency in these new matrices were 
also performed at the end of the Ph.D. research. Both the Atlac 430 and Synolite TDCB 
samples were fractured following the established procedure, manually injected with the  
HDI3-Tetrathiol mixture and allowed to heal for 3 days at 25 °C. This was then followed by a 
second fracture test. At least 4 samples were tested for each material. The virgin peak loads of 
these new matrices were slightly lower than the EPON 828 epoxy material, reaching 52 ± 8 N 
and 49 ± 11 N for the Atlac 430 epoxy vinyl ester and Synolite unsaturated polyester material 
respectively. The healed peak loads obtained after the second fracture were similar, 
respectively yielding recoveries of 100 ± 12% and 95 ± 16%. These healing efficiencies are 
comparable to the results obtained for the EPON 828 epoxy matrix (111 ± 12% after 3 days). 
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3.5 Conclusion 
In this chapter, the potential of the thiol-isocyanate combination for self-healing 
applications was demonstrated. Firstly, it was possible to select multiple thiol and isocyanate 
healing agents that are thermally stable under industrially used epoxy curing conditions, have 
a low toxicity and still demonstrate sufficient adhesive bonding of two epoxy plates. HDI and 
its isocyanurate trimer proved to be very suitable isocyanates for self-healing, while 
TetraThiol and TriThiol rendered similarly good results. 
Secondly, the reaction kinetics were analyzed using FTIR, demonstrating the high 
reaction rate of the thiol-isocyanate chemistry in the presence of a tertiary amine catalyst 
(within minutes). Furthermore, the catalytic effect of ground epoxy powder containing tertiary 
amines at the surface was demonstrated as well and confirmed by additional microcalorimetry 
experiments. The calorimetric experiments also showed that the thiol-isocyanate reaction also 
proceeds slowly without catalyst, reaching the gel point after about one week and full 
hardening after approximately 10 days. 
Thirdly, manual injection of the healing agent mixtures into the fractured area of 
epoxy thermosets was performed in order to quantify the adhesive strength. Both the HDI- 
and HDI3-TetraThiol combination reached peak load recoveries over 100% after 3 or 5 days 
in the EPON 828 and RIM 135 epoxy materials respectively. This indicates that the formed 
network has a higher resistance to fracturing than the original epoxy matrix. When novel 
damage would occur on the same spot in the epoxy matrix, the cracks are expected to 
propagate next to the healed material. Similar tests were also done in unsaturated polyester 
and vinyl ester matrices, yielding comparable results. 
To conclude this chapter, we can state that the thiol-isocyanate chemistry meets all the 
requirements concerning stability and costs to develop self-healing systems for industrial use 
and for different matrices, while toxicity issues were also taken into account. 
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3.6 Experimental section 
3.6.1 Materials 
Pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol, Aldrich, >95%), 4,4′-
methylenebis(phenyl isocyanate) (MDI, Aldrich, 98%), toluene-2,4-diisocyanate (TDI, 
Aldrich, 95%), isophorone diisocyanate (IPDI, Aldrich, 98%), hexamethylene diisocyanate 
(HDI, Sigma, ≥99%), EPIKOTE 828 LVEL epoxy resin (Low viscosity, Momentive Specialty 
Chemicals GmbH), diethylenetriamine (DETA, Sigma-Aldrich, 99%), RIM 135 epoxy resin 
(Momentive Specialty Chemicals GmbH), RIMH137 (Momentive Specialty Chemicals 
GmbH), isocyanurate-based hexamethylene diisocyanate trimer (HDI3, Tolonate HDT-LV, 
Vencorex Chemicals), uretonimine-based methylenebis(phenyl isocyanate) trimer (MDI3, 
Suprasec 2020, Huntsman Polyurethanes), trimethyl hexamethylene diisocyanate (TMDI, 
Evonik Industries), trimethylolpropane tris(3-mercaptopropionate) (TriThiol, Aldrich, ≥95%), 
isooctyl 3-mercaptopropionate (Sigma-Aldrich, ≥99%), N,N-diisopropylethylamine (DIPEA, 
Sigma-Aldrich, 99%), Atlac 430 epoxy vinyl ester (DSM Resins BV), Synolite 1717-N-1 
unsaturated polyester resin (DSM Resins BV), methyl ethyl ketone peroxide (MEKP, 
Butanox M-50 or LPT-IN, AkzoNobel Functional Chemicals) and cobalt octoate (AkzoNobel 
Functional Chemicals) were used as received.  
The EPIKOTE 828 LVEL resin is a bisphenol A/epichlorohydrin derived epoxy resin 
with a MW ≤ 700 g.mol-1. The RIM 135 epoxy resin is a combination of bisphenol A 
diglycidyl ether and 1,6-hexanediol diglycidyl ether. The RIMH 137 hardener is mainly 
composed of low MW poly(propylether amine) (MW ≈ 230 g.mol-1) and isophorone diamine. 
The isocyanurate-based hexamethylene diisocyanate trimer (HDI3, Tolonate HDT-LV) was 
kindly provided by Vencorex Chemicals. The uretonimine-based methylenebis(phenyl 
isocyanate) trimer (MDI3, Suprasec 2020, Huntsman Polyurethanes) was kindly provided by 
Recticel. Trimethyl hexamethylene diisocyanate (TMDI, Vestanat TMDI) is a 1:1 mixture of 
2,2,4-trimethylenehexane diisocyanate and 2,4,4-trimethylenehexane diisocyanate and was 
kindly provided by Evonik Industries. The Atlac 430 resin is a bisphenol A diglycidyl ether-
based vinyl ester dissolved in styrene. The Synolite 1717-N-1 resin is an isophtalic acid-based 
unsaturated polyester dissolved in styrene. The Atlac 430 and Synolite 1717-N-1 resins were 
kindly provided by DSM Resins BV. Butanox M-50 and Butanox LPT-IN both consist of 
methyl ethyl ketone peroxide, dissolved either in dimethyl phthalate or diisononyl phthalate. 
Accelerator NL-49P is a cobalt(II) 2-ethylhexanoate (also called octoate) solution (1% Co in 
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aliphatic ester). Butanox M-50, Butanox LPT-IN and Accelerator NL-49P were kindly 
provided by AkzoNobel Functional Chemicals. Solvents were purchased from Sigma-Aldrich 
or Acros and used without purification. 
 
3.6.2 Instrumentation 
Differential Scanning Calorimetry (DSC) thermograms were recorded using a Mettler-
Toledo DSC 1/700 instrument with an FRS5 sensor and Automatic Sample Robot. Nitrogen 
gas was used as purge gas. Liquid nitrogen was used to cool the system. The samples were 
studied in standard 40 µL aluminum sample pans and at a scan rate of 10 °C min
-1
. The 
thermograms were analyzed with the STARe software from Mettler-Toledo. 
Thermogravimetric analyses (TGA) were performed on a TGA/SDTA851e equipment 
(Mettler-Toledo). The samples were heated from 25 to 800 °C at a rate of 10 °C min
-1 
under 
nitrogen or ambient atmosphere. The thermograms were analyzed with the STARe software 
from Mettler-Toledo. Online Fourier-Transform InfraRed (FTIR) spectroscopy was 
conducted using a React-IR 4000 Instrument (Mettler Toledo AutoChem ReactIR) equipped 
with a diamond ATR probe. Microcalorimetric measurements were performed on a TAM III 
(TA Instruments). Approximately 1 g of the different mixtures was placed in the equipment 
and kept at isothermal conditions while the reaction heat flow was recorded. Tapered Double 
Cantilever Beam (TDCB) load-displacement curves were recorded with a Tinius Olsen 
H10KT testing machine equipped with a HTE-5kN load cell. A displacement rate of 0.3 
mm.min
-1
 was used. The data were analyzed with Tinius Olsen Test Navigator software. 
Viscosimetry was performed using a Brookfield Digital Viscosimeter Model DV-II with 
spindle 4 (rod, 3 mm diameter) from the Brookfield LV Spindle Set.  
 
3.6.3 Qualitative adhesion tests 
Smooth epoxy, epoxy vinyl ester or unsaturated polyester plate pieces of 
approximately 1 cm² were used for qualitative adhesion tests. Therefore, the healing agents 
were homogeneously mixed in a 1:1 functional group ratio and a droplet (approximately 10 
µL) was placed in between two pieces. The mixture was then allowed to react at room 
temperature without any applied pressure. The adhesion was checked manually at different 
time intervals, distinguishing liquid adhesion from adhesive bonding by the reacted network. 
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3.6.4 Online FTIR kinetic measurements 
For the online FTIR kinetic measurements, 1.61 mL (0.010 mol) of HDI was mixed 
with chloroform to obtain an 0.5 M solution. The ATR probe was then inserted into the 
mixture. Secondly, 4.60 mL (0.020 mol) of isooctyl 3-mercaptopropionate was added while 
stirring. After 1 hour of stirring at 200 rpm, 0.174 mL (0.001 mol) of DIPEA (5 mol% 
compared to the thiol) was added. 
 
3.6.5 Synthesis of silicon molds 
Tapered Double Cantilever Beam (TDCB) silicon molds were manufactured by 
mixing Elastosil 4670 A (57 g) with the Elastosil 4670 B hardener (5,7 g) for 5 minutes with a 
spatula until a homogeneous mixture is reached. The mixture was then poured and equally 
distributed in an aluminum mold with specific dimensions to produce the inverse silicon 
TDCB mold (Figure 3.11). Air bubbles that might still be present, were removed by gently 
tapping the mold on the bottom. The silicon mixture was allowed to cure for 1 day. To ensure 
complete hardening, the mold can be placed on a heating plate at 40 °C for 4 hours.  
 
 
 
Figure 3.11. Aluminium mold (top), inverse silicon mold halves (bottom) and closed mold set-up (right). 
 
3.6.6 Synthesis of epoxy TDCB test samples 
EPIKOTE 828 LVEL epoxy resin was mixed with DETA in an equimolar 100:11 
weight ratio, RIM 135 resin was mixed with RIMH 137 in an equimolar 100:30 weight ratio. 
After homogeneous mixing, the air was removed by applying high vacuum for 5 minutes. The 
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solution was then poured in a silicon mold with specific dimensions to produce the TDCB 
samples.
34, 35
 The EPIKOTE 828 mixture was cured for 1 day at 25 °C and 1 day at 40 °C, 
while the RIM 135 mixture was cured for 1 day at 40 °C and 16 hours at 80 °C. 
 
3.6.7 Quantification of healing efficiency using TDCB test samples 
The TDCB test samples were used for the quantification of the healing efficiency. In 
accordance with the protocol introduced by White et al.
34, 35
, a tapered epoxy sample with a 
side groove (47 mm in length) and a thickness of 2.5 mm in the groove was used. A precrack 
was generated by tapping the TDCB sample onto a razor blade (ASTM D4045 standard), 
which was inserted into the notch of the TDCB specimen. The samples were then pin loaded 
at a displacement rate of 0.3 mm.min
-1
.
34
 The specimens were loaded until failure occurs, 
resulting in the peak load necessary to break the virgin sample. If multiple peak loads were 
obtained, the average was used as the load to failure for the TDCB sample.  
When broken, healing agents were delivered to the crack by manual injection of the 
healing mixture. Therefore, 30 µL of healing agent was injected in the crack plane and both 
crack surfaces were brought into contact by gentle clamping. The healed samples were stored 
at 25 °C for the designated period and then broken at the same displacement rate to calculate 
the healing efficiency, which is defined as the ratio of the average peak load of the healed 
sample over the average peak load of the same virgin sample. At least 3 samples were tested 
for each composition. 
 
3.6.8 Synthesis of epoxy vinyl ester and unsaturated polyester matrices 
Epoxy vinyl ester plates and TDCB samples were made by mixing the Atlac 430 resin 
consecutively with the MEKP initiator (Butanox LPT-IN) and cobalt octoate (Accelerator 
NL-49P) in a 100:2:1 weight ratio.
41
 After homogeneous mixing, the air was removed by 
applying high vacuum for 5 minutes. The solution is then poured in a silicon mold with 
specific dimensions to produce plates or TDCB samples. The Atlac 430 mixture is cured for 1 
day at room temperature and 1 day at 80 °C. 
Unsaturated polyester plates and TDCB samples were made by mixing the Synolite 
1717-N-1 resin consecutively with the MEKP initiator (Butanox M-50) and cobalt octoate 
(Accelerator NL-49P) in a 100:1.5:1 weight ratio.
42
 After homogeneous mixing, the air was 
removed by applying high vacuum for 5 minutes. The solution is then poured in a silicon 
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mold with specific dimensions to produce plates or TDCB samples. The Synolite 1717-N-1 
mixture is cured for 1 day at room temperature, 2 hours at 80 °C and 3 hours at 110 °C. 
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Abstract 
Maleimide chemistry involving amines and thiols was evaluated for the design of 
extrinsic self-healing epoxy materials. Model reactions show that amines react rapidly with 
maleimide compounds at room temperature via the Michael addition reaction. Moreover, 
thiols and maleimides react readily in the presence of tertiary amines that are present in the 
epoxy material. The maleimide conjugation reaction with residual amines in the epoxy 
material ensures chemical bonding of the newly formed network with the surrounding matrix 
during crack healing, while multifunctional thiols react with difunctional maleimides to fill 
the crack area. The solubility of both commercial aromatic and synthesized aliphatic 
maleimides was investigated, as well as their self-healing potential. Healing efficiencies are 
evaluated using the tapered double cantilever beam (TDCB) test method with manual 
injection of the healing agents, revealing a healing efficiency up to 120% for the EPIKOTE 
828 epoxy material. While the healing efficiency is strongly dependent on the type of epoxy 
material used, the average maximum peak load for fracture after healing is roughly the same 
for all tested epoxy materials. The effect of the solvent was also evaluated. 
 
Parts of this chapter are also published in: S. Billiet, W. Van Camp, X. K. D. Hillewaere, H. Rahier,  
F. E. Du Prez. Development of optimized autonomous self-healing systems for epoxy materials based on 
maleimide chemistry. Polymer, 2012, 53 (12), 2320. 
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Chapter 4 
Thiol-maleimide chemistry for self-healing 
 
4.1 Introduction 
Thiol-ene reactions are well established in the area of polymer chemistry.
1, 2
 Both 
radical thiol-ene and nucleophilic Michael additions have found their way into the toolkit for 
monomer synthesis
3, 4
, post-polymerization modification (PPM)
5-7
, polymerization processes
4, 
8-10
 and peptide synthesis
11
. The radical thiol-ene addition reaction has already been applied in 
self-healing coatings with microcapsules.
12, 13
 In this chapter, the nucleophilic Michael 
addition reaction of amines and thiols to maleimides is evaluated for use in self-healing 
applications. 
Maleimides are commercially used in the synthesis of polyimides for aerospace carbon 
fiber-reinforced composites.
14
 In this case, oligomers end-capped with maleimide functions 
are crosslinked upon heating through homopolymerization of the double bonds. Secondly, 
bismaleimides are also applied in rubber vulcanization where they react with the double bonds 
in the rubber, generally via a radical addition reaction in combination with a radical initiator 
such as dicumyl peroxide.
15
 Maleimides are also often used to label proteins via the cysteine 
thiol groups.
16-18
  
In the field of self-healing, maleimides have mainly been combined with furan groups 
in intrinsic self-healing polymer networks, comprising epoxy materials
19-22
, 
poly(meth)acrylates
23, 24
, polyesters
25-29
, polyurethanes
30-32
, polyethers
33, 34
, polyketones
35
 and 
silsesquioxane nanocomposites
36
. In this case, the reversible Diels-Alder reaction gives the 
polymer material the capability to reform the broken bonds after a damage event. In most 
cases however, a temperature increase is required to heal the sustained damage, defining the 
material as remendable rather than self-healing. 
As mentioned in Chapter 3, thiols are often combined with electrophiles such as 
epoxides and isocyanates to generate polymer networks. However, the combination of thiols 
and maleimides is one of the fastest nucleophilic thiol addition reactions
37
 and forms stable 
thio-ether bonds when aliphatic thiols are used as the nucleophile
18, 38-41
. As such, this 
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reaction should also be considered as a potentially suitable reaction for self-healing 
applications. Although not many multifunctional maleimides are commercially available and 
cheap, several synthetic options can be considered. In this chapter, maleimides are also 
combined with amines in spite of the difficulty to encapsulate these amines due to reactivity 
and polarity reasons. Comparable addition reactions such as the thiol-bromo
42
 and thiol-vinyl 
sulfone
43
 combinations were also considered, but not further elaborated after the first 
qualitative screening tests (see Appendix). 
In this chapter, two commercially available aromatic bismaleimides are screened for 
their thermal stability and adhesive capability in combination with multifunctional thiols. A 
range of aliphatic bis- and trismaleimides is also synthesized and tested for their self-healing 
suitability, mainly by focusing on the maleimide solubility. Furthermore, the amine-
maleimide and thiol-maleimide reaction kinetics are compared to those of the amine-epoxy 
and amine-methacrylate combinations, which were already used in another self-healing 
concept.
44
 Again, a fast reaction is required to induce early inhibition of crack propagation in 
order to minimize the crack volume to be healed. The most suitable healing agent mixtures 
are then manually injected into the crack area of a broken epoxy matrix to evaluate the 
maximal healing potential of these adhesives. The research on the aliphatic maleimides was 
fully performed by the author, while the performance of the aromatic maleimides was 
investigated in close collaboration with dr. Wim Van Camp. Several master students 
contributed significantly to the whole thiol-maleimide research. 
 
4.2 Reaction kinetics 
4.2.1 Theoretical description 
The reaction kinetics of the thiol Michael addition reaction have been studied 
extensively in the past decade.
45-48
 Electrophiles frequently used in Michael addition reactions 
with thiols as the nucleophile – without being exhaustive – include (meth)acrylates, 
(meth)acrylamides, maleimides, acrylonitriles, vinyl sulfones and cyanoacrylates
39, 47
, with 
one of the fastest additions taking place between a thiol and a maleimide. Only the reaction 
rate of the thiol Michael addition to vinyl sulfones or acrylates, catalyzed by tertiary 
phosphines, approaches that of the uncatalyzed thiol-maleimide reaction.
37
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In the thiol-maleimide Michael addition reaction, the thiol is deprotonated by a tertiary 
amine catalyst with the formation of a strongly nucleophilic thiolate anion (Scheme 4.1).
46
 
The anion then adds to the double bond, generating an enolate intermediate with a delocalized 
negative charge. In the last step, the proton is subtracted again from the amine catalyst, 
resulting in a stable thio-ether adduct when using aliphatic thiols.
39, 41
 n-Alkyl thio-ethers 
generally are difficult to cleave, while in the case of thiols directly attached to aromatic 
structures, the adduct is reversible under specific conditions, eg. involving bases 
39
 or sodium 
41
.  
 
 
 
Scheme 4.1. General scheme of the thiol-maleimide reaction, catalyzed by a tertiary amine, with the 
formation of a thio-ether product.
46
 
 
In Equation 4.1, the overall reaction rate is given as a function of the disappearance of 
the maleimide, which is the functional group used in the kinetic study in Subsection 4.2.2, and 
indicates a dependency on the concentration of the thiol, the maleimide and the tertiary amine 
catalyst; k is the reaction rate constant. This is completely analoguous to the base-catalyzed 
thiol-isocyanate reaction. 
 
 
   3''
d maleimide
k maleimide R SH R N
dt

   (4.1) 
 
Because the concentration of the tertiary amine catalyst remains constant, the reaction 
rate is given by Equation 4.2, indicating a second-order reaction where k’ is the apparent 
reaction rate constant. 
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 
  '
d maleimide
k maleimide R SH
dt

   (4.2) 
 
Although this equation considers the main base-catalyzed mechanism, other catalytic 
mechanisms may also play a significant role. Most importantly, the thiol Michael addition 
reaction can also be catalyzed efficiently by primary amines or tertiary phosphines.
46-48
 This is 
considered to proceed via a nucleophilic initiation mechanism
46
, where the primary amine or 
tertiary phosphine adds to the double bond and generates the enolate. Since the enolate has a 
pKa of approximately 25 (in the case of an acrylate)
49
, it is capable of subtracting the thiol 
proton, leading to the formation of the required thiolate. Recurrent addition of the thiolate and 
deprotonation by the enolate results in an anionic chain process with the formation of a 
polymer or polymer network.
46
 The resulting side products – the adducts formed via addition 
of the catalyst to the double bond – are only observed with primary amine and phosphine 
catalysts and not with tertiary amines such as triethylamine (TEA).
46-48
 
 
The anionic chain mechanism results in an extremely fast reaction, leading to 
difficulties in measuring the apparent reaction rate, especially for the thiol-maleimide 
reaction.
46
 For example, when propylmaleimide (5 mmol) is mixed with 5 mmol hexanethiol 
and 2 wt% of hexylamine, the rate constant value could not be determined with 
1
H NMR 
spectroscopy. Although the base-catalyzed thiol-maleimide reaction is slightly slower than the 
nucleophilic initiated one, it still has a very high reaction rate as well. The rate constant value, 
which was calculated via modelling of a methane thiolate addition to a maleimide
48
, equals 
2.3 x 10
7
 L.mol
-1
.sec
-1
 for the rate determining step. Unfortunately, the thiolate deprotonation 
step was not taken into account. As stated by the authors, the high reaction rate can be 
attributed to the two electron-withdrawing groups on the maleimide double bond and the 
release of ring strain upon addition of the thiol. The model study also indicates activation 
energies and transition states of the thiol-maleimide reaction. 
 
As for the thiol-isocyanate reaction, the reaction rate is influenced both by the basic 
strength of the catalyst, as well as by the steric hindrance around the tertiary amine.
48
 
Additionally, the nature of the both the thiol and the activated double bond plays a significant 
role. It was shown by Chan et al. that a maleimide is more susceptible to nucleophilic attack 
by a thiolate than a fumarate, maleate, acrylamide, acrylonitrile, crotonate, cinnamate and 
methacrylate.
46
 They also demonstrated that thiols are more reactive towards hexylacrylate  
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– with hexylamine as the catalyst – in the following order: mercaptoglycolate >  
2-mercaptopropionate >> 3-mercaptopropionate >> hexanethiol, which is fully related to their 
pKa value. Furthermore, due to the pKa range, it is possible to perform the thiol Michael 
addition in the presence of small amounts of water.
46
 
 
4.2.2 Kinetic study with 
1
H NMR spectroscopy 
In order to check the feasibility of the proposed maleimide chemistry for self-healing 
applications, we have first performed a detailed study of the reaction kinetics at room 
temperature of monofunctional maleimides with amines and thiols using 
1
H NMR 
spectroscopy. As the lifetime of a material is dependent on the result of crack growth vs. crack 
repair, reaction kinetics are of utmost importance. At the same time, we have compared the 
maleimide-amine/thiol reaction rate with that of the methacrylate-amine and epoxide-amine 
reactions, already published in the field of self-healing (see Chapter 2).
44
 
Therefore, we have selected several model compounds, each containing the respective 
reactive group. Butyl glycidyl ether (BGE) was chosen as a model compound for the epoxide 
ring-opening reaction with amines, while methyl methacrylate (MMA) was chosen as a model 
compound to assess the reactivity of the C=C bond in the nucleophilic Michael addition 
reaction (Scheme 4.2, reaction 1 and 2). Both compounds were reacted with a primary amine 
and the conversion was monitored by 
1
H NMR spectroscopy.  
For the maleimides, the aromatic phenylmaleimide (PM) was monitored as a model 
compound (Scheme 4.2, reaction 3). In the case of MMA and PM, the aliphatic, 
monofunctional propylamine (PA) was chosen as the amine to mimic the reactivity of the 
diethylenetriamine (DETA) primary groups, while in the case of BGE, benzylamine (BA) was 
chosen to prevent overlap of the 
1
H NMR signals. All reactions were performed in m-cresol to 
ensure similar reaction conditions and because of bismaleimide solubility reasons mentioned 
in Subsection 4.3.1. 
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Scheme 4.2. Model reactions in m-cresol to compare the reactivity of amines with (1) an epoxide (two 
different adducts possible due to a limited regioselectivity), (2) a methacrylate and (3) a maleimide 
functionality and (4) the reactivity of a thiol with a maleimide functionality. 
 
 
Figure 4.1. Reaction kinetics at room temperature of the reaction of butyl glycidyl ether (BGE) with 
benzylamine (BA), methyl methacrylate (MMA) and phenylmaleimide (PM) with propylamine (PA), and 
PM with dodecanethiol (DT) without a catalyst, catalyzed by triethylamine (TEA) or by ground EPON 
828 epoxy material.  
 
As can be noticed from Figure 4.1, maleimides are more reactive towards amines than 
the epoxide or methacrylate groups. The reaction of PM with PA reaches full conversion after 
10 min, while the reaction of BGE and BA reaches only 14% conversion after 120 min, and 
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only 10% of the C=C bonds react with PA after 120 min. The high reactivity of the 
maleimides may therefore increase the rate of crack healing in comparison to crack 
propagation. On the other hand, preliminary reaction of the maleimides with amines at the 
crack surface cannot be avoided. 
In a similar way, we have also investigated the reactivity of thiols with maleimides, 
using PM and dodecanethiol (DT) to mimic the reactivity of the used multifunctional thiols 
(Scheme 4.2, reaction 4). As can be seen in Figure 4.1, the reaction proceeds rather slowly, 
reaching 15% of maleimide conversion in 120 minutes. However, the use of triethylamine 
(TEA) as a tertiary amine catalyst dramatically increases the reaction rate
37, 46, 48
 and full 
conversion is reached in less than 10 minutes. An identical reaction with ground epoxy 
material added as the catalyst (average size of the particles ±100 µm) reached 90% of 
conversion of the maleimide functionalities in 120 minutes, clearly demonstrating the ability 
of the tertiary amines in the epoxy material to catalyze the thiol-maleimide reaction. The 
reaction of an aliphatic maleimide (Jeffamine D-2000 bismaleimide, vide infra) with DT in 
the presence of TEA was also followed using 
1
H NMR spectroscopy, reaching full conversion 
in less than 10 min as well. This demonstrates that the reactivity of the maleimide in this case 
is not significantly influenced by the substituent on the nitrogen atom. As with the thiol-
isocyanate reaction, it is worth mentioning that this high reaction rate could also hamper 
proper mixing of the healing agents in the crack area. 
 
4.3 Selection and synthesis of suitable healing agents 
4.3.1 Qualitative screening of healing agents 
To our knowledge, only a small number of multifunctional maleimides are 
commercially available. The bifunctional 1,1-(methylenedi-4,1-phenyl)bismaleimide (MBM) 
and N,N’-(1,3-phenylene)bismaleimide (PBM) (Scheme 4.3) were selected as potential 
healing agents and combined with pentaerythritol tetrakis(3-mercaptopropionate) 
(TetraThiol), DETA and TEA in qualitative adhesion tests (Table 4.1). The structural 
similarity of the maleimides and the applied epoxy resins should ensure a good compatibility 
of the newly formed material with the matrix material. As both maleimide compounds are 
solid compounds, they were solubilized in m-cresol, which was chosen because of the lack of 
solubility of the bismaleimides in other solvents (see Subsection 4.3.3). Moreover, m-cresol 
has some additional advantages such as its high boiling point (203 °C) and the ability to act as 
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an inhibitor for the homopolymerization of bismaleimides
39, 50
, a possible side reaction that 
would limit the shelf-life of the healing agent. MBM and PBM were used as nearly saturated 
solutions in m-cresol at a loading of 25 and 15 wt% respectively. The liquid TetraThiol was 
chosen for reasons outlined in Chapter 3.  
The healing agents were mixed in equimolar ratios of functional groups unless stated 
otherwise. Adhesive bonding was then evaluated by inserting these mixtures in between two 
smooth epoxy plate pieces and allowing them to react at room temperature without any 
applied pressure. The adhesion was checked manually after 16 hours and 3 days, 
distinguishing liquid adhesion from adhesive bonding by the reacted network. The same 
epoxy compositions, described in Chapter 3, were used: the bisphenol A glycidyl ether-based 
EPON 828 resin with an equimolar or excess amount of DETA as the hardener (respectively 
100:11 and 100:20 ratio in weight) and the RIM 135 resin with an an equimolar or excess 
amount of RIMH 137 as the hardener (respectively 100:30 and 100:50 ratio in weight). The 
excess amount of hardener was applied to provide an increased amount of residual primary 
and secondary amines in the epoxy matrix, which could react with the maleimide at the 
surface. 
 
 
 
Scheme 4.3. 1,1-(methylenedi-4,1-phenyl)bismaleimide (MBM), N,N’-(1,3-phenylene)bismaleimide (PBM) 
and pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol) used as healing agents. 
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Table 4.1. Qualitative adhesion tests with different healing agent mixtures and epoxy plates. Weak 
adhesion is indicated in light grey, strong adhesion (non-detachable) is indicated in dark grey. 
 
    EPON 828 
100:11 
EPON 828 
100:20 
RIM 135 
100:30 
RIM 135 
100:50 
# Mal. SH Amine 16 h 72 h 16 h 72h  16h  72h 16h 72h 
1 MBM TetraThiol - -  -      
2 MBM TetraThiol TEA * -  -  -    
3 MBM TetraThiol DETA *     - - - - 
4 MBM - DETA -  -      
5 PBM TetraThiol -   -      
6 PBM TetraThiol TEA * - - -  - - - - 
7 PBM TetraThiol DETA * - -   -    
8 PBM - DETA -    - - -  
* 1 wt% of amine. 
 
Several trends were observed in the qualitative tests. Firstly, most of the compositions 
did not yield strong adhesion after 16 hours, indicating that more time is required for the 
formation of a strong crosslinked network. Secondly, the PBM-TetraThiol combination with 
TEA as a tertiary amine catalyst demonstrated little to no adhesion in all cases (Entry 6). Due 
to the increased reaction rate, early precipitation of the reaction product was noticed, leading 
to diffusion issues and the formation of a weak network (as already indicated in Chapter 3 for 
aromatic isocyanates). To a certain extent, this was also noticed with the MBM-TetraThiol-
TEA combination (Entry 2), especially with the RIM material. Additionally, this could 
explain the limited adhesion noticed with the PBM-TetraThiol-DETA combination in all 
epoxy materials (Entry 7) and the MBM-TetraThiol-DETA combination in the RIM 135 
matrix (Entry 3), since DETA reacts significantly faster than TetraThiol, forming tertiary 
amines in the process and thus autocatalyzing the reaction.  
However, in spite of this faster reaction with amines, combining DETA with either 
MBM or PBM resulted in relatively strong adhesion after 3 days (Entry 4 and 8). The 
combination of MBM or PBM with TetraThiol only (Entry 1 and 5) rendered the most 
consistent strong adhesion over all matrix materials after 3 days. Therefore, only the 
combination of MBM and PBM with either TetraThiol or DETA was further quantified 
(Section 4.4). 
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4.3.2 Synthesis of aliphatic maleimides 
Because the solubility of these commercial aromatic bismaleimides is limited (see 
Subsection 4.3.3), a selection of multifunctional aliphatic maleimides was synthesized. It was 
anticipated that the lack of aromatic-aromatic interactions would lead to an enhanced 
solubility, facilitating the encapsulation process and increasing the amount of reactants in the 
healing agent solution. In a first stage, maleic anhydride was reacted with a range of linear 
aliphatic diamines following an established synthesis procedure (Scheme 4.4, reaction 1).
51
 In 
this process, the amine nucleophile opens up the maleic anhydride ring, forming an open 
butenoic acid intermediate, after which the ring is closed with expulsion of water. Acetic 
anhydride is added to remove the water from the reaction mixture, as such aiding the 
formation of the maleimide ring structures. If desirable, the reaction can be performed in 
acetic anhydride as the solvent, omitting the toluene. 
 
 
 
Scheme 4.4. Synthesis of bismaleimides from maleic anhydride: (1) with diamines, (2) via a maleimide 
alcohol intermediate with (3) diisocyanates or (4) diacid chlorides. 
 
1,2-ethanediamine, 1,6-hexanediamine and 1,12-dodecanediamine were combined 
with maleic anhydride to generate 1,2-ethane bismaleimide (EBM), 1,6-hexane bismaleimide 
(HBM) and 1,12-dodecane bismaleimide (DBM) (Scheme 4.5) in yields up to approximately 
65%. The loss in yield is almost completely related to the second ring closure step. A clear 
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increase in solubility, compared to the aromatic maleimides, was already noticed (see 
Subsection 4.3.3). 
 
 
 
Scheme 4.5. Synthesized aliphatic maleimides: 1,2-ethane bismaleimide (EBM), 1,6-hexane bismaleimide 
(HBM), succinic acid-based bismaleimide (SBM), 1,12-dodecane bismaleimide (DBM), 4,9-dioxa-1,12-
dodecane bismaleimide (DDBM), Jeffamine D-2000 bismaleimide (JBM), trimethylhexane-based 
bismaleimide (TMBM), Jeffamine T-403 trismaleimide (JTM), isophorone-based bismaleimide (IPBM). 
 
In order to further enhance the solubility, 4,9-dioxa-1,12-dodecane bismaleimide 
(DDBM), Jeffamine D-2000 bismaleimide (JBM), and Jeffamine T-403 trismaleimide (JTM) 
were synthesized using a similar procedure (Scheme 4.5). For DDBM, the equivalent  
4,9-dioxa-1,12-dodecanediamine was used as the starting compound, while for JBM and JTM 
a poly(propylene oxide) (PPO)-based di- or triamine was added to the maleic anhydride. 
Jeffamine D-2000 consists of a linear PPO chain of approximately 2000 g.mol
-1
, end-capped 
with two primary amine functionalities, while Jeffamine T-403 is a branched PPO oligomer of 
approximately 440 g.mol
-1
, end-capped with three primary amines. 
Although DDBM had a slightly improved solubility compared to the linear aliphatic 
maleimides, the most promising result was obtained with the Jeffamine-based maleimides. 
Both JBM and JTM are high viscous liquids because the methyl groups of the PPO hinder the 
Chapter 4 – Thiol-maleimide chemistry for self-healing 
122 
 
van der Waals interactions between the polymer chains and as such prevent crystallization of 
the product. Because they are liquid, JBM and JTM could easily be mixed with a wide range 
of organic solvents in varying amounts to finetune the viscosity, providing a suitable healing 
agent solution that was used in both qualitative and quantitative tests (Section 4.4). For the 
qualitative tests, TetraThiol was mixed with JBM or JTM in an equimolar ratio of functional 
groups, inserted in between two EPON 828 or RIM 135 epoxy plates and allowed to heal for 
3 days. After this period, the plates were strongly adhered together, indicating that both 
maleimides have great potential. Furthermore, a color change from dark brown to red was 
noticed upon crosslinking, which could be used as a visual indicator. 
However, it is not easy to fully remove the residual acetic acid and acetic anhydride 
from these liquid healing agents due to their viscosity and quantification of the ring closure in 
the final product via 
1
H NMR spectroscopy is also difficult (Figure 4.2). As can be seen in the 
NMR spectrum, large signal broadening and overlap prevent the comparison of signals. 
 
 
 
Figure 4.2. 
1
H NMR spectrum of JTM (300 MHz, CDCl3). 
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As a consequence, a different strategy was also followed to ensure complete ring 
closure in the bis- or trismaleimides. This was done by first synthesizing a monofunctional 
maleimide with a nucleophilic alcohol group that can react with a range of electrophiles 
(Scheme 4.4, reaction 2).
52
 Maleic anhydride is dissolved in ethanol and reacted with 
ethanolamine at 90 °C for 3 hours, after which the heating is stopped and the reaction is 
allowed to cool down slowly. This results in crystallization of the alcohol-functionalized 
maleimide in high purity and moderate yields (55%).  
This pure alcohol-functionalized maleimide is then combined with the diisocyanates 
TMDI and IPDI (see Chapter 3), together with dibutyltin dilaurate as a catalyst, to generate a 
trimethylhexane-based and an isophorone-based bismaleimide (respectively TMBM and 
IPBM). The diisocyanates were specifically selected because they both have an asymmetrical 
structure and are a mixture of isomers (TMDI is a 1:1 mixture of 2,2,4-trimethyl-
hexamethylene diisocyanate and 2,4,4-trimethylhexamethylene diisocyanate (structural 
isomers), while IPDI contains different stereoisomeric ring structures), which could both aid 
in the final solubility of the bismaleimide. Good yields (over 80%) were obtained for both 
compounds and the solubility was also higher than the aromatic maleimides. Both 
bismaleimides were used in quantitative analysis as well (Section 4.4). 
The alcohol-functionalized maleimide was also mixed with succinyl chloride and 
triethylamine (TEA) as a catalyst, generating a succinic acid-based bismaleimide (SBM) 
(Scheme 4.4, reaction 4). Although the maximal solubility of SBM is slightly lower than 
those of TMBM and IPBM, it is nevertheless soluble in more solvents than the aromatic 
compounds and demonstrates the versatility of the starting compound in the generation of a 
series of multifunctional maleimides. 
In this alcohol-functionalized maleimide strategy, the furan-protected maleic 
anhydride was also used for better solubility during synthesis. Therefore, the maleic 
anhydride is reacted with furan at 80 °C to form the Diels-Alder adduct in almost 100% yield 
(Scheme 4.6). At the end of the reaction procedure, the furan-protected bismaleimide is 
redissolved in toluene and refluxed at 120 °C overnight to completely remove the furan via a 
retro-Diels-Alder reaction. 
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Scheme 4.6. The reversible Diels-Alder reaction between furan and maleic anhydride. 
 
4.3.3 Solubility of maleimides 
Since most of the maleimides are solid, dissolution in a suitable solvent is required to 
apply these as healing agents. Because maleimides in general are hard to dissolve due to 
strong dipole-dipole interactions between the planar maleimide groups, the solubility of both 
the aromatic and aliphatic maleimides was screened in a wide range of solvents (Table 4.2). 
From this solubility table, it is clear that the aliphatic maleimides are soluble in more 
solvents than the aromatic maleimides. The solubility of aromatic maleimides is restricted to 
dimethyl sulfoxide (DMSO), dimethyl formamide (DMF), acetone, chloroform, 
dichloromethane and m-cresol. Because DMSO and DMF are too polar to encapsulate and 
acetone, chloroform and dichloromethane have boiling points (respectively 56, 61 and 40 °C) 
that are too low for epoxy curing conditions, m-cresol was the only option to dissolve the 
aromatic maleimides for self-healing tests, with the additional advantages mentioned in 
Subsection 4.2.2. In this phenolic solvent, up to 30 and 15 wt% (0.8 and 0.6 M) of 
respectively MBM and PBM could be dissolved. Furthermore, since m-cresol dissolved all 
presented maleimides and could potentially be used in microcapsules, a quantitative solubility 
comparison was performed in this solvent. An increased maximal solubility compared to the 
aromatic maleimides was recorded for HBM (45 wt% or 1.7 M), DBM (47 wt% or 1.3 M), 
TMBM (47 wt% or 1.0 M) and IPBM (45 wt% or 0.9 M). 
HBM also dissolved well in chloroform and dichloromethane (40 wt%), and to a 
limited extent in more polar solvents. Furthermore, it dissolves to a certain extent in phenyl 
acetate (PA), ethyl phenylacetate (EPA) and methyl benzoate (MB), three high boiling 
solvents (respectively 196, 200 and 226 °C) that are immiscible with water and used in 
respectively the pharmaceutical, food and perfume industry.
53, 54
 PA has been applied as an 
agent to cure nitrogen accumulation disorders associated with cancer and anemia, while EPA 
is a non-mutagenic solvent and certified Kosher food additive.
53, 55
 Phenyl acetate was also 
encapsulated together with maleimides more recently.
56
 A similar solubility was noticed for 
EBM and DBM, while DDBM dissolves in slightly higher amounts in the same solvents. 
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Table 4.2. Solubility of aromatic and aliphatic maleimides in a range of solvents. The grey or white color 
respectively indicates solubility or insolubility. The number indicates the maximal solubility in wt%, while 
a dash indicates that the solubility in that solvent was not tested. 
 
Solvent (PI)* MBM PBM EBM HBM DBM DDBM TMBM IPBM SBM 
Water (9.0) 0 0 0 0 0 0 - - - 
DMSO (7.2)    <10  <20 - - - 
DMF (6.4)    <10  <20 - - - 
DMA (6.5) - -  <10  <20 - - - 
acetonitrile (5.8) - -  <10  <20 - - - 
methanol (5.1) - -  <10  <20 - - - 
acetone (5.1)    <10  <20 - - - 
MEK (4.7) 0 0 - - - - - - - 
chloroform (4.1)    40  40 - - - 
dichloromethane (3.1)    40  40 - - - 
ethyl acetate (4.4) 0 0  <10  <20 - - - 
n-butyl acetate (3.9) 0 0 - - - - - - - 
sec-butyl acetate 0 0 - - - - - - - 
phenyl acetate 0 0 - - 10 - 12 10 <10 
ethyl phenylacetate 0 0  <10 15 <20 15 12 <10 
methyl benzoate - -  <10 12 <20 10 10 <10 
m-cresol 30 15  45 47 <20 47 45 - 
anisole 0 0 - - - - - - - 
chlorobenzene (2.7) 0 0 - - - - - - - 
xylene (2.5) 0 0 - - - - - - - 
toluene (2.4) 0 0 0 0 0 0   - 
1,4-dioxane (4.8) 0 0  <10   - - - 
THF (4.0) 0 0  <10   - - - 
diethyl ether (2.8) 0 0 0 0 0 0 - - - 
diisopropyl ether (2.2) - - 0 0 0 0 - - - 
decalin 0 0 - - - - - - - 
hexane (0.0) 0 0 0 0 0 0 - - - 
dodecane (0.0) 0 0 - - - - - - - 
* PI = Polarity Index. 
 
Apart from m-cresol, only PA, EPA and MB were quantitatively tested for TMBM and 
IPBM, demonstrating a solubility around 10-15 wt%, while less than 10 wt% of SBM was 
soluble in these solvents. Quantitative self-healing tests were performed with m-cresol as well 
as PA, EPA and MB (see Section 4.4). Since JBM and JTM are liquid, these can be mixed 
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with a range of organic solvents. Without being exhaustive, these compounds are easily 
miscible with DMSO, DMF, methanol, acetone, chloroform, dichloromethane, PA, MB, 
toluene, THF and with ethyl acetate, EPA and toluene to a certain extent. 
 
4.3.4 Thermal stability of maleimides 
As mentioned in Chapter 3, the thermal stability of the healing agents is important for 
their use in high-end epoxy applications, for which curing occurs at temperatures up to  
180 °C. From the TGA measurements (Figure 4.3, left), it is clear that the aromatic 
bismaleimides can withstand these high temperatures easily, with a 2 wt% mass loss only 
occurring at 316 and 197 °C for MBM and PBM respectively. The aromatic bismaleimides 
are stable for a long period when stored in a dry and cool place. The aliphatic maleimides on 
the other hand (Figure 4.3, right) show a small drop of approximately 1-2 wt% around  
140 °C, fully related to the presence of residual acetic anhydride from the synthesis 
procedure. If the 5 wt% mass loss temperatures are compared, IPBM only starts degrading at 
191 °C, while HBM and JBM only reach this point at 242 and 328 °C respectively. These 
values indicate that the thermal stability of both the aromatic and aliphatic multifunctional 
maleimides is sufficient, even for the highest temperature curing applications. 
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Figure 4.3. TGA curves of aromatic (left) and aliphatic (right) bismaleimides: 1,1-(methylenedi-4,1-
phenyl)bismaleimide (MBM), N,N’-(1,3-phenylene)bismaleimide (PBM), 1,6-hexane bismaleimide (HBM), 
Jeffamine D-2000 bismaleimide (JBM), isophorone-based bismaleimide (IPBM). Curves of 1,12-dodecane 
bismaleimide (DBM), Jeffamine T-403 trismaleimide (JTM), trimethylhexane-based bismaleimide 
(TMBM), succinic acid-based bismaleimide (SBM) can be found in the Appendix. 
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4.4 Healing of thermosets with manual injection 
4.4.1 Manual healing with aromatic maleimides  
Since the model reactions described in Section 4.2 have demonstrated that the 
maleimide-amine reaction proceeds faster than the epoxide-amine or methacrylate-amine 
reaction, the former reaction could become a promising chemical strategy for application in 
self-healing materials. Consequently, we propose a self-healing concept based on maleimide 
and thiol compounds on the one hand, and amine species that are present in the epoxy 
material on the other hand.  
Actually, a distinction can be made between the bulk area of the crack and the crack 
interface in a damaged epoxy material. At the crack interface, residual unreacted primary and 
secondary amines, that arise from the incomplete curing reaction of the epoxy matrix, can 
react with maleimide compounds. The covalent bond will ensure a chemical link between the 
newly formed network and the original epoxy material. Moreover, it has been shown that the 
use of an excess of amine hardener during the synthesis of the epoxy material can result in an 
important contribution to the healing reaction.
44
 On the other hand, in the bulk area of the 
crack, a healing reaction can occur by reaction of thiols with the maleimide compounds. 
These reactions are catalyzed by the tertiary amines that are present at the crack interface, as 
has been shown in the model reaction of PM and DT catalyzed by ground EPON 828 epoxy 
material, which obviously contains tertiary amines at the surface. Moreover, multifunctional 
thiols have been encapsulated for the use in self-healing materials before
57-63
, mostly as an 
alternative chemical to amines, which are more difficult to encapsulate because of their 
reactivity and hydrophilicity. More successful attempts at encapsulating amines were only 
reported recently.
64-66
 
  
Based on the results obtained in Subsection 4.3.1, the combinations of MBM or PBM 
with either TetraThiol or DETA were selected for quantification, using a Tapered Double 
Cantilever Beam (TDCB) test method. To ensure a strong network formation via the thiol-
maleimide reaction, nearly saturated maleimide solutions in m-cresol were applied (see Table 
4.2). The effect of solvents on the healing performance is further analyzed in Subsection 
4.4.3. TDCB samples with a long side-groove of 47 mm were used to evaluate the self-
healing ability, according to the protocol described by White et al.
67, 68
 In this test, epoxy 
TDCB samples were pulled apart until the precrack propagated, which resulted in a measured 
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maximum load that the virgin epoxy material can resist. 30 µL of a combination of healing 
agents in an equimolar ratio of functional groups was then injected into the crack plane, 
followed by clamping of the sample and allowing a healing time of 3 or 5 days at 25 °C. The 
same test was then repeated to obtain the maximum load that is necessary to break the healed 
sample. The ratio of these two values is defined as the healing efficiency.
67
  
 
The TDCB tests have been applied to two types of epoxy materials: EPON 828 and 
RIM 135 resin (vide supra). For the latter material, we have also evaluated the effect of the 
use of excess hardener during the epoxy material preparation. 
In the case of the EPON 828 resin, only samples with an equimolar amount of 
hardener were used (100:11 weight ratio), since in this case already 15% of residual unreacted 
amine or epoxide groups are present when using the standard curing program (see Chapter 3). 
The results of the quantitative TDCB tests in EPON 828 epoxy material with four mixtures of 
healing agents are shown in Figure 4.4. The healing efficiency shows the average value of a 
minimum of 10 specimens, with the corresponding standard deviation. This standard 
deviation can be assigned to small variations in the precrack orientation or geometry, the 
limited amount of samples and deviations in the crack plane. The deviation values are in 
accordance to previous reports concerning TDCB testing self-healing materials.
53, 67-69
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Figure 4.4. Healing efficiency for the healing of EPON 828 epoxy material with various mixtures of 
healing agents at 25 °C for 3 and 5 days. All the specimens were cured at an equimolar ratio of epoxy resin 
to DETA hardener (100:11 weight ratio). TetraThiol is abbreviated as TT for clarification. 
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The results clearly indicate a difference between the various mixtures of healing 
agents, while also the time allowed for healing proved to be an important parameter. The 
MBM compound resulted in a higher healing efficiency compared to PBM (maximum of  
120 ± 10% compared to 50 ± 10% after 5 days, respectively). The combination of maleimides 
with TetraThiol rendered higher healing efficiencies than the combination with DETA  
(120 ± 10% vs. 69 ± 13%). These results show significant healing effects, with the 
combination of TetraThiol with MBM as the most effective healing agent combination. 
 
When using an equimolar ratio of RIM 135 epoxy resin to RIMH 137 hardener 
(100:30 weight ratio) and using the standard temperature program for curing, a DSC study 
(see Chapter 3) revealed a complete conversion of the epoxides, with a final Tg of 76 °C. 
Hence, because of equimolarity, no residual amine functionalities are available at the crack 
surfaces that can help in chemically linking the epoxy surface to the healed network. The 
results of the TDCB tests are shown in Figure 4.5, illustrating that again the MBM curing 
agent performed better than PBM.  
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Figure 4.5. Healing efficiency for the healing of RIM 135 epoxy material with various mixtures of healing 
agents at 25 °C for 3 and 5 days. Specimens were cured at an equimolar ratio of RIMH 137 hardener to 
epoxy resin (30:100 weight ratio) or at an excess ratio of RIMH 137 hardener to epoxy resin  
(50:100 weight ratio). TetraThiol is abbreviated as TT for clarification. 
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The difference resulting from the use of TetraThiol or DETA is less clear in this case. 
Healing efficiencies after 5 days were slightly higher than after 3 days. When compared to the 
healing efficiencies of EPON 828 material, the healing efficiency for the RIM material is 
generally lower with a maximum healing efficiency of 83 ± 8%, but this is only related to the 
relatively higher virgin epoxy peak load (84 ± 8 N vs 61 ± 7 N for the EPON 828 matrix). For 
example, the average healed peak loads obtained after 5 days with the MBM-TetraThiol 
combination are 65 ± 6 N and 67 ± 15 N for the RIM and EPON material respectively. 
 
The effect of using an excess ratio of hardener for the preparation of RIM 135 epoxy 
material (100:50 weight ratio) was evaluated, since this epoxy material will also have residual 
amine functionalities at the crack surface that can react with the maleimide healing agents. In 
this case, the Tg of the material after the curing process is 48 °C; this value remains identical 
after a heating cycle up to 200 °C, again revealing that all epoxy functionalities have reacted. 
Figure 4.5 also shows the healing efficiency for various mixtures of healing agents at 25 °C 
for 3 and 5 days with the RIM 135 excess matrix composition. Again, MBM revealed to be a 
more efficient healing agent than PBM. However, the healing efficiencies are significantly 
lower than in the case of the EPON 828 and RIM 135 materials with an equimolar ratio of 
hardener to resin. This is explained by the material properties of the excess matrix. Because of 
the lower crosslinking density and Tg (48 °C) of this epoxy material, the TDCB test samples 
deformed plastically, yielding higher virgin peak loads (168 ± 36 N) and consequently lower 
recoveries. The healed peak loads are similar for the equimolar and excess RIM 135 matrices 
(e.g. respectively 65 ± 6 N and 63 ± 17 N in the case of the MBM-TetraThiol combination), 
indicating that the additional amine functionalities that are available at the crack surface do 
not have a large effect on the recovery. 
 
4.4.2 Manual healing with aliphatic maleimides 
As indicated in Section 4.3, the liquid JBM and JTM as well as the solid TMBM and 
IPBM were evaluated quantitatively using the TDCB geometry. Since no significant effect of 
an excess amount of amine hardener on the healing efficiency was noticed with the aromatic 
maleimides, only EPON 828 or RIM 135 epoxy materials with an equimolar ratio of resin to 
hardener were used further on. 
When the bifunctional JBM was combined with TetraThiol in a 1:1 functional group 
ratio and manually injected into the crack (30 µL), low healing efficiencies were obtained 
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(Figure 4.6). After 5 days, a recovery of 34 ± 11% and 15 ± 4% was measured for the EPON 
828 and RIM 135 matrix respectively. This low recovery can most likely be attributed to the 
long PPO chain (2000 g.mol
-1
) in between the maleimide functions, significantly decreasing 
the crosslinking density of the healed network. This problem was solved by using JTM with a 
branched PPO oligomer of approximately 440 g.mol
-1
 in between and an increased 
functionality of 3 maleimide groups, resulting in a healing efficiency of 98 ± 14% and 78 ± 
10% for the EPON 828 and RIM 135 material respectively. These recoveries are higher than 
those obtained with the aromatic PBM and approach the results of MBM with TetraThiol. 
 
 
Figure 4.6. Healing efficiency and healed load after 1, 3 or 5 days at 25 °C, combining TetraThiol with 
JBM (upper graph) or JTM (lower graph) as healing agents in EPON 828 or RIM 135 epoxy material. 
Only epoxy matrices with an equimolar ratio of resin to hardener were used. 
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Since TMBM and IPBM are solid crystalline maleimides, these were dissolved in m-
cresol, MB, EPA and PA for their use in healing tests. To ensure a strong network formation 
via the thiol-maleimide reaction, nearly saturated maleimide solutions were used (see Table 
4.2) and TetraThiol was again added in a 1:1 functional group ratio. The healing efficiencies 
obtained with manual injection of the TMBM-TetraThiol and IPBM-TetraThiol combination 
in the EPON 828 material after 5 days of healing at 25 °C are shown in Figure 4.7 and 
compared with the recoveries using the solvent only. 
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Figure 4.7. Healing efficiency after 5 days at 25 °C, using solvent only or a combination of TetraThiol with 
dissolved TMBM or IPBM as the healing agent in EPON 828 epoxy material. Only epoxy matrices with an 
equimolar ratio of resin to hardener were used. 
 
Under the conditions used, the solvent apparently healed the EPON 828 material better 
than the mixture of TetraThiol and the maleimide solution. It is known from literature that 
solvents can also repair epoxy materials through local swelling of the matrix, generating 
mobility of the residual amine and epoxide functionalities and allowing them to react.
53, 69
 In 
this case, the addition of the maleimide most likely has a negative effect on the swelling 
capability of the solvent. Unfortunately, the formation of a healed network does not 
compensate for this loss, probably because the network is not strong or rigid enough (swollen 
state). When the aromatic maleimides were used, this problem was not observed, which is 
ascribed to the additional aromatic-aromatic interactions that are present in the network. 
Nevertheless, a healing efficiency of 82 ± 4% and 86 ± 5% was obtained with respectively the 
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TMBM-TetraThiol and IPBM-TetraThiol combination in m-cresol. These results are again 
higher than the recovery obtained with PBM (50 ± 10%), but are lower than the MBM healing 
efficiency (120 ± 10%). 
From this subsection, we can conclude that properly selected aliphatic bis- and 
trismaleimides can approach the results generated with the aromatic bismaleimides. 
 
4.4.3 Solvent effect on healing efficiency 
As stated above, the addition of a solvent has an important effect on the recovery of 
the original epoxy properties. It is even capable of re-establishing covalent bonds between the 
epoxy crack surfaces via solvent swelling, followed by reactions between residual amine and 
epoxide functionalities.
53, 69
 A furan-maleimide epoxy system published recently also 
indicates this solvent effect.
56, 70, 71
 In order to better understand this effect, broken EPON 828 
epoxy TDCB samples were healed by manually injecting 30 µL of m-cresol, MB, EPA and 
PA into the crack and clamping them with minimal pressure for 1, 3 or 5 days at 25 °C 
(Figure  4.8).  
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Figure 4.8. Healing efficiency after 1, 3 or 5 days at 25 °C, using m-cresol, MB, EPA or PA as the healing 
agent in EPON 828 epoxy material. Only epoxy matrices with an equimolar ratio of resin to hardener 
were used. 
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m-Cresol clearly demonstrated the best results with recoveries over 100%, followed by 
MB and EPA, while PA performed the worst (still reaching around 50% recovery). This trend 
can be fully correlated with the polarity of the solvents. Since the epoxy matrix contains a vast 
number of polar groups (alcohols, epoxides and amines), the creation of mobility through 
swelling is expected to be easier with more polar solvents. As modelled with the GaussView 
4.1.2 software, m-cresol indeed has a dipole moment (2.0983 debye) higher than that of MB 
(1.7184 D), EPA (1.2534 D) and PA (1.0361 D).  
The results obtained with EPA and PA are comparable to the literature studies
53, 56
, 
while m-cresol and MB were not tested earlier. Furthermore, the results already reach the 
maximal value after 1 day and do not change significantly after 5 days of healing. However, 
based on a recent study by Neuser et al.
72
, we can assume that this solvent effect will diminish 
over time when using microcapsules to deliver the solvent. For EPA microcapsules, they 
recorded a decrease from 77% after 1 day to 13% after 2.5 months. This was mainly attributed 
to premature diffusion of the solvent from the microcapsule into the epoxy matrix. 
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4.5 Conclusion 
In this chapter, the potential of the thiol-maleimide chemistry for the use in self-
healing materials was investigated.  
Firstly, the reaction kinetics were monitored using 
1
H NMR spectroscopy, 
demonstrating the high reaction rate of the amine-maleimide chemistry, but also of the  
thiol-maleimide chemistry in the presence of a tertiary amine catalyst (full conversion within 
minutes). In the thiol-maleimide case, the catalytic effect of ground epoxy powder containing 
tertiary amines at the surface was shown, reaching 90% conversion after 2 hours.  
Secondly, qualitative adhesive testing was performed, combining a multifunctional 
amine or thiol with commercial aromatic bismaleimides. Strong adhesion was observed with 
MBM and PBM in combination with TetraThiol and DETA. Due to the limited commercial 
availability of multifunctional maleimides, an array of aliphatic maleimides was also 
synthesized. The solubility of these novel aliphatic maleimides was significantly higher than 
the aromatic bismaleimides in a larger range of solvents. In qualitative tests, JBM and JTM 
performed as good as the aromatic maleimides. 
Thirdly, manual injection of the healing agent mixtures into the damaged area of 
epoxy thermosets was done in order to quantify the adhesive strength. The MBM-TetraThiol 
combination in m-cresol performed best, with a peak load recovery after 5 days of healing of 
120 and 80% in the EPON 828 and RIM 135 epoxy matrix respectively. The combination 
with DETA or the use of PBM resulted in lower healing efficiencies. The aliphatic 
multifunctional maleimides JTM, TMBM and IPBM, together with TetraThiol, rendered peak 
load recoveries in the EPON 828 material of respectively 100, 80 and 85% after 5 days, 
approaching the results obtained with the aromatic MBM. Important to notice is that healing 
by manually injecting the solvent only, also yields significant recovery results with m-cresol 
reaching about 100% healing efficiency as well. The solvent swelling effect has to be 
distinguished from the adhesion caused by the healed network. 
To conclude this chapter, we can state that the thiol-maleimide chemistry certainly has 
a large potential for use as an efficient self-healing system. However, the requirement of a 
solvent and the limited availability might cause industrial restraint. 
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4.6 Experimental section 
4.6.1. Materials 
Butyl glycidylether (BGE, Aldrich, 95%), methyl methacrylate (MMA, Aldrich, 99%), 
phenylmaleimide (PM, Aldrich, 97%), propylamine (PA, Acros, 98%), diethylene triamine 
(DETA, Sigma-Aldrich, 99%), benzylamine (BA, Acros, 99,5%),  1-dodecanethiol (DT, 
Fluka, 97%), triethylamine (TEA, Acros, 99%), EPIKOTE 828 LVEL epoxy resin (Low 
viscosity, Momentive Specialty Chemicals GmbH), 1,1-(methylenedi-4,1-
phenyl)bismaleimide (MBM, Aldrich, 95%), N,N’-(1,3-phenylene)bismaleimide (PBM, 
Acros, 97%), pentaerythritol(3-mercaptopropionate (Tetrathiol, Aldrich, >95%), RIM 135 
epoxy resin (Momentive Specialty Chemicals GmbH), RIMH 137 hardener (Momentive 
Specialty Chemicals GmbH), 1,2-ethanediamine (Sigma-Aldrich, 99%), 1,6-hexanediamine 
(Acros, 99,5%), 1,12-dodecanediamine (Sigma-Aldrich, 98%), maleic anhydride (Acros, 
99%), 4,9-dioxa-1,12-dodecanediamine (Sigma-Aldrich, 97%), Jeffamine D-2000 (Huntsman 
Coorporation), Jeffamine T-403 (Huntsman Coorporation), ethanolamine (Sigma-Aldrich, 
99%), succinyl chloride (Sigma-Aldrich, 99%), trimethylenehexane diisocyanate (TMDI, 
Evonik Industries), isophorone diisocyanate (IPDI, Aldrich, 98%), Furan (Acros, 99%), 
sodium acetate (Sigma-Aldrich, 99%) and dibutyltin dilaurate (DBTL, TCI, 99%) were used 
as received. Jeffamine D-2000 and Jeffamine T-403 were kindly provided by Huntsman 
Corporation. Solvents were purchased from Sigma-Aldrich or Acros and used without 
purification. 
 
4.6.2 Instrumentation 
1
H NMR spectra were recorded with a Bruker AVANCE 300 (300 MHz) FT-NMR 
spectrometer. The spectra were analyzed with the ACD/Spec Manager software from 
ACD/Labs. Thermogravimetric analyses (TGA) were performed on a TGA/SDTA851e 
equipment (Mettler-Toledo). The samples were heated from 25 to 800 °C at a rate of 10 °C 
min-1 under nitrogen or ambient atmosphere. The thermograms were analyzed with the 
STARe software from Mettler-Toledo. Tapered Double Cantilever Beam (TDCB) load-
displacement curves were recorded with a Tinius Olsen H10KT testing machine equipped 
with a HTE-5kN load cell. A displacement rate of 0.3 mm.min
-1
 was used. The data were 
analyzed with Tinius Olsen Test Navigator software. 
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4.6.3 Nuclear Magnetic Resonance (NMR) kinetic measurements 
Model study for the kinetics of the reaction of amines and epoxide or carbon-carbon 
double bonds: PA (0.44 mL – 5.28 mmol) is added to MMA (0.56 mL – 5.26 mmol) in m-
cresol (10 wt%) in a glass (10 mL) vial as reference for the amine-methacrylate reactivity. As 
a reference for the amine-epoxide reaction, BA (0.43 mL – 3.96 mmol) is added to BGE (0.57 
mL – 3.99 mmol) in m-cresol (10 wt%). 1H NMR spectroscopy is used to follow conversions 
of the mentioned reactions.  
Model study for the kinetics of the reaction of maleimides and amines/thiols: PM 
(0.208 g – 1.20 mmol) is dissolved in m-cresol (1.72 mL – 10 wt%) at room temperature, in a 
glass (2 mL) vial. The vial is put in the ultrasonic bath for a short time to ensure that a 
homogeneous solution is obtained. To this solution, PA (0.1 mL – 1.20 mmol) or DT (0.285 
mL – 1.20 mmol) is added. For the reaction with DT, a reaction was conducted without 
catalyst, with TEA (17 µL – 0.122 mmol) as a catalyst, or EPON 828 as a catalyst (0.125 g - 
100:11 wt% - ground epoxy, average size of grains ± 100 µm), respectively. Conversion of 
the maleimide functionality was monitored by 
1
H NMR spectroscopy.  
Stock solutions of healing agents: MBM (0.385 g – 1 mmol) is dissolved in m-cresol 
(1.24 mL – 25 wt%) in a glass vial (2 mL), followed by addition of TetraThiol (190 µL – 0.5 
mmol) or DETA (108 µL – 1 mmol), respectively. Alternatively, PBM ( 0.268 g – 1 mmol) is 
dissolved in m-cresol (1.60 mL – 15 wt%) in a glass vial (2 mL), followed by addition of 
TetraThiol (190 µL – 0.5 mmol) or DETA (108 µL – 1 mmol), respectively.  
 
4.6.4 Synthesis of aliphatic maleimides 
Scheme 4.3, reaction 1: 1,6-hexane bismaleimide (HBM) – Maleic anhydride (MA) 
(0.5 g, 5.09 mmol) is dissolved in 20 mL diethyl ether at room temperature in a round-
bottomed flask of 100 mL. 1,6-hexanediamine (0.29 g, 2.55 mmol) in dissolved in 20 mL 
diethyl ether and added to the stirring solution of MA. A white precipitate is formed almost 
instantly. The solution is further stirred for 3 hours at room temperature and 3 hours at 50 °C 
(reflux). The white precipitate is filtered off, washed with diethyl ether (3 x 50 mL) and dried 
under vacuum. The intermediate open form is obtained in a yield of 94%. 
1
H NMR (300 
MHz, DMSO-d6): δ (ppm) = 9.27 (s, 2H, NH), 6.31 (dd, 4H, CH=CH), 3.18 (q, 4H, NH-CH2), 
1.47 (m, 4H, N-CH2-CH2), 1.30 (m, 4H, N-CH2-CH2-CH2). 
The intermediate and 0.4 g dry sodium acetate are mixed with 15 mL acetic anhydride 
in a round-bottomed flask of 50 mL under nitrogen. The dispersion is then stirred and heated 
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to 100 °C for 4-6 hours. The reaction mixture is then poured in cold water. The brown 
precipitate is filtered off and washed with water. The precipitate is then redissolved in 
dichloromethane and further washed with water. The organic phase is dried over MgSO4, 
followed by solvent removal under vacuum to obtain HBM in a yield of 65%. 
1
H NMR (300 
MHz, CDCl3): δ (ppm) = 6.69 (s, 4H, CH=CH), 3.50 (t, 4H, N-CH2), 1.58 (m, 4H, N-CH2-
CH2), 1.30 (m, 4H, N-CH2-CH2-CH2). 
The synthesis of HBM was also performed on a 5-10 g scale, without redissolving the 
brown precipitate but drying it under vacuum. Similar procedures were used for the synthesis 
of EBM (yield: 25%), DBM (yield: 60%) and DDBM (yield: 20%). 
1
H NMR (300 MHz, 
CDCl3): EBM: δ (ppm) = 6.69 (s, 4H, CH=CH), 3.70 (s, 4H, N-CH2). DBM: δ (ppm) = 6.68 
(s, 4H, CH=CH), 3.50 (t, 4H, N-CH2), 1.57 (m, 4H, N-CH2-CH2), 1.26 (m, 16H, N-CH2-CH2-
(CH2)8). DDBM: δ (ppm) = 6.70 (s, 4H, CH=CH), 3.63 (t, 4H, N-CH2), 3.42 (t, 8H, O-CH2), 
1.86 (m, 4H, N-CH2-CH2), 1.58 (m, 4H, O-CH2-CH2-CH2-CH2-O). 
Jeffamine bismaleïmide 2000 (JBM) – MA (5 g,  50.9 mmol) is dissolved in 150 mL 
diethyl ether at room temperature in a round-bottomed flask of 500 mL. Next, Jeffamine D-
2000 (51 g, 25.5 mmol) is dissolved in 150 mL diethyl ether and slowly added to the stirring 
solution of MA. A yellow oil is obtained and refluxed for 5 hours at 50 °C. The solvent is 
removed under vacuum, rendering the intermediate open form in a yield of 95%.  
Dry sodium acetate (4 g, 50.9 mmol) and 25 mL acetic anhydride are added to the 
intermediate. 250 mL toluene is added to the mixture to dissolve all compounds. This solution 
is then heated to 100 °C for 6 hours. Upon cooling, the mixture is washed with water (3 x 150 
mL). The solvent is then removed under vacuum and the obtained oil is azeotropically 
distilled with toluene (3 x 100 mL) to remove remaining water and acetic acid/anhydride. 
JBM is obtained as a dark brown, viscous oil with a yield of 75%. 
1
H NMR (300 MHz, 
CDCl3): δ (ppm) = 6.63 (s, 4H, CH=CH), 3.94-3.24 (m, ±102H, O-CH2 and O-CH), 1.33 (d, 
6H, N-CH-CH3), 1.13 (d, ±96H, O-CH-CH3). 
A similar procedure was applied for the synthesis of JTM (yield: 67%), starting from 
Jeffamine T-403 (7.5 g, 17 mmol).
 1
H NMR (300 MHz, CDCl3): δ (ppm) = 6.63 (s, 6H, 
CH=CH), 4.50-3.00 (m, 24H, O-CH2, O-CH and N-CH), 1.50-0.50 (m, 23H, N-CH-CH3, O-
CH-CH3, CH2-CH3 and CH2-CH3). 
 
Scheme 4.3, reaction 2: Furan-maleic anhydride adduct – The Diels-Alder adduct of 
furan and maleic anhydride is synthesized as follows
52
: MA (5 g, 0.051 mol) is dispersed in 
25 mL toluene in a round-bottomed flask and then furan (3.47 g, 0.051 mol) is added. The 
Chapter 4 – Thiol-maleimide chemistry for self-healing 
139 
 
mixture is stirred and heated to 80 °C for 16 hours. A white precipitate is formed rapidly. The 
precipitate is filtered off, washed with toluene and dried under vacuum. Yield: 95%. 
1
H NMR 
(300 MHz, CDCl3): δ (ppm) = 6.59 (s, 2H, CH=CH), 5.47 (s, 2H, O-CH), 3.18 (s, 2H, CH-
CO). 
Furan-protected maleimide alcohol – The furan-maleic anhydride adduct (50 g, 0.303 
mol) is dispersed in 80 mL ethanol in a round-bottomed flask. Ethanolamine (20 mL, 0.325 
mol) is dissolved in 20 mL ethanol and added dropwise to the other solution. This mixture is 
stirred and refluxed for 3 hours at 90 °C. After cooling to room temperature, the flask is 
placed at – 18 °C overnight. The white crystals that are formed, are filtered off, washed with 
ice-cold ethanol and dried under vacuum. The product is obtained in a yield of 55%. 
1
H NMR 
(300 MHz, CDCl3): δ (ppm) = 6.53 (s, 2H, CH=CH), 5.29 (s, 2H, O-CH), 3.74 (dt, 4H, CH2-
CH2-OH), 2.90 (s, CH-CO), 2.24 (s, OH). This synthesis can also be performed without the 
furan protection. 
 
Scheme 4.3, reaction 3: Trimethylhexane-based bismaleimide (TMBM) – The furan-
protected maleimide alcohol (15.82 g, 0.076 mol) is dissolved in 320 mL dry ethyl acetate in 
a round-bottomed flask, together with the DBTL catalyst (0.36 g, 0.57 mmol). TMDI (7.95 g, 
0.038 mol) is then added and the mixture is heated to 70 °C for 16 hours (overnight). A clear 
liquid is obtained after heating. After evaporation of the solvent, the resulting yellow oil is 
dried under vacuum for 24 hours to remove the remaining solvent. The furan-protected 
TMBM is obtained as a white-yellow crystalline powder with a yield of 83%.  
The deprotection is done by dissolving 1 g of the product in 50 mL of toluene and 
refluxing the solution at 120 °C for 16 hours. The solvent is then evaporated and TMBM is 
dried under vacuum. 
1
H NMR (300 MHz, CDCl3): δ (ppm) = 6.72 (s, 4H, CH=CH), 4.20 (m, 
O-CH2), 3.77 (m, N-CH2), 3.50-0.50 (m, TMDI aliphatic). 
A similar procedure was applied for the synthesis of IPBM (yield: 83%). 
1
H NMR 
(300 MHz, CDCl3): δ (ppm) = 6.74 (s, CH=CH), 4.80-4.40 (m, NH-CH en NH-CH2), 4.20 (m, 
O-CH2), 3.78 (m, N-CH2), 3.3-2.8 (m, IPDI ring), 2.00-0.75 (m, IPDI ring). 
 
Scheme 4.3, reaction 4: Succinic acid-based bismaleimide (SBM) – The furan-
protected maleimide alcohol (1 g, 4.78 mol) is dissolved in 5 mL dry THF in a round-
bottomed flask. Succinyl chloride (0.37 g, 2.39 mol) and several droplets of TEA are added 
consecutively, leading to the formation of a dispersion. The mixture is refluxed at 90 °C for 4 
hours under nitrogen. Upon heating, a clear solution is formed. After 4 hours, a white 
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precipitate has formed, which is filtered off and washed with THF. Yield: 47%. 
1
H NMR (300 
MHz, CDCl3): δ (ppm) = 6,52 (s, CH=CH), 5,27 (s, O-CH); 4,25 (t, O-CH2); 3,75 (t, N-CH2); 
2,89 (s, O-CH-CH2-CO); 2,55 (s, CO-CH2-CH2-CO). 
The deprotection is done by dissolving 1 g of the product in 50 mL of toluene and 
refluxing the solution at 120 °C for 16 hours. The solvent is then evaporated and SBM is dried 
under vacuum. 
1
H NMR (300 MHz, CDCl3): δ (ppm) = 6.73 (s, CH=CH), 4.25 (t, O-CH2); 
3.80 (t, N-CH2); 2.58 (s, CO-CH2-CH2-CO). 
 
4.6.5 Synthesis of epoxy TDCB test samples 
EPIKOTE 828 LVEL epoxy resin is mixed with DETA in an equimolar 100:11 weight 
ratio, RIM 135 resin is mixed with RIMH 137 in a 100:30 (equimolar) or 100:50 (excess 
hardener) weight ratio. After homogeneous mixing, the air was removed by applying high 
vacuum for 5 minutes. The solution is then poured in a silicon mold with specific dimensions 
to produce the TDCB samples.
67, 68
 The EPIKOTE 828 mixture is cured for 1 day at 25 °C 
and 1 day at 40 °C, while the RIM 135 mixtures are cured for 1 day at 40 °C and 16 hours at 
80 °C. 
 
4.6.6 Other 
For the qualitative adhesion tests, the synthesis of the silicon molds and the 
quantification of the healing efficiency using TDCB test samples, the reader is redirected to 
Chapter 3. 
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Abstract 
The encapsulation of a tetrafunctional thiol and different maleimides was performed 
using a polycondensation reaction of melamine-formaldehyde, while the hexamethylene 
diisocyanate isocyanurate trimer (HDI3) was embedded in polyurea microcapsules formed via 
an interfacial reaction of aromatic isocyanates and amines. The core content, size and shell 
morphology of the microcapsules was evaluated, showing large differences for the two 
methods. While the MF polycondensation consistently yielded microcapsules with a thin, 
rigid shell and high core contents up to 85 wt%, the interfacial polymerization resulted in 
lower core contents and thicker shells due to water diffusion. However, after shell 
modification with different hydrophobic agents, the core content increased up to 70-85 wt% 
and the water permeability was lowered as indicated by dynamic vapor sorption (DVS) 
measurements. The shell functionalization was verified using HR-MAS 
1
H NMR and SEM-
EDX. 
 
Parts of this chapter are also published in: L.-T. T. Nguyen, X. K. D. Hillewaere, R. F. A. Teixeira,  
O. van den Berg, F. E. Du Prez, Efficient microencapsulation of a liquid isocyanate with in situ shell 
functionalization, Polymer Chemistry, 2015, 6, 1159. 
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Chapter 5 
Encapsulation of healing agents 
 
5.1 Introduction 
Microcapsules are core-shell structures where an active substance is surrounded by a 
protective membrane. The active substance can be a solid, liquid or gaseous material. 
Microcapsules are used for increasing storage life, decreasing powder agglomeration, 
protecting the core from the effects of UV-irradiation, moisture or oxygen, and preventing 
early chemical reactions between two active substances by physical separation.
1
 Furthermore, 
microcapsules can be designed to release the core whenever the active substance is required 
or even on demand
2
 by modifying the shell properties. 
Microencapsulation is used in a wide variety of markets.
1
 In cattle breeding and 
industrial fish farming, animal feed additives are often encapsulated for improved storage or 
controlled release. Encapsulation of pesticides is also regularly performed to reduce health 
hazards, while drugs are in most cases encapsulated to prevent early gastrointestinal irritation. 
Furthermore, flavor and fragrance compounds can also be incorporated into a protective shell 
in order to prevent evaporation. Free-radical catalysts can already be mixed with 
thermosetting resins when they are embedded in microcapsules, preventing preliminary 
reactions, while liquid active substances can be converted into easily manageable powders, 
eg. in the food industry, for the facilitation of mixing. And finally, microcapsules are also 
used to provide textiles with controlled fragrance release and anti-microbial properties, or 
even thermal regulation properties via encapsulated phase change materials.
3
 
A more recent development is the use of microcapsules in self-healing materials. For a 
complete overview of encapsulated active substances, the reader is redirected to Chapter 2. 
They mainly consist of DCPD, solvents, epoxy resins and multifunctional amines and thiols. 
The majority of the capsules used in self-healing are prepared by in situ and interfacial 
polymerization techniques in an oil-in-water emulsion. Without being exhaustive, typical 
compositions used for the shell material are poly(urea-formaldehyde)
4-7
, poly(melamine-
formaldehyde)
8-11
, poly(melamine-urea-formaldehyde)
12
, polyurethane
13
 and polyurea
14-16
. 
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Double walled microcapsules are also possible
17-20
, rendering more robust microcapsules with 
eg. an increased thermal stability
18
 or an additional curing agent or catalyst
17, 19
. 
In this chapter, the encapsulation processes for a multifunctional thiol, hydrophobic 
solvents, dissolved maleimides and a liquid isocyanate are described. Several parameters that 
are playing a role are briefly discussed. All the microcapsules shown in this chapter were 
synthesized and analyzed by the author. The procedure to encapsulate maleimides was 
developed by the author, while the isocyanate encapsulation process was optimized by the 
author in close collaboration with dr. Le-Thu Nguyen. Full development and optimization of 
the thiol encapsulation process was performed by dr. Catheline Colard and dr. Roberto 
Teixeira. 
 
5.2 Encapsulation of thiols 
5.2.1 Synthesis of thiol-containing microcapsules 
Microcapsules containing TetraThiol in the core were synthesized according to a 
modified procedure reported by Zhang et al. in 2008.
9
 Poly(melamine-formaldehyde) (MF) 
was selected as the shell material for its enhanced curing rate and improved mechanical 
properties, stability and chemical resistance compared to poly(urea-formaldehyde).
9
 In an 
interfacial polycondensation process, MF-walled microcapsules containing TetraThiol with  
0-10 wt% of methyl benzoate (MB) as a viscosity lowering solvent were prepared. This was 
done by first emulsifying TetraThiol in water using cumene terminated poly(styrene-co-
maleic anhydride) (PSMA) as a surfactant. This emulsion is then acidified to a pH of 3.2  
– a value specifically suited for the TetraThiol encapsulation – using an H2SO4 solution. 
Separately, a melamine-formaldehyde precondensate was prepared, by mixing melamine and 
a formaldehyde solution at a temperature of 70 °C under basic conditions (pH = 9-10) by 
adding triethanolamine.  
Under these circumstances, melamine nucleophilically adds to the formaldehyde, 
yielding a mixture of adducts (mono- up to hexamethylol melamine) (Scheme 5.1a).
9
 This 
precondensate was then slowly added to the acidic emulsion of TetraThiol, keeping the pH at 
3.2 with additional sulphuric acid. When the emulsion was heated to 50 °C consequently, the 
polycondensation of MF started, together with the precipitation onto the TetraThiol droplets. 
As a consequence, polymerization of MF predominantly takes place at the interface, forming 
a solid shell wall around the TetraThiol core. This polycondensation involves the reaction via 
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an SN2 mechanism of either two alcohol functions or an alcohol and an amine function with 
the elimination of water (Scheme 5.1b).
9
 After reacting for at least 1 hour, the formed 
microcapsules were collected via filtration and dried under vacuum to remove any residual 
moisture. Finally, the microcapsules were stored under a dry atmosphere. 
 
 
 
Scheme 5.1. (a) reaction of melamine and formaldehyde with the formation of a precondensate mixture 
under basic conditions, (b) further reaction of the precondensate under acidic conditions. 
 
5.2.2 Analysis of thiol-containing microcapsules 
To analyse the core content – this is the amount of liquid core compared to the total 
microcapsule weight – of the TetraThiol-containing microcapsules, a Soxhlet extraction with 
acetone was performed for 1-2 days, indicating a high core content of 75-85 wt% depending 
on the batch. The extracted core was analyzed with 
1
H NMR spectroscopy for verification and 
consisted exclusively of TetraThiol with 0-10 wt% of MB. Furthermore, these microcapsules 
were sufficiently stable up to at least one year, only losing around 10 wt% of the core when 
kept as a powder in dry conditions. 
Microcapsule sizes were analyzed using a combination of optical microscopy, 
scanning electron microscopy (SEM) and a particle sizer, showing a mean diameter of  
150 μm after removal of agglomerates using a sieve with 500 µm openings (Figure 5.1 & 
5.2). This size was easily lowered to 50 µm, either by increasing the amount of surfactant or 
the stirring rate.  
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Figure 5.1. Particle size distribution after sieving over a 500 µm mesh of TetraThiol-containing 
microcapsules. 
 
 
 
Figure 5.2. SEM pictures after sieving over a 500 µm mesh of TetraThiol-containing microcapsules. 
 
The SEM pictures indicate two potential issues with these microcapsules. Firstly, the 
microcapsule powder also contains MF particles with irregular shapes that are inherent to the 
in situ polymerization process (Figure 5.2). These particles are formed due to 
polycondensation reactions of the MF precondensate that occur in the water phase and not at 
the interface. Secondly, adhesive joints are noticed between some of the microcapsules, 
making it harder to properly disperse them in the epoxy resin afterwards. However, the 
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separation between the microcapsules was considered to be sufficiently good to use them as 
such. 
With a rough outer shell and a smooth inner shell (Figure 5.3), the shell morphology 
is similar to earlier described microcapsules.
5, 6, 11
 This is generally explained by additional 
precipitation of small MF particles, formed in the water phase, onto the droplets during the 
polycondensation process. The shell is also very thin, with a thickness of approximately  
200-400 nm, as indicated by multiple measurements using SEM. Nevertheless, these 
microcapsules are strong enough to survive processing conditions when incorporating them 
into epoxy thermosets (see Chapter 6). 
 
 
 
Figure 5.3. SEM pictures of shell fragments, showing a rough outer shell and a smooth inner shell 
morphology of TetraThiol-containing microcapsules. 
 
5.3 Encapsulation of maleimides 
5.3.1 Synthesis of solvent- and maleimide-containing microcapsules 
The synthesis procedure for the encapsulation of solvents and maleimides is very 
similar to the one used for encapsulating TetraThiol. However, in this case it is possible to 
perform the reaction at a pH value of 5.0 with the addition of MgCl2 as a Lewis acid catalyst 
for the in situ polymerization. These conditions consistently lead to better separated 
microcapsules and less MF particles in the case of solvents and maleimides, but never worked 
properly when using TetraThiol. Most likely, the TetraThiol also takes part in the reaction due 
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to the catalytic activity of MgCl2, resulting in large agglomerates and early precipitation in the 
reaction vessel. 
As a solvent, ethyl phenylacetate (EPA) was selected, since it dissolves the aliphatic 
maleimides relatively well and because it has been encapsulated before.
21
 It is also a non-
mutagenic solvent and certified Kosher food additive as indicated in Chapter 4.
21, 22
 EPA was 
emulsified in water using PSMA as a surfactant. This emulsion was then acidified to a pH 
value of 5.0 using an H2SO4 solution. Again, a separate melamine-formaldehyde 
precondensate was prepared and slowly poured into the acidic emulsion of EPA, keeping the 
pH at 5.0 with additional sulphuric acid. Next, the MgCl2 catalyst was added and the emulsion 
was heated to 50 °C for at least 1 hour, initiating the in situ polymerization of MF. The 
formed microcapsules were then collected via filtration and dried under vacuum to remove 
any residual moisture. Finally, the microcapsules were stored under a dry atmosphere.  
This procedure was repeated both for the encapsulation of Jeffamine T-403 
trismaleimide (JTM), mixed in either a 1:2 or a 2:1 weight ratio with MB, and for the 
encapsulation of 15 wt% of trimethylhexane-based bismaleimide (TMBM) in EPA. 
 
5.3.3 Analysis of solvent- and maleimide-containing microcapsules 
The core contents of the solvent- and maleimide-containing microcapsules were 
determined via Soxhlet extraction with acetone for 1-2 days, yielding 74, 86 and 73 wt% for 
EPA, JTM/MB and TMBM/EPA respectively. 
Microcapsule sizes were analyzed using a combination of optical microscopy and 
SEM, in all cases indicating an average diameter of approximately 100 μm after removal of 
agglomerates using a sieve with 500 µm openings (Figure 5.4 & 5.5). This size again was 
easily lowered to 50 µm, either by increasing the amount of surfactant or the stirring rate. It is 
clear from the SEM pictures that in this case no adhesive joints are formed between the 
microcapsules.  
As can be seen in Figure 5.4, the EPA- and TMBM/EPA-containing microcapsules 
have a similar shell morphology, which can be explained by the fact that only a small amount 
of TMBM could be dissolved in EPA. Consequently, the parameters playing a role in the 
encapsulation process – such as the interfacial tension and the viscosity – were practically 
those of the solvent. The particles on the surface of the microcapsules in these samples are 
much more pronounced than in the TetraThiol case. Energy-dispersive X-ray spectroscopy 
(EDX) indicated that these are not MgCl2 particles, but most likely again MF particles that 
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precipitated onto the shell surface. In the TMBM/EPA sample, plenty of detached MF 
particles are also visible, as well as shell structures that encompass multiple microcapsules. 
No clear reason was found for this difference, but this might be related to a slight increase in 
viscosity, leading to an increase in droplet size and as such easier colliding droplets.
23
 A 
second possibility is that TMBM has a negative effect on the interfacial tension, also leading 
to collisions during the in situ polymerization process. 
 
 
 
Figure 5.4. SEM pictures after sieving over a 500 µm mesh of (a) EPA- and (b) TMBM/EPA-containing 
microcapsules.  
 
In the case of JTM/MB in a 1:2 weight ratio, a more irregular outer surface was 
obtained (Figure 5.5). EDX again showed that these bulges are not MgCl2 particles. Due to 
the increased viscosity, some microcapsules appear to have collided during the in situ 
polymerization process and formed big irregular shaped core-shell structures. Nevertheless, 
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the overall quality of encapsulation was considered good with well separated microcapsules 
and a high core content.  
 
 
 
Figure 5.5. SEM pictures after sieving over a 500 µm mesh of JTM/MB-containing microcapsules. 
 
 
 
Figure 5.6. From left to right: 2 mL vials containing the microcapsules with a 1:2 weight ratio JTM/MB 
core, the MF shell after extraction and the JTM/MB core after extraction. 
 
When the JTM/MB weight ratio was reversed to 2:1, the viscosity increase was so 
large that most microcapsules were no longer spherical, either due to collisions or just 
extension of the droplets. This also resulted in a size increase up to approximately 250 µm in 
length or width of the microcapsules. Suprisingly, the core content in this case remained  
86 wt%. The Soxhlet extracted core was fully analyzed with 
1
H NMR spectroscopy for 
verification and consisted solely of JTM and MB in a close to 2:1 weight ratio. An example of 
an 
1
H NMR spectrum of extracted JTM-MB is given in the Appendix. In both JTM 
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microcapsule compositions, the extracted core was also visually comparable to the dark 
colored JTM (Figure 5.6).  
The inner surface of the solvent- and maleimide-containing microcapsules was again 
completely smooth (Figure 5.7). The shell thickness, without considering the particles or 
bulges, was measured using SEM to be approximately 1.1-1.4 µm in the case of the EPA- and 
TMBM/EPA-containing microcapsules and around 2 µm for the JTM/MB-containing 
microcapsules, which is significantly larger than the shell thickness in the TetraThiol case. 
This can most probably be explained by the higher hydrophobicity of the core, resulting in an 
increased migration of MF prepolymer towards the oil droplet and a more efficient MF shell 
formation. These solvent-containing microcapsules were thus expected to withstand the epoxy 
processing conditions as well, while still breaking readily when the matrix material fractures 
since it was fairly easy to crush them using a spatula. 
 
 
 
Figure 5.7. SEM pictures of shell fragments, showing a rough outer shell and a smooth inner shell 
morphology of (a) EPA- and (b) JTM/MB-containing microcapsules. 
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5.4 Encapsulation of isocyanates 
5.3.1 Synthesis of isocyanate-containing microcapsules 
The hexamethylene diisocyanate isocyanurate trimer (HDI3) was selected for 
encapsulation because of its high isocyanate functionality, high thermal stability, very low 
vapor pressure and low toxicity (see Chapter 3). The procedure is based on the work of Yang 
et al.
15, 16
, using the interfacial polymerization between an active isocyanate present in the 
core and an active amine present in the water phase to obtain a polyurea walled microcapsule 
with HDI3 in the core. Several adaptations to the procedure of Yang were made to 
accommodate for the higher viscosity of HDI3 and to enhance the shelf-life of the 
microcapsules. 40 g of HDI3 was first mixed with 19 g of the uretonimine trimer of methylene 
diphenyl diisocyanate (MDI3) and then emulsified in 150 mL of water with gum arabic as a 
surfactant. Next, triaminopyrimidine (TAP) is dissolved in water and added to the emulsion as 
a second reactant.  
Because of the higher reactivity of the aromatic MDI3 compared to the aliphatic HDI3, 
the MDI trimer reacts first at the oil–water interface with TAP to form a stable, crosslinked 
polyurea shell wall via a step-wise polymerization. However, some reaction of TAP with 
HDI3 most likely cannot be avoided. The reaction was accelerated by heating the emulsion 
from 20 to 75 °C within a timeframe of 20 min, following a mostly linear temperature profile. 
On account of the hardly avoidable reaction between isocyanate groups and water and the low 
reactivity of the TAP primary amine groups due to resonance effects
24
, the formation of the 
crosslinked polyurea shell plausibly occurred via two reactions: 1) via the nucleophilic 
addition reaction of the MDI3 isocyanate groups with TAP amine groups and 2) via reactions 
with water involving the consecutive formation of N-substituted carbamic acids and amines 
(see Chapter 2 and 3). Carbon dioxide gas bubbles, formed by the second reaction, indeed 
escaped the reaction vessel at elevated temperatures. Furthermore, unreacted TAP was still 
present upon reaction completion, which was indicated by the yellow color of the water 
phase. It is important to note that the reaction was stopped after a temperature of 70–75 °C 
was reached, since the opening of the MDI3 uretonimine ring, with the formation of an MDI 
carbodiimide and MDI, is known to be initiated at 80 °C.
25
 The microcapsules were collected 
via filtration, washed with water and dried under vacuum to remove any residual moisture. 
The microcapsules were then stored under a dry atmosphere. 
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In order to modify the shell properties for water permeability reasons (see Subsection 
5.3.3), 20 mol% of the primary amine groups of TAP was replaced by monofunctional amines 
bearing different hydrophobic groups – either 2-ethylhexylamine (EHA) or  
3,4-difluorobenzylamine (DFBA) – or by hexamethyldisilazane (HMDS) (Scheme 5.2), 
which were involved in reactions with the isocyanate groups throughout the shell formation. 
For a facile comparison, all microcapsules with and without shell modification were 
synthesized at the same stirring rate and shell-to-core feeding mass ratio to generate 
microcapsules with similar sizes. 
 
 
 
Scheme 5.2. Chemical structures of 2-ethylhexylamine (EHA), 3,4-difluorobenzylamine (DFBA) and 
hexamethyldisilazane (HMDS). 
 
5.3.2 Size and morphology of the isocyanate-containing microcapsules 
In the case of the isocyanate-containing microcapsules, the core content was analyzed 
via FT-IR spectroscopy using DMF as the solvent to extract the core from the polyurea shell. 
In order to quantify the HDI3 core content, a calibration of the absorption peak of the 
isocyanate carbonyl stretch (2278 cm
-1
) was made using increasing concentrations of HDI3 in 
DMF. Based on this absorption peak, an isocyanate core content up to 50 and 73 wt% was 
measured for the non-functionalized and functionalized microcapsules respectively. Although 
the increasing reaction temperature and longer reaction time strengthened the shell structure, 
it has to be noted that the core fraction is reduced at the same time as a result of water 
diffusing through the shell wall and reacting with the isocyanate core. As such, the shell wall 
kept growing in thickness, while the core volume was decreasing (see Appendix). 
Additionally, further reaction of residual TAP with the HDI3 core cannot be excluded.  
When part of the HDI3 core was replaced by methyl benzoate (MB, 40 wt%) to lower 
the viscosity of the isocyanate, smooth microcapsules with a core content of 60 wt% were 
obtained, with a MB core fraction of only 15 wt%. The lower relative fraction of MB was 
ascribed to its partial solubility in water. Unfortunately, the addition of MB to the core 
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resulted in a faster loss of core content over time, most likely due to solvent swelling of the 
polyurea shell. Therefore, these microcapsules were not used further on. 
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Figure 5.8. Particle size distribution after sieving over a 500 µm mesh of HDI3-containing microcapsules. 
 
Microcapsule sizes were measured using optical microscopy, SEM and a particle sizer, 
showing a mean diameter of 150 μm for the EHA-functionalized microcapsules after removal 
of agglomerates using a 500 µm mesh (Figure 5.8). Similar sizes were observed for the 
DFBA-, HMDS- and non-functionalized microcapsules. All synthesized HDI3-containing 
microcapsules had the tendency to form strong agglomerates, even after the sieving step, as 
can be seen in the graph by the presence of a broad peak above 250 µm. This agglomeration 
could partially be prevented by adding nanoclay to the emulsion during the heating step.  
 
In the case of the EHA-, HMDS- and non-functionalized samples, microcapsules with 
a smooth exterior were obtained (Figure 5.9a), while the DFBA-functionalized microcapsules 
consistently had a more wrinkled shell morphology (Figure 5.9b). This could be caused 
simultaneously by inhomogeneous reaction kinetics and by fluid-induced viscous and shell-
related elastic stresses.
26, 27
 The interior of the microcapsules on the other hand was rough and 
irregular in all cases (Figure 5.10). This rough interior could again be explained by 
inhomogeneous reaction kinetics, but was more likely formed by diffusion of water into the 
microcapsules over time, where it further reacted with the isocyanate core.  
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Figure 5.9. SEM pictures after sieving over a 500 µm mesh of (a) EHA-functionalized (Table-top SEM) 
and (b) DFBA-functionalized HDI3-containing microcapsules. 
 
 
 
Figure 5.10 SEM pictures of shell fragments, showing a smooth outer shell and a rough inner shell 
morphology of (a) non-functionalized, (b) DFBA-functionalized and (c) HMDS-functionalized HDI3-
containing microcapsules. 
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It has to be noted that the SEM pictures above were taken approximately one month 
after synthesis. If a longer waiting period of approximately two months was applied, an 
almost fully solidified microcapsule core was observed (Figure 5.11). This is consistent with 
the results of the water permeability study discussed in Subsection 5.3.3. A shell thickness of 
approximately 1.9-3.2 µm was measured for these microcapsules using SEM, and reached up 
to 5.6 µm if the inner bulges are taken into account. 
 
 
 
Figure 5.11 SEM pictures of solidified EHA-functionalized HDI3-containing microcapsules. 
 
5.3.3 Functionalization and water permeability of the HDI3-containing microcapsules 
Due to the problem of water diffusing into the HDI3-containing microcapsules, the 
polyurea shell was functionalized with hydrophobic groups (EHA and DFBA) or reinforced 
with an additional crosslinker (HMDS) by adding these compounds to the emulsion feed. The 
monofunctional primary amines were able to participate in the nucleophilic addition reactions 
to MDI3, thus covalently linking the hydrophobic group to the crosslinked shell material, 
while the HMDS reacted with isocyanates via the formation of ammonia or immediately with 
the generation of silyl urea (Scheme 5.3).
24, 28-30
  
Ammonia is formed when HMDS is hydrolyzed and this compound readily reacts with 
an isocyanate to yield a substituted urea. When HMDS reacts with an isocyanate on the other 
hand, a silyl urea is generated via a nucleophilic addition reaction and subsequent migration 
of the trimethylsilyl group.
30
 This reaction between silazanes and isocyanate groups already 
occurs at 20 °C
28, 29
 and is expected to occur simultaneously with the polyurea forming amine-
isocyanate and water-isocyanate reactions.  
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Scheme 5.3. Reaction of HMDS and isocyanates with the formation of urea derivatives and 
trimethylsilanol (TMS) in the presence of water. 
 
In a next step, the silyl urea can either be hydrolyzed with the formation of a 
substituted urea or can further react with more isocyanates, generating silyl biurets or silyl 
polyisocyanates, especially at more elevated temperatures in the reaction vessel (up to  
70-75 °C).
28-30
 These can then again be hydrolyzed with the formation of urea derivatives and 
the release of two trimethylsilanol (TMS) molecules. Further side-reactions might include 
isocyanurate trimerization via the degradation of silyl ureas to silyl amines
30
, although this is 
not likely at the applied temperature, and reaction of isocyanates with TMS and urea 
derivatives. 
 
The modification of the shell was evaluated both with EDX and High Resolution 
Magic Angle Spinning (HR-MAS) 
1
H NMR spectroscopy. EDX spectra of washed and dried 
shell fragments showed the presence of fluor in the DFBA-functionalized microcapsule wall 
(Figure 5.12), indicating that the DFBA was covalently bound to the polyurea network. In the 
HMDS-functionalized microcapsules on the other hand, no silicon was measured in the shell, 
demonstrating that the silyl urea derivatives were fully hydrolyzed. 
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Figure 5.12. EDX spectrum of a 3,4-difluorobenzylamine (DFBA)-functionalized microcapsule shell, 
clearly showing the presence of fluor. 
 
In order to further confirm the chemical structure of the shell, HR-MAS 
1
H NMR 
measurements were performed. Therefore, four batches of polyurea model microcapsules 
(EHA-, DFBA-, HMDS- and non-functionalized) were synthesized with butyl acetate as the 
core liquid. The solvent core was removed by crushing the capsules and performing a Soxhlet 
extraction with acetone for one day to be able to analyze the shell material only. An overlay 
of the HR-MAS 
1
H NMR spectra is shown in Figure 5.13. Full conversion of the TAP amine 
functional groups into polyurea bonds (polyurea NH signal at 8.4–8.9 ppm in spectra A, B, C 
and D) is demonstrated by the disappearance of the TAP amine signals at 5.3–5.8 ppm. 
Incorporation of MDI3 into the shell network is indicated by broadening and slight shifting of 
the MDI3 signals. More importantly, the incorporation of EHA (B) and DFBA (C) could be 
seen by the presence of signals at 3.2 ppm (EHA CH2-NH), 0.7–1.5 ppm (EHA aliphatic) and 
4.4 ppm (DFBA CH2-NH). In these samples, a double urea NH signal is also visible, which 
could be attributed to the reaction of the hydrophobic amine with MDI3. Furthermore, no 
signal of trimethylsilyl compounds could be seen around 0 ppm in spectrum D, indicating that 
these were not covalently bound to the polyurea shell, as already observed with EDX. 
 
Next, the influence of this shell modification on the HDI3 microcapsule stability was 
investigated. This was first done by immersing the microcapsules in water for prolonged 
periods of time, while measuring the release of core content using online FT-IR spectroscopy.  
Chapter 5 – Encapsulation of healing agents 
161 
 
Indirectly, the stability of microcapsules in water can be compared to their shelf-life in a 
humid environment. The isocyanate core content after one day of immersion could be 
compared to that after one month of exposure to air and ambient conditions. Once embedded 
in a thermosetting matrix, it is expected that the core content will be stable for much longer 
periods.  
The immersion tests demonstrated that the non-functionalized microcapsules lose a 
considerable amount (70%) of the initial core fraction after immersion in water for one day 
and almost all of the core after two days. In contrast, the EHA-, DFBA- and HMDS-
functionalized microcapsules maintained their initial isocyanate core fraction after immersion 
for one day, owing to the lower affinity of water towards the hydrophobic shell or the 
decreased diffusion through the denser crosslinked shell. During the second day, the HDI3 
core of the EHA- and HMDS-functionalized microcapsules rapidly decreased, while it 
proceeded more gradually for the microcapsules with the DFBA modification, most likely due 
to a more water repellent shell material. Based on this harsh test, both shell modifications 
with hydrophobic amines or HMDS appeared to significantly enhance the microcapsule 
stability in wet conditions. 
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Fig. 5.13. HR-MAS 
1
H NMR spectra of triaminopyrimidine (TAP), MDI3, the non-functionalized polyurea 
shell (A) and the polyurea shells functionalized with EHA (B), DFBA (C) and HMDS (D). 
 
The water permeability of the modified shell material was also investigated using 
dynamic water vapor sorption (DVS) measurements after core removal. With DVS, the 
weight of a solid is monitored as a function of the humidity of the surrounding atmosphere, 
expressed as % relative humidity (% RH). To avoid the water-isocyanate reaction during the 
DVS measurements, the four batches of polyurea microcapsules, synthesized for HR-MAS 
1
H 
NMR spectroscopy with butyl acetate as the core liquid, were used. Again, the solvent core 
Chapter 5 – Encapsulation of healing agents 
163 
 
was removed by crushing the capsules and performing a Soxhlet extraction with acetone for 
one day.  
DVS analysis demonstrated a small water uptake by the shell material, i.e. 1.0 to  
2.4 wt% after approximately 15 min at 80% RH. A decreasing water uptake was observed in 
the following order of microcapsules: non-functionalized (2.4 wt%), HMDS- (2.3 wt%), 
DFBA- (1.9 wt%) and EHA-functionalized (1.0 wt%) (Figure 5.14). This showed that the 
functionalization had a significant effect on the water permeability of the microcapsules and 
that especially the hydrophobicity of DFBA and EHA significantly lowers the water uptake. 
In all cases, a small mass loss (<1 wt%) at 80% RH was also noticed over a longer period of 
time. This was attributed to the reaction of water with residual isocyanate groups in the shell, 
releasing CO2 in the process. 
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Figure 5.14. DVS measurements demonstrating water uptake of the different shell materials (full line) 
upon increasing the relative humidity from 0.1% to 80% (dashed line). 
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5.5 Conclusion 
In this chapter, the encapsulation of the most promising healing agents for the  
thiol-isocyanate and thiol-maleimide combinations was described. These agents encompassed 
a multifunctional thiol, hydrophobic solvents, dissolved maleimides and a liquid isocyanate. 
Firstly, TetraThiol with 0-10 wt% of MB as a viscosity lowering solvent was 
encapsulated in an MF shell via an in situ polymerization process. Fairly well dispersed 
microcapsules with a diameter of around 150 µm and a high core content were obtained. Very 
thin and brittle shells were formed, but these were still strong enough to withstand processing 
conditions. MF particles were also observed in the microcapsule powder, as well as on the 
outside of the microcapsule shell. 
Secondly, EPA and several maleimides were embedded in MF microcapsules using a 
similar procedure as for TetraThiol. Again, high core contents were achieved in all cases. 
When only a solvent (EPA) was encapsulated, very well dispersed and smooth microcapsules 
were obtained, with MF particles only present on the outer shell surface. When the 
bismaleimide TMBM was dissolved in a solvent (EPA), plenty of detached MF particles were 
also visible, as well as shell structures that encompassed multiple microcapsules. This was 
improved when the trismaleimide JTM was used as the functional core compound in a  
1:2 weight ratio with MB. JTM/MB could also be encapsulated in a 2:1 weight ratio, but in 
this case larger and non-spherical microcapsules were generated. 
Finally, HDI3-containing polyurea microcapsules were also made using a different 
interfacial polymerization process. Microcapsules with medium to high core contents and 
thicker shell structures were obtained using this method, with both smooth and wrinkled 
morphologies. The polyurea shell could be modified with hydrophobic amines to decrease the 
water permeability and as such improve the shelf-life. In principle, other specific functional 
groups could also be introduced into the shell structure using the corresponding functional 
amines, which allows the synthesis of microcapsules with on-demand shell properties, 
depending on the type of thermosetting matrix and the application requirements. 
As a conclusion, we can state that we were able to incorporate all the required healing 
agents into microcapsules in order to produce fully autonomous self-healing materials. 
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5.6 Experimental section 
5.6.1 Materials 
Pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol, Aldrich, >95%), 2,4,6-
triamino-1,3,5-triazine (melamine, Sigma-Aldrich, 99%), formaldehyde (Sigma-Aldrich, 37 
wt% in H2O with 10-15% of methanol as stabilizer), cumene terminated poly(styrene-co-
maleic anhydride) (PSMA, Aldrich, Mn = 1600 g.mol
-1
), H2SO4 (Fischer Scientific UK Ltd, 
>95%), triethanolamine (Sigma-Aldrich, ≥99%), MgCl2.6H2O (Sigma-Aldrich, ≥99%), 
isocyanurate-based hexamethylene diisocyanate trimer (HDI3, Tolonate HDT-LV, Vencorex 
Chemicals), uretonimine-based methylenebis(phenyl isocyanate) trimer (MDI3, Suprasec 
2020, Huntsman Polyurethanes), gum arabic (Acros), 2,4,6-triaminopyrimidine (TAP, Acros, 
97%), 2-ethyl-1-hexylamine (EHA, Sigma-Aldrich, 98%), 3,4-difluorobenzylamine (DFBA, 
Sigma-Aldrich, 98%), hexamethyldisilazane (HMDS, Aldrich, 99,9%), nanoclay (Nanomer® 
I.28E, montmorillonite clay surface modified with 25-30 wt% trimethyl stearyl ammonium, 
Nanocor Corporation via Sigma-Aldrich), Na2CO3 (J.T. Baker BV, anhydrous), 1-octanol 
(Acros, 99%) and CaCl2 (Carl Roth GmbH, ≥96%) were used as received. 
The isocyanurate-based hexamethylene diisocyanate trimer (HDI3, Tolonate HDT-LV) 
was kindly provided by Vencorex Chemicals. The uretonimine-based methylenebis(phenyl 
isocyanate) trimer (MDI3, Suprasec 2020, Huntsman Polyurethanes) was kindly provided by 
Recticel. aliphatic ester). Solvents were purchased from Sigma-Aldrich or Acros and used 
without purification. 
 
5.6.2 Instrumentation 
1
H NMR spectra were recorded with a Bruker AVANCE 300 (300 MHz) FT-NMR 
spectrometer. The spectra were analyzed with the ACD/Spec Manager software from 
ACD/Labs. For the HR-MAS 
1
H NMR measurements, the solid shell powder was placed in a 
4 mm rotor (50 μL) and DMF-d7 was added to make the network swell. 1H NMR spectra 
were recorded on a Bruker Avance II 700 at 700 MHz with an HR-MAS probe. Samples were 
rotated at a frequency of 6 kHz. Online Fourier-Transform InfraRed (FTIR) spectroscopy was 
conducted using a React-IR 4000 Instrument (Mettler Toledo AutoChem ReactIR) equipped 
with a diamond ATR probe. Average particle sizes and dispersities of the microcapsules were 
measured by laser diffraction using a Beckman Coulter LS 200 instrument (0.2 to 2000 μm 
range). Scanning Electron Microscopy (SEM) pictures were recorded with a FEI Quanta 200F 
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microscope connected to an EDAX type Genesis 4000 equipment for Energy Dispersive X-
ray spectroscopy (EDX) measurements or with a TM-3000 Hitachi tabletop microscope, 
using Leit adhesive Carbon Tabs (12 mm) from Agar Scientific. Dynamic Vapor Sorption 
(DVS) measurements were performed on a DVSA-STD Dynamic Vapor Sorption Advantage 
(Surface Measurement Systems) instrument equipped with an active control of the relative 
humidity (RH) and organic vapors, sample pre-heating and a Cahn-D200 ultra-microbalance 
allowing gravimetric analysis up to 0.05 µg of resolution. To prevent the influence of any 
humidity present on the pans, compressed dry air at a 200 mPa pressure was flown over the 
two closed chambers for approximately 10 minutes. The sample was pre-equilibrated at 0% 
RH in a continuous flow of dry air at 200 mPa before the sample was ramped to the desired 
%RH. The temperature was set constant at 25 °C. The sample was then exposed to 80% RH 
with dm/dt (change in mass/time) mode. The instrument maintained the sample at a constant 
RH until the rate of change in mass (dm/dt) was less than 0.02% min
-1
. 
 
5.6.3 Synthesis thiol-containing microcapsules 
In order to synthesize TetraThiol-containing microcapsules, a 2.5 wt% poly(styrene-
co-maleic anhydride) (PSMA) solution was first prepared, using either cumene terminated 
PSMA with an Mn of 1600 g.mol
-1
 or partially methyl ester terminated PSMA with an Mw of 
35 x 10
4
 g.mol
-1
. To dissolve the PSMA, two teaspoons of Na2CO3 were added per 100 mL of 
water and the mixture was heated to 50 °C until a clear solution was obtained. With larger 
volumes, overnight heating was required. The cumene terminated PSMA dissolved more 
easily and was used in all recipes further on. 
Next, TetraThiol (60 g, 0.123 mol) was mixed with 200 g of 2.5 wt% PSMA solution 
or with 100 g of 2.5 wt% PSMA solution and 100 g water, depending on the desired 
microcapsule size. This two phase mixture was then emulsified using an ULTRA-TURRAX® 
T 18 basic homogenizer (IKA, Germany) at speed 1 (3000 rpm), while decreasing the pH to 
3.5 with a 13 wt% H2SO4 solution. The foaming occurring during this process around a 
neutral pH of 7 was stopped by adding 1-2 drops of 1-octanol. Next, the emulsified mixture 
was poured into a double-walled cylindrical glass reactor (Radleys), equipped with an 
external circulating heating bath (Julabo F-12 unit) and a three-bladed low-shear teflon 
overhead turbine stirrer (Cowie Ltd) fitted at approximately 2 cm from the bottom of the 
reactor vessel, rotating at 300 rpm. Another 200 mL of water was then added to increase the 
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reaction volume and the pH was further decreased to 3.2 with the 13 wt% H2SO4 solution. 
Once ready, the rotation speed of the reactor was increased to 450 rpm. 
In a next step, the melamine-formaldehyde precondensate was prepared. Therefore, 
melamine (12 g, 0.095 mol) was mixed with 25 mL of a 37 wt% formaldehyde solution, 
followed by the addition of 30 drops of triethanolamine to obtain a pH value of approximately 
9-10 (determined with pH paper). This mixture is then placed in an oil bath at 25 °C, which is 
set to 70 °C (it takes approximately 10 min to reach that temperature) and allowed to react at 
70 °C for another 30 min. The mixture should go from a milky white to a clear solution. 
Finally, the precondensate is slowly added to the reactor containing the emulsion of 
TetraThiol, while keeping the pH value at 3.2. Once added, the water heating was set to 50 °C 
for 1 (or 2) hour(s). After this time period, the emulsion of microcapsules was quenched in 
cool water to stop the reaction and allowed to settle. Then, the top layer containing MF 
particles was decanted, while the microcapsules remained at the bottom of the beaker. These 
were then filtered over a Buchner funnel and excessively rinsed with water to remove any 
remaining reactants or surfactant. The collected microcapsules were then dried under vacuum 
at 45 °C to remove any residual moisture and stored under a dry atmosphere in a dessicator 
using CaCl2 as the drying agent. 
Note: In order to obtain microcapsules with a partial MB core content of 5-10 wt%, 30 
wt% of MB has to be added. A significant amount of this solvent is lost due to its partial 
solubility in water. 
 
5.6.4 Synthesis solvent- and maleimide-containing microcapsules 
For the synthesis of solvent-containing microcapsules, EPA (60 g, 0.365 mol) was 
mixed with 200 g of 2.5 wt% PSMA solution or with 100 g of 2.5 wt% PSMA solution and 
100 g water, depending on the desired microcapsule size. This two phase mixture was then 
emulsified using an ULTRA-TURRAX® T 18 basic homogenizer (IKA, Germany) at speed 1 
(3000 rpm), while decreasing the pH to 5.5 with a 13 wt% H2SO4 solution. The foaming 
occurring during this process around a neutral pH of 7 was stopped by adding 1-2 drops of 1-
octanol. Next, the emulsified mixture was poured into a double-walled cylindrical glass 
reactor (Radleys), equipped with an external circulating heating bath (Julabo F-12 unit) and a 
three-bladed low-shear teflon overhead turbine stirrer (Cowie Ltd) fitted at approximately 2 
cm from the bottom of the reactor vessel, rotating at 300 rpm. Another 200 mL of water was 
then added to increase the reaction volume and the pH was further decreased to 5.2 with the 
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13 wt% H2SO4 solution. Once ready, the rotation speed of the reactor was increased to 450 
rpm. 
In a next step, the melamine-formaldehyde precondensate was prepared. Therefore, 
melamine (12 g, 0.095 mol) was mixed with 25 mL of a 37 wt% formaldehyde solution, 
followed by the addition of 30 drops of triethanolamine to obtain a pH value of approximately 
9-10 (determined with pH paper). This mixture is then placed in an oil bath at 25 °C, which is 
set to 70 °C (it takes approximately 10 min to reach that temperature) and allowed to react at 
70 °C for another 30 min. The mixture should go from a milky white to a clear solution. 
Finally, the precondensate is slowly added to the reactor containing the emulsion of 
EPA, while keeping the pH value at 5.2, followed by the addition of MgCl2.6H2O (10.63 g) as 
a catalyst. At this point, the pH will decrease slightly. After the pH was further decreased to 
5.0 using the 13 wt% H2SO4 solution, the water heating was set to 50 °C for 1 (or 2) hour(s). 
After this time period, the emulsion of microcapsules was quenched in cool water to stop the 
reaction and allowed to settle. Then, the top layer containing the microcapsules was decanted, 
filtered over a Buchner funnel and excessively rinsed with water to remove any remaining 
reactants or surfactant. The collected microcapsules were then dried under vacuum at 45 °C to 
remove any residual moisture and stored under a dry atmosphere in a dessicator using CaCl2 
as the drying agent.  
The procedure to encapsulate the maleimides with a large fraction of solvent 
(TMBM/EPA and JTM/MB 1:2) was similar, while the encapsulation of JTM/MB 2:1 due to 
the increased viscosity always required 200 g of the 2.5 wt% PSMA solution. More surfactant 
was added if the emulsion was not stable. 
 
5.6.5 Synthesis isocyanate-containing microcapsules 
The synthesis of EHA-functionalized microcapsules is described below. To prepare 
the emulsion, a 13 wt% solution of gum arabic in water was prepared first. Dissolving the 
gum arabic required prolonged stirring (several hours), especially with larger volumes. Next, 
HDI3 (40 g, 0.079 mol) was homogeneously mixed with MDI3 (19 g, 0.064 mol). 150 mL of 
the 13 wt% gum arabic solution was added to this mixture and the two phase system was 
emulsified using an ULTRA-TURRAX® T 18 basic homogenizer (IKA, Germany) at speed 1 
(3000 rpm) for 3 min (using a timer). This mixture was then immediately poured into a 
double-walled cylindrical glass reactor (Radleys), equipped with an external circulating 
heating bath (Julabo F-12 unit) and a three-bladed low-shear teflon overhead turbine stirrer 
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(Cowie Ltd) fitted at approximately 2 cm from the bottom of the reactor vessel, rotating at 
450 rpm. 
Separately, TAP (4.44 g, 0.035 mol) was dissolved in 130 mL water and added to an 
addition funnel on top of the reactor vessel. Approximately 4/5 of this solution was added 
dropwise to the reactor over a period of 5 min, immediately followed by the dropwise 
addition of 4.36 mL (0.027 mol) of EHA together with 10 mL of THF and the last 1/5 of TAP 
over a period of 4 min. 
After further stirring of the emulsion for 5 min at room temperature, the heating was 
set to 90 °C, as such slowly increasing the temperature of the set-up. After another 15 min and 
a temperature of approximately 76 °C), the microcapsule emulsion was quenched in cold 
water to stop the reaction and allowed to settle. Then, the top layer containing smaller 
particles was decanted, while the microcapsules remained at the bottom of the beaker. 
Decanting was repeated until the water is clear and no longer yellow. The slurry was then 
filtered without vacuum to avoid compacting of the microcapsules and further washed with 
water. The collected microcapsules were then dried under vacuum at 45 °C to remove any 
residual moisture and stored under a dry atmosphere in a dessicator using CaCl2 as the drying 
agent. 
Similar conditions were used for the DFBA-, HMDS- and non-functionalized 
microcapsules, respectively replacing EHA by 3.81 g (0.027 mol) of DFBA, 4.3 g (0.027 mol) 
of HMDS or nothing at all. Optional: One teaspoon of Nanoclay (Nanomer® I.28E, modified 
with trimethyl stearyl ammonium) can be added to the emulsion just before the gradual 
heating step to prevent agglomeration of the microcapsules later on. 
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Abstract 
Autonomous extrinsic self-healing epoxy materials were generated using a dual 
microcapsule strategy with thiol-isocyanate and thiol-maleimide chemistries, new to the field 
of self-healing. Therefore, a tetrafunctional thiol was combined with hexamethylene 
diisocyanate isocyanurate trimer (HDI3) on the one hand, and with Jeffamine T-403 
trismaleimide (JTM) or a trimethylhexane-based bismaleimide on the other hand. The tapered 
double cantilever beam geometry was used for evaluating the recovery of the fracture 
toughness at room temperature after 5 days. With both the HDI3- and JTM-TetraThiol 
combination, a reinforcing effect of the microcapsules on the fracture toughness was observed 
and a healing efficiency over 50% could be achieved. The spatial distribution and the fracture 
behavior of the microcapsules were also investigated, as well as the flow of the healing agents 
into the crack. Furthermore, parameters such as the microcapsule loading and core content 
were evaluated for the thiol-isocyanate combination, while the influence of the microcapsule 
ratio and solvent effect was checked for the thiol-maleimide chemistry. Finally, a first attempt 
to generate a glass fiber-reinforced polymer composite was made. 
 
Parts of this chapter are also published in: X. K. D. Hillewaere, R. F. A. Teixeira, L.-T. T. Nguyen,  
J. A. Ramos, H. Rahier, F. E. Du Prez. Thiol-isocyanate chemistry for autonomous self-healing of epoxy 
thermosets. Advanced Functional Materials, 2014, 24 (35), 5575.  
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Chapter 6 
Autonomous self-healing thermosets and composites 
 
6.1 Introduction  
The need for fully autonomous self-healing polymer systems is created by the cost of 
manual interventions to maintain and repair polymer materials. Since all materials throughout 
their lifetime sustain damage due to impact, degradation, fatigue, wear or mechanical 
overload, these interventions are inevitable. But even if performed proficiently, manual 
intervention is not capable of repairing unreachable or hidden microcracks in the bulk of the 
material and as such, recover the full integrity of the polymer structure. Autonomous repair of 
microcracks, induced by the propagation of the crack itself, would eliminate the need for 
maintenance, reducing costs and at the same time extending the lifetime and safety of polymer 
materials.
1-3
 To perform this repair in polymer thermosets and composites, an extrinsic self-
healing mechanism with additional healing agents is recommended, due to the limited 
molecular mobility in stiff polymeric crosslinked structures. Furthermore, the ease of 
application by simply adding the healing agent containers to an existing polymer thermoset or 
composite could lead to accelerated industrial use. 
The market for polymer thermosets and composites is vast, including the transport 
sector (cars, ships, air- and spacecrafts), sporting goods, construction and electronics.
1
 
Potential thermoset applications for which self-healing could have a significant impact are 
coatings
4-6
, structural foams
7
 and vulcanized rubbers (eg. self-sealing tires). A very important 
class of materials, which is often aimed at for autonomous self-healing applications, are the 
carbon or glass fiber-reinforced polymer composites. These are mostly used in applications 
where the thermoset requires a higher strength or stiffness.
8
 Carbon fibers have an 
exceptionally high modulus and tensile strength
8
 and are often applied in aerospace
9
, wind 
turbine blades
10
 or other large structures. More specific applications for glass fiber reinforced 
composites are outlined in Subsection 6.4. 
In this chapter, the synthesis and efficiency of autonomous self-healing epoxy 
thermosets, based on the thiol-isocyanate and thiol-maleimide healing chemistry, are 
discussed. Several parameters playing a role in the self-healing process are investigated, such 
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as the microcapsule spatial distribution, fracture behavior and loading, as well as the flow of 
the healing agents and the effect of added solvents. 
 
6.2 Thiol-isocyanate: self-healing of thermosets with microcapsules 
6.2.1 Synthesis and analysis of self-healing epoxy TDCB test samples 
To generate a fully autonomous, self-healing thermoset system, the two types of 
microcapsules, one containing the TetraThiol and the other the HDI3 (see Chapter 3) have 
been embedded into the epoxy material. So far, only the amine-epoxy and thiol-epoxy healing 
chemistries have been incorporated into an epoxy matrix using a dual microcapsule approach 
(see Chapter 2). In a first step, poly(melamine-formaldehyde) (MF) microcapsules with a 
TetraThiol-methyl benzoate (MB) core were mixed with polyurea microcapsules with an 
HDI3 core in a 1:1 ratio of thiol-isocyanate groups. Next, the dry microcapsule mixture was 
blended into the EPON 828 epoxy resin and DETA hardener prior to curing of the epoxy 
resin. The microcapsules were only added to the EPON 828 material around the crack area in 
the TDCB geometry by applying a silicon insert while casting (Figure 6.1).
11
 At first, TDCB 
test samples with a long groove of 47 mm were used, but in order to avoid complete fracture 
of the sample, the switch to TDCB samples with a short groove of 25 mm was made. 
Complete filling of the mid-section with the viscous epoxy-microcapsule mixture was also 
facilitated in the short-groove TDCB geometry. 
 
 
Figure 6.1. Epoxy TDCB samples with TetraThiol- and HDI3-containing microcapsules around the crack 
area. Left: long-groove TDCB samples with different compositions: the EPON 828 samples are colorless, 
the RIM 135 sample is blue. In one sample, a red dye was added to the core of the microcapsules.  
Right: short-groove TDCB sample. 
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Next, the epoxy TDCB samples with embedded microcapsules were precracked by 
tapping the samples onto a fresh razor blade following the ASTM D4045 standard. The virgin 
epoxy material was then loaded until fracture, followed by gentle clamping of the samples to 
make sure both crack surfaces are in contact with one another.  The samples were then 
allowed to heal for 5 days at 25 °C and fractured in a second test. At least three samples were 
tested per composition. The efficiency of healing fracture damage was again determined by 
calculating the ratio of the healed over the virgin peak load to fracture, as this equals the ratio 
of the measured fracture toughness after healing and before initial fracture in the TDCB 
geometry
12
 and thus gives an indication of the recovery of the resistance to fracture. 
 
The best healing results were obtained using the TetraThiol/MB-containing 
microcapsules with a core content of 75-85 wt% in combination with HDI3-containing 
microcapsules with a content of 70 wt%. With a microcapsule loading of 20 wt% in the 
EPON 828 epoxy material, up to 54% (average 48 ± 9%) of the original peak load to fracture 
was recovered with a healed peak load exceeding 40 N. If this healed peak load would be 
compared to the virgin peak load of the EPON 828 material without microcapsules (61 ± 7 
N)
13
, a healing efficiency up to 68% can be calculated. The lower value of 54% is explained 
by an enhanced virgin peak load of the unbroken epoxy material (Figure 6.2), as a result of a 
reinforcing effect of the microcapsules. As described by Brown et al.
14
, microcapsules tend to 
strengthen the epoxy material through increased hackle markings and subsurface 
microcracking. Furthermore, asymmetric tail formation is noticed in the crack plain. This tail 
formation in the wake of the microcapsules could be visualized using X-ray computed 
tomography (CT) and scanning electron microscopy (SEM) on the crack surface (Figure 6.3). 
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Figure 6.2. Virgin peak load increase with a higher amount of microcapsules added to the EPON 828 
epoxy material. 
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Figure 6.3. Scanning electron micrographs of tail formation in the wake of both TetraThiol- and HDI3-
containing microcapsules. The direction of the crack is indicated by the arrow in the top left figure. The 
small particles on top of the fracture plane originate from the SEM sample preparation procedure 
(sawing). 
 
In the autonomous self-healing samples, the healing efficiency is lower than the results 
obtained using manual injection (see Chapter 5), because several additional parameters play a 
role: the microcapsule spatial distribution, the microcapsule fracture behavior, the flow and 
mixing of the healing agents in the crack and the resulting healing agent volume delivered to 
the crack. 
The microcapsule spatial distribution was looked at with CT, which is able to 
visualize the spatial arrangement in 3D without destroying the sample. Since TetraThiol has a 
slightly higher electron density compared to the epoxy matrix – as a result of the presence of a 
sufficient number of sulphur atoms – these microcapsules could be distinguished from the 
matrix. To show the microcapsule spatial distribution within an epoxy TDCB sample, the 
Chapter 6 – Autonomous self-healing thermosets and composites 
177 
 
density of the epoxy is removed for part of the sample, thus only showing the TetraThiol 
density (Figure 6.4). As such, well separated and mostly spherical TetraThiol-containing 
microcapsules were observed, indicating a good dispersion and intact microcapsules. 
Furthermore, the size of the microcapsules measured via CT was in good agreement with the 
SEM and particle size measurements (see Chapter 5). The lower resolution in the images is 
caused by the relatively large epoxy sample size. 
 
 
 
Figure 6.4. X-Ray CT image of the 3D distribution of TetraThiol-containing microcapsules in an epoxy 
TDCB sample, with two zoom-sections on the right. Measurements were performed at the Centre for  
X-Ray Tomography at Ghent University (UGCT, Department of Geology and Soil Science). 
 
Unfortunately, the HDI3-containing microcapsules have the same electron density as 
the epoxy material, making them invisible in a normal EPON 828 sample. Therefore, a TDCB 
sample with a higher electron density was prepared by replacing 20 wt% of EPON 828 by 
EPIKOTE 1163 (or EPON 1163, Scheme 6.1). EPON 1163 is a typical flame retardant 
additive used in standard epoxy materials. In this way, the electron density of the epoxy 
matrix is higher than that of both microcapsules, resulting in visualization of the full 
microcapsule spatial distribution (Figure 6.5). Although the TetraThiol-containing 
microcapsule batch (Ø = 150 µm) used in this sample showed more agglomeration (blue 
areas), the smaller HDI3 microcapsules (Ø = 50 µm) were nicely distributed as separate units 
(pink areas). This CT study, being the first that visualizes a dual capsule healing system to our 
knowledge, demonstrates that it is possible to properly spread out both types of microcapsules 
in the epoxy matrix and that the spatial distribution as such should not have a large negative 
effect on the healing efficiency.  
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Scheme 6.1. The brominated epoxy resin EPON 1163.
15
 
 
 
 
Figure 6.5. X-Ray CT image of the 2D distribution of both TetraThiol- and HDI3-containing 
microcapsules in an epoxy TDCB sample (respectively blue and pink areas). 
 
The microcapsule fracture behavior was visualized using SEM and CT, demonstrating 
that both types of microcapsules were embedded into the epoxy without severely damaging 
the protective shell. This conclusion was drawn from the spatial distribution images (Figure 
6.4) and the SEM surface images, showing spherical, non-collapsed microcapsules in both 
cases. When looking at the crack surface where the microcapsules had to break, a different 
behavior was observed for the TetraThiol-containing MF microcapsules compared to the 
HDI3-containing polyurea microcapsules. Indeed, CT scans of the crack surface indicated that 
delamination of several microcapsules occurred (Figure 6.6 left). These were confirmed to be 
isocyanate-containing microcapsules by taking slices through the microcapsules, showing an 
electron density of the core that is the same as the epoxy matrix (grey color, Figure 6.6 right). 
The higher density TetraThiol-containing microcapsules were given a red color as seen in the 
bottom right part of the slice. 
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Figure 6.6. Left: X-Ray CT image of the crack surface, showing delamination of the HDI3-containing 
microcapsules (indicated with red arrows for clarity). Right: Slice through delaminated microcapsules, 
indicating an electron density similar to the epoxy matrix. 
 
This different fracture behavior could also be observed in the SEM images. The 
TetraThiol-containing microcapsules were always completely broken, mostly with full release 
of the TetraThiol as a result (Figure 6.7a, left image). In some cases however, these 
microcapsules were not empty (right image). EDX measurements on both the interior and 
exterior of the microcapsule – EDX locations are indicated by crosses in the figure – both 
showed a large peak of sulphur, indicating the presence of TetraThiol on both sides of the 
shell wall.  
Based on the EDX results and the blurred shell wall edges, most likely indicative of 
overflowing, we concluded that only part of the TetraThiol was released from these 
microcapsules. This can have two reasons: 1) the capillary forces acting on these 
microcapsule cores were not sufficient to extract the liquid, maybe as a result of a larger gap 
between both crack surfaces, or 2) the TetraThiol rapidly reacted with HDI3 in its vicinity. In 
this case, it can be assumed that option 2 – the reaction with the isocyanate – took place, due 
to the presence of an isocyanate-containing microcapsule nearby (bottom right corner) and the 
formation of solid material on top of the microcapsule (upper right corner).  
Furthermore, good adhesion was observed between the epoxy matrix and the MF shell, 
preventing any delamination of the TetraThiol-containing microcapsules (Figure 6.8). 
Compared to the shell thickness in the dry state (200-400 nm), the shell thickness of the 
microcapsules embedded in epoxy appeared to be significantly thicker (3.3-5.0 µm), most 
likely due to swelling of the shell by the epoxy. This swelling effect is expected to even 
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further enhance the adhesion between the shell and the matrix. More images of the MF 
microcapsules in epoxy are provided in the Appendix. 
 
 
 
Figure 6.7. Scanning electron micrograph of microcapsules embedded in an epoxy TDCB test sample.  
(a) Fractured TetraThiol-containing MF microcapsules; left: completely emptied microcapsule; right: 
partially emptied microcapsule; the two crosses mark the spots of the EDX measurements. (b) HDI3-
containing polyurea microcapsules; left: fractured microcapsule; right: delaminated (unbroken) 
microcapsule. 
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Figure 6.8. SEM image of the MF microcapsule shell of a TetraThiol-containing microcapsule, showing 
good adhesion between the epoxy matrix and the shell wall. 
 
In contrast, the HDI3-containing microcapsules did not break easily. The SEM images 
confirmed that part of these microcapsules were ruptured and that some were detached from 
the epoxy matrix (Figure 6.7b). This might be related to the thicker microcapsule shell, but 
also to solidification of the core, generating solid beads (see Chapter 5). The porous structure, 
which in our case is characteristic for solidified isocyanate cores, was indeed observed in 
some of the SEM surface images (Figure 6.9). As a result, we believe that the HDI3 volume 
delivered to the crack was too low compared to the TetraThiol healing agent, which is 
considered to be the main reason for the decrease in healing efficiency. 
 
 
 
Figure 6.9. Scanning electron micrograph of broken HDI3-containing microcapsules in the crack, 
revealing a solidified core structure. 
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The flow of the healing agents into the crack was already mentioned for both 
microcapsules (vide supra). Since most of the TetraThiol was released from the 
microcapsules, it can be assumed that this core compound flowed well across the crack 
surface. CT scans of a fractured cylindrical sample containing only TetraThiol microcapsules 
and with both crack surfaces in close proximity also showed that the liquid multithiol travels 
through the cut in the direction of the crack tip (see Appendix). Flow patterns around the 
TetraThiol-containing microcapsules further confirm this assumption (Figure 6.10).  
In the image on the left, several flow patterns can be identified and the most obvious 
one is indicated. Based on the rough structural appearance and the presence of both 
TetraThiol- and HDI3-containing microcapsules around this pattern (respectively above and 
below the indicated area), it is likely that this consists of solid thiourethane material, formed 
by the reaction between the two healing agents. Also above this area, several small areas of 
similar material are present around the larger microcapsule. On the other hand, the image on 
the right shows a smooth area where only the TetraThiol has been released in the crack. These 
SEM images give further indications of a too small HDI3 volume flowing from the polyurea 
microcapsules into the crack area. This could be related to the microcapsule issues mentioned 
earlier, but also to preliminary reaction of the isocyanate with amines at the crack surface, 
causing early solidification. More images indicative of these flow patterns can be found in the 
Appendix. 
 
 
 
Figure 6.10. Scanning electron micrograph of the crack surface, showing flow patterns outside of the 
microcapsules. 
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From the above SEM and CT analysis, it can be concluded that the TetraThiol/MB 
combination is readily released into the crack and that the more viscous HDI3 renders 
difficulties in release and flow from the polyurea microcapsules. In order to assess the 
potential for optimization, an experiment was performed using an EPON 828 epoxy TDCB 
sample containing only 20 wt% of MF microcapsules with TetraThiol in the core (no MB). 
Upon fracture after testing, a small volume of the low viscous HDI (2-15 µL) was manually 
injected into the crack and the samples were allowed to heal for 3 days at 25 °C. The samples 
with the smallest amount of HDI injected into the crack rendered the best results with an 
improved healed load up to 56 N and a healing efficiency up to 67%. This value indicates that 
improvement in the isocyanate release and flow could indeed result in higher recoveries, even 
without the viscosity lowering MB present in the TetraThiol microcapsules. 
 
6.2.2 Parameter study and influence on the healing efficiency 
In a next step, the microcapsule loading in the EPON 828 epoxy material was lowered 
to 10 and 15 wt% to further investigate the influence of the healing agent volume. Again, at 
least 3 samples were used per composition and healed for 5 days at 25 °C. In both cases, an 
average healing efficiency of only 30% (24 ± 8 and 25 ± 4 N) was reached due to a lower 
healing agent volume delivery to the crack. To further confirm this, the core content of the 
isocyanate microcapsules was lowered while retaining a microcapsule loading of 20 wt%. 
When HDI3-containing microcapsules with a core content of 40, 50 and 60 wt% were used, 
lower healing efficiencies of respectively 13 ± 5, 26 ± 6 and 39 ± 1% (11 ± 3, 26 ± 9 and  
33 ± 1 N) were indeed obtained. 
 
As mentioned in the previous subsection, the flow of the healing agents into the crack 
plays a key role in the effectiveness of the self-healing process. In order to assess the 
influence of the viscosity of the healing agents on the wetting of the epoxy surface, contact 
angle measurements of TetraThiol with and without 10 wt% of MB were performed on EPON 
828 epoxy plates. The viscosity lowering effect of this amount of MB on TetraThiol was 
already indicated in Chapter 3, showing a decrease from 500 to 185 cP. This resulted in 
contact angles of 81° and 94° with and without the solvent respectively. From experiments 
modelling the flow of the healing agents from a microcapsule into the crack area, performed 
within the Mechanics of Materials and Structures research group at Ghent University (MMS, 
Department of Materials Science and Engineering), it became clear that only healing agents 
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with a contact angle lower than 90° could readily flow out of the microcapsule under the 
influence of capillary forces. Therefore, the addition of MB is actually a necessary 
requirement to ensure good wetting of the epoxy by the TetraThiol. The contact angle of HDI3 
(88°) was just on the limit to generate easy flow into the crack, which could be an additional 
reason for the low volume delivered to the damage area. A table of contact angles and an 
image of the model can be found in the Appendix. 
 
6.3 Thiol-maleimide: self-healing of thermosets with microcapsules 
6.3.1  Synthesis and analysis of self-healing epoxy TDCB test samples 
To generate a fully autonomous, self-healing thermoset system based on the  
thiol-maleimide chemistry, a similar synthesis and analysis procedure was followed as 
mentioned in Subsection 6.2.1. Again, the two types of MF microcapsules, one containing the 
TetraThiol/MB mixture and the other the maleimide, were mixed in a 1:1 ratio of thiol-
maleimide groups and embedded into EPON 828 epoxy TDCB samples, which were 
consequently tested to measure the load to fracture before and after self-healing. 
Three different maleimide solutions were used as healing agents in these autonomous 
self-healing materials. Jeffamine T-403 trismaleimide (JTM) was mixed with MB in a 1:2 and 
a 2:1 weight ratio, while 15 wt% of the trimethylhexane-based bismaleimide (TMBM) was 
dissolved in ethyl phenylacetate (EPA, near saturation). The best self-healing results were 
obtained after 5 days of healing when combining TetraThiol/MB-containing microcapsules 
with a core content of 75-85 wt% and 2:1 JTM/MB-containing microcapsules with a core 
content of 86 wt%. In the EPON 828 epoxy material, a healing efficiency up to 53% was 
reached, using only 10 wt% of microcapsules, while up to 44% of the load to fracture was 
recovered when 20 wt% of microcapsules was applied (Table 6.1, Entry 3 and 4). The healing 
efficiency is higher in the first case due to a significantly lower virgin peak load of the 
unbroken epoxy material, in spite of the similar healed loads that were obtained. When a 
healing time of only 3 days was considered, this JTM/MB-TetraThiol combination rendered 
recoveries up to 24% with 10 wt% of microcapsules (Entry 2). Although the recovery after  
5 days of healing is quite significant, it is nevertheless much lower than the result obtained 
with manual injection of the JTM-TetraThiol combination (98 ± 14%). Since the spatial 
distribution and the fracture behavior of the maleimide-containing MF microcapsules are 
expected to be the same as for the TetraThiol-containing MF microcapsules, the lower healing 
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efficiencies in this case can most likely be attributed to the viscosity of JTM and consequently 
by the lack of flow of this healing agent into the damaged area. 
 
Table 6.1. Loads to fracture before initial fracturing (virgin) and after self-healing (healed), and 
maximum healing efficiencies for different thiol-maleimide compositions. All compounds were used in a 
1:1 maleimide/thiol functional group ratio. H.E. = Healing Efficiency. 
 
# Mal. Weight 
Ratio * 
SH # capsules 
(wt%) 
Healing 
time (h) 
Virgin 
load (N) 
Healed 
load (N) 
H. E. 
(%) 
1 JTM/MB 1:2 TetraThiol 20 120 80 13 16 
2 JTM/MB 2:1 TetraThiol 10 72 86 20 24 
3 JTM/MB 2:1 TetraThiol 10 120 62 33 53 
4 JTM/MB 2:1 TetraThiol 20 120 82 36 44 
5 TMBM/EPA 15:85 TetraThiol 15 120 99 30 31 
* Maleimide/solvent weight ratio. 
 
Unfortunately, the use of 1:2 JTM/MB-containing microcapsules with a lower viscous 
core did not result in higher healing efficiencies after 5 days, at best reaching a much lower 
recovery of 16% (Entry 1). However, when TMBM/EPA-containing microcapsules were 
applied, with even more solvent in the core, a peak load recovery of up to 31% was achieved 
after 5 days of healing, with a similar healed load compared to the 2:1 JTM/MB case of 30 N 
(Entry 5). Furthermore, this is close to the maximum achievable healing efficiency with this 
TMBM/EPA-TetraThiol combination as observed using manual injection (Chapter 4). It has 
to be noted that in this case a 20 wt% microcapsule loading could not be used due to a too 
high viscosity increase. This increase is fully related to the large volume of low density 
TMBM/EPA-containing microcapsules that had to be added to sustain the 1:1 maleimide/thiol 
functional group ratio. 
The thiol-maleimide self-healing results suggest that either a sufficiently high 
maleimide core content or a very good wettability by the healing agent is required. In the 
former case, sufficient thiol-maleimide reactions would occur locally, while in the latter, the 
mobility of the maleimide compensates for the loss in local concentration. The microcapsule 
loading does not seem to have a large effect. 
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6.3.2 Parameter study and influence on the healing efficiency 
Because the core of the maleimide-containing microcapsules also holds a large amount 
of solvent, their volumetric mass density is lower than that of the TetraThiol-containing 
microcapsules. This can be seen during collection of the microcapsules after synthesis: the 
EPA- and TetraThiol-containing microcapsules respectively float on top or sink to the bottom 
of the water phase (see Chapter 5). Consequently, a large volume of the maleimide-containing 
microcapsules had to be added to sustain the 1:1 maleimide/thiol functional group ratio, 
which results in a less balanced spatial distribution of both microcapsules. Since this might 
have a large effect on the healing efficiency, different weight ratios of the 2:1 JTM/MB- and 
TetraThiol-containing microcapsules were tested at a 10 wt% loading in EPON 828 epoxy 
material. These microcapsules were mixed in a 1:1, 1:2 and 1:3 weight ratio, thus increasing 
the amount of TetraThiol-containing capsules compared to the 1:1 functional group ratio. 
After 3 days of healing at 25 °C, this resulted in a maximum healing efficiency of respectively 
20% (15 N), 27% (25 N) and 15% (18 N). Although the 1:2 weight ratio appeared to work 
better than the other two ratios and actually rendered a result slightly higher than for the  
1:1 functional group ratio after 3 days (24%), the improvement is not significant enough to 
state that changing the ratio has a large effect on the healing efficiency. A similar conclusion 
was reached when the TMBM/EPA-TetraThiol functional group ratio was increased from  
1:1 to 1:7. Using the same 15 wt% microcapsule loading and allowing the samples to heal for 
5 days at 25 °C, a recovery up to 33% (27 N) was obtained, which is similar to the healing 
efficiency of 31% (30 N) with the 1:1 ratio. 
 
In order to further investigate the effect of solvent swelling and consequent healing via 
reaction of residual epoxide and amine functional groups
15, 16
, 25 wt% of EPA-containing 
microcapsules were added to the EPON 828 matrix. After healing for 5 days at 25 °C, a 
maximum recovery of only 18% (20 N) was reached, while literature studies report a value of 
77% for freshly prepared samples.
15, 17
 However, for aged samples, this value rapidly 
decreased to 27% after three weeks and further decreased to 13% after 2.5 months due to 
premature EPA diffusion from the microcapsule into the epoxy.
17
 It is possible that this effect 
is also present in our samples, but this was not further investigated. 
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6.4 Self-healing fiber-reinforced polymer composites 
The first experiments to generate glass fiber-reinforced epoxy composites with 
microcapsules were initiated in collaboration with the MMS group. Glass fibres are used in a 
wide range of applications as the cheapest fibre reinforcement available, while still providing 
sufficient tensile strength and stiffness to the matrix material.
8
 Chopped glass fibers are  
eg. applied in bath tubs, shower stalls, marine applications, automotive body panels, roofing 
shingles and asbestos replacements, while continuous glass fiber reinforcement is eg. used in 
a filament winding process for the production of tanks or pipes, or as fiber mats in corrosion-
resistant liners, boat hulls or vinyl flooring.
18
 
 
At the end of the PhD research project, the first glass fiber-reinforced epoxy plates 
with microcapsules were made via a resin transfer molding (RTM) process, applying the RIM 
135 epoxy resin and RIMH 137 hardener. In RTM, the glass fiber mats are placed in a closed 
mold, followed by injection of the epoxy mixture. This technique is typically used in the 
manufacturing of large, complex-shaped structures with well-defined surface finishes on all 
sides.
19
 So far, RTM was only used for the synthesis of self-healing materials in combination 
with hollow glass fibers (see Chapter 2). In our experiment, the dry microcapsule powder was 
manually distributed onto the fiber mats, followed by mold closure and injection of the epoxy 
mixture. Preliminary results indicated that most of the microcapsules were present in large 
clusters throughout the cured epoxy sample, but this was rather related to an insufficiently 
good distribution than to migration of the microcapsules in the mold upon injection. More 
research is required to optimize the synthesis process of these glass fibre-reinforced 
composites, but the results are promising for the generation of the first fiber-reinforced epoxy 
composites with microcapsules via RTM. A hand lay-up process could also be considered in 
future experiments, as microcapsules have already been embedded in fiber-reinforced 
composites in that way.
20-23
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6.5 Conclusion 
In this chapter, autonomous self-healing epoxy thermosets were generated using both 
the thiol-isocyanate and thiol-maleimide chemistry embedded in microcapsules. These two 
combinations are completely new in the field of self-healing polymers. 
Firstly, TetraThiol/MB- and HDI3-containing microcapsules were embedded in epoxy 
TDCB samples to quantify the autonomous recovery of the fracture toughness. After 5 days 
of healing at room temperature and with 20 wt% of the microcapsules added to the epoxy, a 
healing efficiency over 50% could be reached. Additionally, an increase in the virgin fracture 
toughness of the epoxy was noticed with an increasing amount of microcapsules. 
Next, the microcapsule spatial distribution and fracture behavior, as well as the flow of 
the healing agents in the crack area, were evaluated using CT scanning and SEM imaging. In 
the CT scans, a good spatial distribution of both the TetraThiol/MB- and HDI3-containing 
microcapsules was observed. Furthermore, analysis of the shape of the microcapsules 
indicated that both types remained intact upon incorporation into the epoxy thermoset. Upon 
fracturing of the epoxy material, the MF microcapsules with a TetraThiol/MB mixture in the 
core were always fully ruptured, while part of the polyurea microcapsules containing HDI3 
were detached from the epoxy matrix, resulting in unbroken microcapsules. This was related 
to their thicker shell, but also to solidification of the isocyanate core. Flow of the viscous 
HDI3 into the damaged area was also hampered, while the TetraThiol/MB mixture seemed to 
flow readily into the crack. The issues with the HDI3 were considered to be the main reason 
for the lower healing efficiency compared to the manual injection experiments. Variations in 
the microcapsule loading or core content did not improve the obtained result. 
 
For the thiol-maleimide self-healing system, two types of MF microcapsules 
containing either TetraThiol/MB or maleimide-solvent mixtures were incorporated into the 
epoxy material. In the case where the trismaleimide JTM was used in a 2:1 weight ratio with 
MB, a fracture toughness recovery of more than 50% could also be obtained with 10 wt% of 
microcapsules. Variations in the microcapsule loading or ratio resulted in similar or lower 
healing efficiencies. 
 
Finally, a first attempt to generate glass fibre-reinforced epoxy composites with 
microcapsules was made with promising results, although the synthesis process requires 
optimization. 
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To conclude this chapter, it can be stated that two fully autonomous systems, new to 
the field of self-healing, were developed, approaching the stringent demands of industry 
concerning toxicity, stability and costs. We believe that both systems could be industrially 
feasible and that the healing efficiency could be improved when additional research would be 
performed on the stability of the isocyanate-containing microcapsules and the wettability by 
both the isocyanate and maleimide compounds. 
 
  
Chapter 6 – Autonomous self-healing thermosets and composites 
190 
 
6.6 Experimental section 
6.6.1 Materials 
EPIKOTE 828 LVEL epoxy resin (Low viscosity, Momentive Specialty Chemicals 
GmbH) was used as received. EPIKOTE 1163 epoxy resin was kindly provided by 
Momentive Specialty Chemicals GmbH. Solvents were purchased from Sigma-Aldrich and 
used without purification. 
 
6.6.2 Instrumentation 
Tapered Double Cantilever Beam (TDCB) load-displacement curves were recorded 
with a Tinius Olsen H10KT testing machine equipped with a HTE-5kN load cell. A 
displacement rate of 0.3 mm.min
-1
 was used. The data were analyzed with Tinius Olsen Test 
Navigator software. Scanning Electron Microscopy (SEM) pictures were recorded with a FEI 
Quanta 200F microscope connected to an EDAX type Genesis 4000 equipment for Energy 
Dispersive X-ray spectroscopy (EDX) measurements. For X-ray Computed Tomography (CT) 
measurements, a scanner was used that was built inside a shielded room to ensure a maximum 
flexibility of the set-up.
24
 The X-ray tube of this high-resolution CT scanner is a FXE-160.50 
dual head open type source from Feinfocus. For the scans, the transmission head was used 
with an accelerating high voltage of 100 kV and an electron current of 80 mA. 1800 
projections were made at a resolution of 5.1 μm and an illumination time of 1000 ms per 
frame, with two frames per projection. The detector used was a VARIAN Paxscan 2520 V 
with 14 bit dynamic range and CsI scintillator. Contact angle measurements were performed 
with an OCA20 instrument from DataPhysics. The contact angle was analyzed with the 
OCA20 software. Every value is an average of 3 measurements. 
 
6.6.3 Synthesis of microcapsule-containing epoxy TDCB test samples 
EPIKOTE 828 LVEL epoxy resin was mixed with DETA in an equimolar 100:11 
weight ratio. After homogeneous mixing, the air was removed by applying high vacuum for 5 
minutes. The solution is then poured in a silicon mold with specific dimensions to produce the 
TDCB samples.
11, 25
 A silicon insert was placed in the TDCB mold to avoid filling the mid-
section around the side-groove. The EPIKOTE 828 mixture was then cured for 1 day at 25 °C. 
Next, the silicon insert was removed and a newly prepared EPIKOTE 828 mixture containing 
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20 wt% of microcapsules was poured into the mid-section. Addition of these microcapsules to 
the epoxy mixture was done by first sieving the two types of microcapsules over a 500 µm 
mesh and mixing them as a dry powder in the required ratio using a flask shaker at 600 
oscillations.min
-1
, followed by addition to the premixed epoxy-hardener mixture in a round-
bottomed flask. Primary mixing was aided using a spatula, followed by complete mixing 
under vacuum at a rotavapor rotating at the maximum speed (Büchi Rotavapor R-210, 280 
rpm) for approximately 5 min. No heating was applied. A good microcapsule dispersion 
without air bubbles should be obtained. Once this mixture is poured into the mould, the 
sample is cured for an additional day at 25 °C and 1 day at 40 °C.  
For the synthesis of the partially brominated epoxy material, 20 wt% of the EPIKOTE 
828 was replaced by EPIKOTE 1163, a solid product that had to be dissolved in the 
remaining EPIKOTE 828 prior to use. Therefore, the solid EPIKOTE 1163 lumps were 
crumbled and mixed thoroughly with the EPIKOTE 828, followed by prolonged heating of 
the mixture to 80 °C (softening point EPIKOTE 1163 = 64 °C). 
For the RTM process, the RIM 135 resin was mixed with RIMH 137 in an equimolar 
100:30 weight ratio, injected and cured for 1 day at 40 °C and 16 hours at 80 °C. 
 
6.6.4 Quantification of healing efficiency using TDCB test samples 
The TDCB test samples were used for the quantification of the healing efficiency. In 
accordance with the protocol introduced by White et al.
11, 25
, a tapered epoxy sample with a 
side groove (47 or 25 mm in length) and a thickness of 2.5 mm in the groove was used. A 
precrack was generated by tapping the TDCB sample onto a razor blade (ASTM D4045 
standard), which was inserted into the notch of the TDCB specimen. The samples were then 
pin loaded at a displacement rate of 0.3 mm.min
-1
.
25
 The specimens were loaded until failure 
occurs, resulting in the peak load necessary to break the virgin sample. If multiple peak loads 
were obtained, the average was used as the load to failure for the TDCB sample. For the 
microcapsule containing TDCB samples, only gentle clamping of the samples was required to 
bring both crack surfaces into contact with one another, followed by storage at 25 °C for the 
designated period. The samples were then broken at the same displacement rate to calculate 
the healing efficiency, which is defined as the ratio of the average peak load of the healed 
sample over the average peak load of the same virgin sample. At least 3 samples were tested 
for each composition. 
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Chapter 7 
General conclusion and perspectives 
 
7.1 General conclusion 
The aim of this research project was to develop autonomous extrinsic self-healing 
systems with an increased stability and enhanced kinetics compared to existing concepts, 
while considering industrial demands such as toxicity, upscalability and cost. 
In this project, we were able to develop two self-healing epoxy systems that meet most 
of the industrial demands. For the thiol-isocyanate concept, two readily available healing 
agents were used – pentaerythritol tetrakis(3-mercaptopropionate) (TetraThiol) and 
hexamethylene diisocyanate isocyanurate trimer (HDI3) – with a relatively low toxicity and 
cost, as well as a good long-term stability. For example, both compounds are already applied 
in industrial coatings.
1, 2
  
In Chapter 3, the thiol-isocyanate combination is shown to react to full conversion 
within minutes if a low molecular weight tertiary amine catalyst is present, demonstrating the 
fast kinetics of this reaction. Moreover, adding the epoxy matrix as a powder to the reaction 
mixture also resulted in a catalytic effect because of the large amount of tertiary amine 
functional groups, present in the epoxy polymer network. A thermal stability up to 200 °C 
was observed, which is similar to the most heat-resistant self-healing systems
3, 4
 and high 
enough to withstand industrial processing temperatures for epoxy resins (up to 180 °C). The 
system is also stable in the presence of oxygen (air) and elegantly deals with moisture by 
forming amines that also participate in the self-healing process. Furthermore, the strong 
adhesive capability of the thiol-isocyanate chemistry was shown by manually injecting 
mixtures of TetraThiol and different isocyanates, yielding over 100% recovery of the peak 
load to fracture at room temperature, while 50% recovery was achieved at temperatures below 
0 °C.  
On the one hand, stable microencapsulation of the TetraThiol was readily performed 
using the well-known process of a polycondensation of melamine and formaldehyde to form 
the shell (Chapter 5). The encapsulation of HDI3 in polyurea microcapsules on the other hand 
proved to be more challenging, since the long-term stability was compromised by water 
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diffusion into the isocyanate core, resulting in core solidification. Therefore, the polyurea 
shell was modified with hydrophobic agents to limit the water permeability. Although 
additional fine-tuning could further enhance the isocyanate microcapsule shelf-life, the 
stability of the capsule powder was acceptable for approximately one month. 
When both TetraThiol- and HDI3-containing microcapsules were embedded in bulk 
epoxy material (Figure 7.1), a healing efficiency over 50% could be obtained (Chapter 6). 
This lower value, compared to the manual injection, was attributed to a limited release and 
flow of HDI3 into the crack. Additionally, an increase in the virgin fracture toughness of the 
epoxy was noticed with an increasing amount of microcapsules. 
 
 
 
Figure 7.1. Final self-healing epoxy product based on a dual microcapsule thiol-isocyanate strategy. The 
self-healing process has been visualized on: https://www.youtube.com/watch?v=sXuU9XrxEOk.  
 
For the thiol-maleimide concept, TetraThiol was again used, but this time available 
aromatic or synthesized aliphatic maleimides were added as the second healing agent. The 
aromatic compounds also have a relatively low toxicity, cost and a good long-term stability. 
The aliphatic maleimides in turn were made from amine precursors, using a straightforward 
and upscalable synthesis strategy, ensuring their accessibility (Chapter 4). All maleimides 
were found capable of withstanding the highest epoxy processing temperatures (up to 180 
°C). Since most of the maleimides were solid, they were dissolved in high boiling solvents in 
near saturation concentrations. 
Also in the thiol-maleimide case, the reaction proceeds to full conversion within 
minutes if a low molecular weight tertiary amine catalyst is present and the epoxy matrix is 
capable of catalyzing this reaction as well. A strong adhesive capability of the thiol-
maleimide combination was demonstrated by manually injecting mixtures of TetraThiol and 
the different maleimide-solvent compositions, again yielding a recovery of 100% or higher. 
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Stable microencapsulation of the maleimide-solvent mixtures was also done using the 
melamine-formaldehyde polycondensation strategy (Chapter 5). When these maleimide-
containing microcapsules were combined with TetraThiol capsules in an epoxy matrix, a 
healing efficiency of 30 to 50% could be obtained (Chapter 6). The best results were obtained 
with the liquid, aliphatic Jeffamine T-403 trismaleimide (JTM). The lower recovery value, 
compared to the manual injection, was in this case ascribed to a limited flow of the maleimide 
into the crack or a too low concentration of dissolved maleimide. Also here, an increase in the 
virgin fracture toughness of the epoxy was noticed with an increasing amount of 
microcapsules. 
Although there is still room for improvement with regard to the healing of stiff 
polymeric matrices, the thiol-maleimide and especially the thiol-isocyanate system are 
definitely valid candidates for industrial applications. Moreover, both systems are new to the 
field of self-healing and already tackled some of the disadvantages of existing systems. This 
indicates that these systems have the potential to grow into an established role within the 
research area of autonomous extrinsic self-healing thermosets and polymer composites. 
 
7.2 Future perspectives 
As already suggested above, both the thiol-isocyanate and thiol-maleimide concepts 
have plenty of opportunities to expand their use in thermosets and polymer composites. 
Firstly, if the flow of the HDI3 or JTM core into the crack could be improved, a significant 
increase in healing efficiency could be expected. A potential solution might be found in 
mixing several reactive healing agents, such as HDI3 with other lower viscous trifunctional 
isocyanates or JTM with different linear Jeffamine-based bismaleimides, and incorporate 
these in the same microcapsules. If industrial concerns are continuously kept in mind, this 
would even further increase the industrial feasibility.  
However, as stated earlier by Mauldin et al.
5
, the economic feasibility and long-term 
activity of the healing agents have to be specifically researched before these self-healing 
materials can begin to replace thermosets and polymer composites in commercial 
applications. Moreover, the conceptual idea of most self-healing systems should, in my 
opinion, be taken to an upscalable application within a reasonable timeframe. As also 
suggested by Blaiszik and co-workers
6
, a commercial application demonstrating successful 
self-healing is really needed. The intensive collaboration in Flanders between the academic 
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partners and companies interested in the field, within the framework of the Strategic Initiative 
Materials (SIM), could continue to aid in the transfer to industry. 
Secondly, both the thiol-isocyanate and thiol-maleimide chemistry would be most 
suited for self-healing of polymeric materials damaged by impact or fatigue, since a high 
reaction rate is crucial to slow down or stop the fatigue crack from propagating through 
hydrodynamic action and reactive crosslinking. Because the reaction rate is higher than 
existing systems, it might even be possible to go to higher efficiencies in the high energy 
impact and stress intensity ranges. Moreover, the thiol-isocyanate combination is also capable 
of repairing vinyl ester and unsaturated polyester thermosets (Chapter 3), allowing for 
expansion of the system to those and potentially other polymeric materials as well. Based on 
the preliminary attempts to make a fiber-reinforced composite, this material class should also 
not be excluded. 
Finally, self-healing is on the rise in the recovery of other than mechanical functions. 
The recovery of barrier properties
7, 8
, hydrophobicity
9, 10
 and conductivity
11, 12
 has already 
been demonstrated. Self-healing of corrosion resistance was already performed with 
isocyanates
13
 and our improved microcapsules could aid in generating an even more stable, 
self-healing coating system. If the microcapsule diameter can be reduced to µm sizes suitable 
for common coatings, the implementation should be straightforward. 
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Chapter 8 
Nederlandstalige samenvatting 
 
8.1 Algemene introductie 
Het principe van zelfherstel bestaat reeds sinds het begin der tijden. Levende 
organismen, zoals het menselijk lichaam, overleven voor langere tijd door hun ingebouwde 
eigenschap te kunnen herstellen van schade, zoals beenfracturen of spierscheuren. Meestal 
gebeurt dit schadebeheer
1
 zelfs zonder menselijke tussenkomst, terwijl in sommige gevallen 
een helpende hand nodig is om het herstelproces te bespoedigen, bijvoorbeeld door spalken of 
steunverbanden aan te brengen. 
In de ontwikkeling van materialen daarentegen is het voorkomen van schade de 
belangrijkste drijfveer.
1, 2
 Om schade evenementen, die onvermijdelijk zullen voorkomen in 
de levensduur van een materiaal, uit te stellen, worden materialen in toenemende mate 
versterkt en vaak buiten proportie ontworpen voor hun specifieke taak. Dit leidt echter tot 
excessief materiaalgebruik tijdens de productie, terwijl inspectie en onderhoud van het 
eindproduct nog steeds nodig is op regelmatig basis. 
Deze problemen kunnen vermeden worden door een materiaal zodanig te ontwerpen 
dat het in staat is om zijn oorspronkelijke eigenschappen via een ingebouwd 
reparatiemechanisme te herwinnen. Dit resulteert in een betrouwbaarder materiaal met een 
langere levensduur
1, 3, 4
, dat bovendien ook onzichtbare, inwendige schade kan herstellen
4, 5
. 
Dit zelfherstel kan in materialen enerzijds verwezenlijkt worden door de chemische 
eigenheid van het materiaal zelf (intrinsiek) of anderzijds door het toevoegen van 
herstelreagentia in het materiaal dat hersteld dient te worden (extrinsiek).
5
 Intrinsiek 
zelfherstellende concepten zijn voornamelijk gebaseerd op het gebruik van reversibele, 
fysische of chemische verbindingen en worden meestal toegepast in thermoplastische 
polymeermaterialen, omdat deze over voldoende moleculaire mobiliteit beschikken.
5, 6
 
Extrinsiek zelfherstellende concepten worden daarentegen vooral in thermohardende 
polymeermaterialen toegepast en maken gebruik van faseseparatie
7
 of verschillende soorten 
containers – microcapsules8, microvasculaire kanalen9 of holle glasvezels10 – voor het 
toevoegen van de externe herstelreagentia. Dit zelfherstel gebeurt ofwel volledig autonoom, 
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ofwel is er een externe stimulus, zoals warmte of UV-licht, noodzakelijk om het herstelproces 
op te starten of te versnellen. Wanneer een dergelijke stimulus nodig is, worden deze 
materialen als niet-autonoom en herstelbaar bestempeld. Warmte is bijvoorbeeld vaak vereist 
in intrinsiek zelfherstellende systemen.
5, 11
 
In dit werk wordt een autonome, extrinsieke duo-microcapsule aanpak gebruikt. 
Hierbij wordt een twee-componenten lijm geïncorporeerd in containers op microschaal en als 
dusdanig ingebed in een vast matrix materiaal. Een driestapsmechanisme is verantwoordelijk 
voor het zelfherstellend proces (Figuur 8.1): 1) openbreken van de microcapsules, 2) het 
opvullen van de barst met vloeibare herstelreagentia en 3) uitharding van het reactieve 
mengsel. 
 
 
 
Figuur 8.1. Het concept van duo-microcapsule zelfherstel. Boven: een barst breekt de microcapsules die 
een vloeibaar herstelreagens bevatten; midden: de herstelreagentia vullen de barst o.i.v. capillaire 
krachten; onder: de herstelreagentia reageren met elkaar, waarbij een vast polymeernetwerk gevormd 
wordt dat beide breukvlakken terug aan elkaar lijmt. 
 
8.2 Overzicht 
Dit doctoraatsproefschrift omvat 4 grote onderdelen: de state of the art (Hoofdstuk 2), 
de evaluatie van chemieën voor zelfherstel d.m.v. manuele injectie (Hoofdstuk 3 en 4), de 
incapsulatie van geschikte herstelreagentia (Hoofdstuk 5) en de ontwikkeling van autonoom 
en extrinsiek zelfherstellende materialen (Hoofdstuk 6). 
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Hoofdstuk 2 heeft als doel zowel nieuwe onderzoekers als gevestigde waarden in het 
onderzoeksgebied van zelfherstel te gidsen door een duidelijk overzicht te bieden van de 
meest belangrijke chemieën tot heden gebruikt in autonome, extrinsieke systemen, samen met 
hun herstellend potentieel voor verschillende matrixmaterialen en types van mechanische 
schade. Een breed spectrum van recente ontwikkelingen wordt besproken, waarbij de sterktes 
en zwaktes aangeduid worden. Een poging werd ook ondernomen om de 
onderzoeksopportuniteiten aan te geven voor elk beschreven systeem en om de domeinen te 
traceren die verder onderzoek vergen. 
In Hoofdstuk 3 wordt een thiol-isocyanaat chemie onderzocht voor de ontwikkeling 
van extrinsiek zelfherstellende epoxy materialen. In eerste instantie is het mogelijk om 
verscheidene thiol en isocyanaat herstelreagentia te selecteren die thermisch stabiel zijn in 
industrieel gebruikte epoxy uithardingscondities, een lage toxiciteit bezitten en niettemin als 
adhesief twee epoxy platen voldoende aan elkaar kunnen hechten. In tweede instantie wordt 
gedemonstreerd dat amine groepen aanwezig in de epoxy matrix zowel kunnen dienen als 
katalysator voor de additie reactie tussen een thiol en een isocyanaat en als middel om het 
nieuw gevormd polymeernetwerk covalent te linken aan de omliggende thermoharder. De 
“tapered double cantilever beam” (TDCB) geometrie wordt gebruikt om het herstel van de 
breuktaaiheid bij kamertemperatuur en na verschillende hersteltijden te evalueren. Het effect 
van temperatuur en het gebruik van andere matrices (vinyl ester en onverzadigd polyester) 
wordt ook onderzocht, waarbij het katalytisch effect van de kobalt initiator aangetoond wordt. 
In Hoofdstuk 4 wordt de maleïmide chemie, waarbij amines en thiolen als nucleofielen 
optreden, geëvalueerd voor het ontwerpen van extrinsiek zelfherstellende epoxy materialen. 
Modelreacties tonen aan dat amines snel reageren met maleïmide componenten bij 
kamertemperatuur via de Michael additie reactie. Verder reageren thiolen en maleïmiden vlot 
in de aanwezigheid van tertiaire amines die beschikbaar zijn in het epoxy materiaal. De 
oplosbaarheid van zowel commerciële, aromatische en gesynthetiseerde, alifatische 
maleïmiden wordt onderzocht in combinatie met hun zelfherstellend potentieel. 
Herstelefficiënties en het solventeffect worden geëvalueerd d.m.v. de TDCB testmethode met 
manuele injectie van de herstelreagentia. 
Hoofdstuk 5 rapporteert de micro-incapsulatie procedures ontwikkeld in onze groep. 
De incapsulatie van een tetrafunctioneel thiol en verschillende maleïmiden wordt uitgevoerd 
d.m.v. een polycondensatie reactie van melamine-formaldehyde. Het isocyanaat daarentegen 
wordt ingebed in polyurea microcapsules die gevormd worden via een grensvlakreactie van 
aromatische isocyanaten en amines. De kernhoeveelheid, grootte en schaal morfologie van de 
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microcapsules werd geëvalueerd, waarbij grote verschillen werden opgemerkt bij de twee 
incapsulatiemethoden. De polyurea schaal werd ook gemodificeerd met met verschillende 
hydrofobe agentia om de waterdoorlaatbaarheid te verlagen.  
In Hoofdstuk 6 worden autonoom extrinsiek zelfherstellende epoxy materialen 
gegenereerd d.m.v. de duo-microcapsule strategie met de thiol-isocyanaat en thiol-maleïmide 
chemieën, nieuw in het onderzoeksgebied van zelfherstel. De TDCB geometrie wordt 
opnieuw gebruikt voor de evaluatie van het herstel van de breuktaaiheid bij kamertemperatuur 
na vijf dagen. Zowel de ruimtelijke verdeling en het breukgedrag van de microcapsules als de 
vloei van de herstelreagentia in de barst wordt onderzocht. Bovendien worden parameters 
zoals het gewicht aan en de kernhoeveelheid van de microcapsules geëvalueerd voor de thiol-
isocyanaat combinatie, terwijl de invloed van de microcapsule verhouding en het 
solventeffect wordt nagegaan voor de thiol-maleïmide chemie. Tenslotte werd ook een eerste 
poging ondernomen om een glasvezelversterkt polymeercomposiet te genereren. 
 
8.3 Besluit 
Het doel van dit project was het ontwikkelen van een autonoom extrinsiek 
zelfherstellend systeem met een verhoogde stabiliteit en verbeterde kinetiek t.o.v. bestaande 
concepten, waarbij rekening gehouden wordt met industriële voorwaarden zoals toxiciteit, 
opschaalbaarheid en kostprijs. 
In dit project waren we in staat om twee zelfherstellende epoxy systemen te 
ontwikkelen die aan de meeste industriële voorwaarden voldoen. In het thiol-isocyanaat 
concept werden twee beschikbare herstelreagentia gebruikt – pentaerythritol tetrakis(3-
mercaptopropionaat) (TetraThiol) en hexamethyleen diisocyanaat isocyanuraat trimeer (HDI3) 
– met zowel een relatief lage toxiciteit en kostprijs als een goede stabiliteit op de lange 
termijn. Beide componenten werden bijvoorbeeld al toegepast in industriële deklagen.
12, 13
  
Wanneer zowel TetraThiol- als HDI3-bevattende microcapsules ingebed worden in 
bulk epoxy materiaal (Figuur 8.2), wordt een herstelefficiëntie van meer dan 50% verkregen 
(Hoofdstuk 6). Deze lagere waarde, in vergelijking met manuele injectie van de 
herstelreagentia (> 100%), wordt toegewezen aan een beperkte vrijgave en vloei van HDI3 in 
de barst. Verder werd een toename in originele breuktaaiheid van het epoxy materiaal 
vastgesteld met een stijgende hoeveelheid microcapsules. 
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Figuur 8.2. Finaal zelfherstellend epoxy product, gebaseerd op een duo-microcapsule thiol-isocyanaat 
strategie. Het zelfherstel werd gevisualiseerd op: https://www.youtube.com/watch?v=sXuU9XrxEOk.  
 
In het thiol-maleïmide concept werd TetraThiol opnieuw gebruikt, maar in combinatie 
met beschikbare aromatische of gesynthetiseerde alifatische maleïmiden als tweede 
herstelreagens. De aromatische componenten hebben ook een relatief lage toxiciteit, kost en 
een goede langetermijnsstabiliteit. De alifatische maleïmiden op hun beurt werden gemaakt 
van amine precursors via een eenvoudige en opschaalbare synthesestrategie die hun 
beschikbaarheid verzekert (Hoofdstuk 4). Aangezien de meeste maleïmiden vaste stoffen zijn, 
werden deze opgelost in hoogkokende solventen in bijna verzadigingsconcentraties. Ook in 
dit geval werd een herstelefficiëntie van meer dan 100% bereikt met manuele injectie, terwijl 
30 tot 50% herstel werd vastgesteld bij gebruik van microcapsules (Hoofdstuk 6). De beste 
resultaten werden gehaald met het vloeibare, alifatische Jeffamine T-403 trismaleïmide 
(JTM). Ook hier werd de lagere waarde bij autonoom herstel toegewezen aan een beperkte 
vloei van het maleïmide in de barst en werd een hogere breuktaaiheid voor het epoxymateriaal 
vastgesteld. 
Hoewel er nog verbetering mogelijk is met betrekking tot het herstel van rigide 
polymeermatrices, zijn het thiol-maleïmide systeem en vooral het thiol-isocyanaat systeem 
zeker degelijke kandidaten voor industriële toepassingen. Bovendien zijn beide concepten 
nieuw in het onderzoeksveld van zelfherstel en werden nu reeds enkele nadelen van bestaande 
systemen weggewerkt. Dit toont aan dat deze systemen potentieel hebben om te groeien in 
een gevestigde positie binnen het domein van de autonoom extrinsiek zelfherstellende 
thermoharders en polymeercomposieten. 
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8.4 Vooruitblik 
Zoals hierboven reeds aangegeven, zijn er zowel voor het thiol-isocyanaat als voor het 
thiol-maleimide concept voldoende opportuniteiten om hun gebruik in thermoharders en 
polymeercomposieten uit te breiden. Ten eerste, als de vloei van de HDI3 of JTM kern in de 
barst verbeterd kan worden, kan een sterke toename in herstelefficiëntie verwacht worden. 
Een mogelijke oplossing zou kunnen gevonden worden in het mengen van verscheidene 
reactieve agentia, zoals HDI3 met lager viskeuze trifunctionele isocyanaten of JTM met 
lineaire, Jeffamine-gebaseerde bismaleïmiden, en het incorporeren van deze mengsels in 
dezelfde microcapsules. Indien industriële voorwaarden voortdurend in het achterhoofd 
worden gehouden, zou dit kunnen leiden tot een toename in industriële haalbaarheid. 
Ten tweede worden de snelle thiol-isocyanaat en thiol-maleimide chemieën uitermate 
geschikt geacht voor het zelfherstel van polymeermaterialen die schade ondervinden door 
impact of vermoeiing, aangezien een hoge reactiesnelheid cruciaal is om het groeien van de 
barst te vertragen of stoppen. Omdat de reactiesnelheid bovendien een stuk hoger ligt dan de 
bestaande herstelsystemen, zou het zelfs mogelijk kunnen zijn om hogere herstelefficiënties te 
halen in het gebied van de hoge impactsenergie en belastingsintensiteit. Verder is de thiol-
isocyanaat combinatie ook in staat om vinyl ester en onverzadigde polyester thermoharders te 
herstellen (Hoofdstuk 3), waardoor uitbreiding van het concept naar deze en mogelijks andere 
polymeermaterialen een optie wordt. Op basis van de eerste poging om een glasvezelversterkt 
composietmateriaal te synthetiseren, zou deze materiaalklasse ook niet over het hoofd gezien 
mogen worden.  
En als laatste optie dient ook het zelfherstel van andere dan mechanische functies 
overwogen te worden. Het herstel van barrière-eigenschappen
14, 15
, hydrofobiciteit
16, 17
 en 
geleidbaarheid
18, 19
 werd reeds eerder gedemonstreerd. Zo werd zelfherstel van corrosie 
resistentie al aangetoond met isocyanaten
20
 en zouden onze verbeterde microcapsules kunnen 
leiden tot een nog meer stabiel, zelfherstellend deklaagsysteem. Indien de microcapsule 
diameter gereduceerd kan worden tot µm groottes die geschikt zijn voor gangbare deklagen, 
zou de implementatie ervan voor de hand liggend moeten zijn.  
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Chapter 9 
Appendix 
 
9.1 Thiol-isocyanate chemistry 
9.1.1 Proton NMR & LC-MS TetraThiol 
1
H NMR and LC-MS measurements of TetraThiol were performed after 2 years to 
check the stability of the thiol functionality. The 
1
H NMR spectrum (Figure 9.1) remained 
unchanged and no disulfide formation was observed. The combined signals a and a* integrate 
for 8 protons. 
 
 
 
Figure 9.1. 1H NMR spectrum of TetraThiol (300 MHz, CDCl3).  
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In the LC chromatogram, 1 major peak at a retention time of 6.38 min and 2 minor 
peaks at retention times 5.59 min and 6.64 min were observed. Mass spectrometry (MS) with 
electrospray ionization (ESI) confirmed that the major peak was TetraThiol with signals at 
m/z = 506 Da (TetraThiol with NH4
+
) and 489 Da (TetraThiol with H
+
). The minor peaks 
might be related to hydrolysis of the ester bond, resulting in the loss of 3-mercaptopropionic 
acid (peak at 5.59 min) and further reaction of TetraThiol with 3-mercaptopropionic acid 
(peak at 6.64 min). No large TetraThiol dimers due to disulfide formation were observed. 
 
9.2 Thiol-maleimide chemistry 
9.2.1 TGA of aliphatic maleimides 
The TGA spectra of DBM, JTM, TMBM and SBM show a good stability at epoxy 
curing temperatures (Figure 9.2). The mass loss at 140 °C is related to residual acetic 
anhydride from the synthesis procedure. The 5 wt% mass loss temperatures of DBM, JTM, 
TMBM and SBM are found at 242, 160, 182 and 256 °C respectively. 
0 200 400 600 800
0
20
40
60
80
100
S
a
m
p
le
 w
e
ig
h
t 
(%
)
Temperature (°C)
 DBM
 JTM
 TMBM
 SBM
 
 
Figure 9.2. TGA thermograms under nitrogen of 1,12-dodecane bismaleimide (DBM), Jeffamine T-403 
trismaleimide (JTM), trimethylhexane-based bismaleimide (TMBM) and succinic acid-based 
bismaleimide (SBM). 
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9.3 Thiol-bromo & thiol-vinyl sulfone 
9.3.1 Tested chemistries 
The thiol-bromo and thiol-vinylsulfone combinations were also screened, but rendered 
insufficient adhesion in the qualitative plate tests. Screening was done by combining two 
bromo-compounds (Scheme 9.1) or divinylsulfone with TetraThiol in a 1:1 functional group 
ratio. In the case of the thiol-bromo reaction, one equivalent of a tertiary amine base 
(N,N,N′,N′,N′′-pentamethyldiethylenetriamine) was required for the reaction to proceed 
properly. Salt formation between the amine and the released bromide anion most likely 
caused the lack of adhesion. When the thiol-vinylsulfone combination was tested, no 
additional tertiary amine catalyst was added. If this thiol-vinylsulfone reaction would be 
reconsidered, it might be necessary to add a catalyst to ensure a sufficiently high reaction rate. 
No further optimization of these reactions was performed. 
 
 
 
Scheme 9.1. Dimethyl 2,6-dibromoheptanedioate and 2,4-dibromo-3-pentanone. 
 
9.4 Encapsulation of healing agents 
9.4.1 Proton NMR of the maleimide core 
1
H NMR spectra of the liquid maleimide core, obtained from the microcapsules via 
Soxhlet extraction with acetone for at least one day, were taken to verify the presence of 
maleimide and also to analyze the solvent-maleimide ratio. An NMR spectrum of the 
Jeffamine T-403 trismaleimide (JTM) core mixed in a 1:2 weight ratio with methyl benzoate 
(MB) after evaporation of the extracting solvent is shown in Figure 9.3. 
 
Chapter 9 – Appendix 
210 
 
 
 
Figure 9.3. 
1
H NMR spectrum of the 1:2 weight ratio JTM-MB core (300 MHz, CDCl3) obtained via 
Soxhlet extraction with acetone after evaporation of the extracting solvent. 
 
9.4.1 Core content as a function of time during the encapsulation of isocyanates 
It has to be noted that the core content of the HDI3-containing microcapsules during 
synthesis is reduced with longer reaction times as a result of water diffusing through the shell 
wall and reacting with the isocyanate core. As such, the shell wall kept growing in thickness, 
while the core volume was decreasing. This can be seen by allowing the mixture to react 5 
min longer than the optimal heating time (OHT) (Table 9.1). The core content was also 
analyzed after one month of aging at room temperature and exposed to air (ambient 
conditions). 
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Table 9.1. Optimal heating time (OHT) and isocyanate core content as a function of the heating time 
during the encapsulation of HDI3. The optimal heating time is defined as the shortest reaction time to give 
well-dispersed and stable microcapsules. The core content was determined using online FT-IR 
spectroscopy. 
 
   Core content (%) 
# Shell modification OHT (min) at OHT at OHT + 5 min After 1 month aging * 
1 non-functionalized 20 49 30 15 
2 2-ethylhexylamine 20 67 51 62 
3 3,4-difluorobenzylamine 15 73 62 68 
4 hexamethyldisilazane 10 83 62 66 
* Aging at room temperature and exposed to air. 
 
9.5 Additional SEM & CT images 
9.5.1 Empty TetraThiol-containing MF microcapsules 
 
 
Figure 9.4. Broken and emptied TetraThiol-containing MF microcapsules. 
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9.5.2 Flow of healing agents in the crack 
 
 
Figure 9.5. Two CT slices of a fractured cylindrical epoxy sample with TetraThiol-containing MF 
microcapsules showing flow of the healing agent into the crack. A zoom section is provided for clarity. 
 
 
 
Figure 9.6. Flow of HDI3 from polyurea microcapsules. 
 
9.5.3 Modelling flow of healing agents 
The contact angle of the different healing agents on the epoxy surfaces was measured 
because the flow of the healing agents into the crack plays a key role in the effectiveness of 
the self-healing process. The results are shown in Table 9.2. These contact angle values were 
also used for modelling the flow into the crack (blue) from a single microcapsule (red) 
(Figure 9.7). According to the model, only healing agents with a contact angle lower than 90° 
could readily flow out of the microcapsule under the influence of capillary forces. 
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Table 9.2. Contact angles of TetraThiol, HDI, HDI3 and JTM-MB in a 1:2 weight ratio on both EPON 828 
and RIM 135 smooth surface epoxy plates. Every value is an average of at least three measurements. 
 
  Contact angle (°) 
Healing agent * Matrix After 10 s After 20 s After 30 s 
HDI EPON 828 44 40 39 
 RIM 135 63 62 62 
HDI3 EPON 828 89 88 88 
 RIM 135 91 90 90 
TetraThiol EPON 828 95 94 94 
 RIM 135 95 95 95 
TetraThiol-MB (9:1) EPON 828 81 81 81 
JTM-MB (1:2) EPON 828 101 90 84 
* The healing agent ratio in between brackets is expressed in weight percent. 
 
 
 
Figure 9.7. The model used for the evaluation of flow of the healing agents from a single microcapsule 
(red) into the crack (blue). 
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